¥xÆW©`¦Ì¬ì§Þ·s»D«H, Vol. III, No. 9, 9/1/2004
Chief Editor: Dr. Sinclair T. Wang, CEO, TAINANO, Inc.

TNN²Ä¤T¨÷ ²Ä¤E´Á ºõ¥Ø


©`¦Ì¤H¤å¬Fªv©Mªk³W

//   ©`¦Ì¬ã¨s§ë¸ê±N¹F$86»õ¨pÀç©ú¦~¶W¤½¦@¾÷ºc  /  ­^°ê¬ì¾Ç®a«ØÄ³³W½d©MÀËÅç©`¦Ì産«~  /
/  ©`¦Ì¬ì¾Ç»P©`¦Ì¬ì§Þªº¾÷·|»P¤£½T©w©Ê  /  ©`¦Ì¶î®Æ«æ¬ß¼Ð·Ç¯Â¼ä¥«³õ  /
/ 
¥xÆW©_¬ü±N«Ø¥ß¨p¦³¤u·~¶é°Ï  /  ¦³«Ý©`¦Ì¬ì§Þ¬ãµo¨Ó¸Ñ¨M¥þ²y¯à·½¦M¾÷  //

©`¦Ì§÷®Æ¬ì§Þ

//  ¾×¦í¼ö¦Ó¥uÅý¥ú½u³q¹Lªº¬Á¼þ¶î¼h  /   ¥ÎRNA¨Ó·í¥¼¨Ó«Øºc©`¦Ì¾÷¾¹ªº©`¦ÌÆN¬[  /
/  ¥Î¼ö³B²z¨Ó½Õ¸`©`¦Ì·L´¹²Õ¸ËÅ骺¾É¹q©Ê  /  ¼w°ê
BYK¡XCHEMIE±À¥X¨âºØ¶ì½¦¥[¤u¥Îªº©`¦Ì²£«~  //

©`¦Ì´¹¤ù¤Î©`¦Ì¹q¤l¾÷¹q¨t²Î¬ì§Þ

//   ¥ú¤l¥æ´«§Þ³N¦³±æ¹ê²{ ¤Wºô³t«×´£¤É¦Ê­¿  /   ¥ú¤l´¹Åé¥i¥H¥Î¨Ó±±¨î¶q¤lÂIµo¥úªº®É¶¡  /
/  ·L¾÷¹q¬ì¾Ç®a§¹¦¨¤F­ì¤lÄÁªºÅ±³y  /  BIOPHAN
¤½¥q©MNASA¦X§@¶}µo¥i¥H´Ó¤J¤HÅ骺©`¦Ìµo¹q¾÷¨t²Î  //

©`¦ÌºÞ, ©`¦ÌŽ, ©`¦ÌÅÖºû©M©`¦Ì²yªº¶i®i

//   ¤é¥»¬ì¾Ç®a»s¦¨·s«¬Âù¼h©`¦ÌºÞ¨ã¦³­@°ª·Å¯SÂI  /  ©`¦Ì½u¤Æ¾Ç·PÀ³¾¹  /
/  §Q¥Î©`¦Ìµ²¨Ó¾É¤Þ¥ú½u  /  ½¬ªá®ÄÀ³¨Ï±o¥ú¥i¥H²¾°Ê¤ô¯]  /
/  ±±¨î©`¦Ì½u¦¨ªøªº¤è¦V 
//

©`¦ÌÂå¾Ç©M©`¦Ì¥Íª«Àô¹Ò¬ì§Þ

//   °ê»Ú°Ó¥Î¾÷¾¹¤½¥q¬ãµo©`¦Ì¦¨¹³§Þ³N¨ú±o¬ð¯}  /   ¥H³J¥Õ½è¬°¬[ºcªºÂù¦V©`¦Ì­P°Ê¾¹  /
/  ­ì¤l¤OÅã·LÃè±´°w¦yºÝ¤Wªº§ÜÅé  /  §Q¥Î¿Ã¤õÂΪº¿Ã¥ú»Ã¯À¨ÓÅã¥Ü¥Íª«¤¤³J¥Õ½èªº¹B°Ê  /
/  ¬ì¾Ç®aµo²{¦Û³¬¯g©ó¥Íª«¾Ç¤Wªº¦¨¦]  /  ¶Pº¸»X¨Ï¥À¿ËÅ@¤lµLÄß  /
/  Åöíw»P¹[Â÷¤l³q¹DªºÃö«Y  /  °ò¦]¬ðÅܬOªü´þ®üÀq¯gªº¥D¦]  /
/  ¦p¦ó§Î¦¨¬V¦âÅ骺»E¦Xµ²ºc  /  ¤T¤d¤T¦Ê¸U¦~«e´Nºt¤Æ¥X¨Óªº§Ü·R´þ³J¥Õ  /
/  ÁA¸Ñ§Ü·R´þ¯f³J¥Õ½è
APOBEC³J¥Õ  /  ªvÀø¥Õ¦å¯fªº¬ã¨s¥X²{­«¤j¬ð¯}  /
/  ¥Îª«²z­«¤O¼Ò«¬¨Ó¹w´ú¯f¬r©Ê¯e¯fªº¶Ç¼½  /  ·P«_¶K¤ù¥i¥H¬@±Ï³\¦h¦Ñ¤H  /
/ 
Cambrios¥H¥Íª«§Þ³N»s³y©`¦Ì¤¸¥ó  /  ¥¿­tÁLÂ÷¤l§Þ³N¥i·À¬¡99.7%ªº©I§l¾¹©x¯f¬r  /
/  ¹q¸Ñ¤ô©M¹q¸ÑÃú¥i°£µß¡B°£¯ä¡B§Ü¹L±Ó­ì  //

©`¦Ì·s§Þ³N©M·s²£«~

//   ©`¦ÌªA¸Ë¤£¥Î¬~ ©_§®ªA¸Ë¤µ¤Ñ¦³¬ù  /  ĵ¹î¦³±æ¬ï¤W©`¦Ì¨¾«B¨îªA  /
/   ¥H¥þ¹³§Þ³N¬ã§Pµ§¸ñ¯u°°  /  µL³zÃ誺Ánªi»EµJ§Þ³N  //

·i§g¤@Ū¶µ¥Ø

//   ®æºô¹q¸£¨t²Î¥¢®Ä¼Ò¦¡  /  ¬ì¾Ç´Á¥Z¥Xª©¬É§¹¥þ§K¶OªºÂ૬´Á  /
/  ¬ì¾Ç®aµo²{ÀH¾÷¹p®g  /  ¬ì¾Ç®aµo²{»y¨¥·|¶ì³y«ä·Q  /
/  ª¼¤Hťı¸û±Ó¾Uªº¬ì¾Ç¤ÀªR  /  ¾Ç­µ¼Öªº¤p«Ä·|§óÁo©ú  /
/  ¤HÃþªº¹Ø©R¶V¨Ó¶Vªø  / 
¨È¬w¬×¤Wªº¤Ï¤é±¡ºü»P¾H¤p¥­ªº¥ý´I²z½×  /
/  ¦L«×¸gÀÙ¶}©l°_­¸¡Aµo®i¼ç¤O¶W¹L¤¤°ê  /  ¦Û¦¨­·®æ¡Bµo®i¨³²rªº¤¤°ê³]­p¬É 
//

 

©`¦Ì¤H¤å¬Fªv©Mªk³W:

©`¦Ì¬ã¨s§ë¸ê±N¹F$86»õ ¨pÀç©ú¦~¶W¤½¦@¾÷ºc

8/17/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A2004¦~±N¦b©`¦Ì§Þ³Nªº¬ãµo¤W§ë¤J¬ù86»õ¬ü¤¸¡A¨ä¤¤¨Ó¦Û¨pÀç»â°ìªº§ë¸ê¥¿¦b¤£Â_¼Wªø¡C
¾Ú­P¤O©ó©`¦Ì¦æ·~¬ã¨sªº¿Ô¸ß¼t°ÓLux ¸ê°T¤½¥qµo§Gªº¤@¥÷¦~«×³ø§iºÙ¡A¤µ¦~¡A¥þ²y©`¦Ì¬ãµo§ë¸ê±N¤ñ¥h¦~ªº30»õ¬ü¤¸Â½¤@µfÁÙ¦h¡C

¥Ø«e¡A¬ù¦³¥]¬A­^¥Nº¸¡B³q¥Î¹q®ðµ¥¥¨Æs¦b¤ºªº¬ù1500®a¤½¥q¦b¬ã¨s©`¦Ì§Þ³N¡CLux ¸ê°T¤½¥qªººÞ²z¥DºÞ°¨§Jªí¥Ü¡A§Ú­Ì¹w­p¤µ¦~±N¬O¬F©²¦b©`¦Ì¬ã¨s¤è­±ªº§ë¸ê¶W¹L¥ø·~ªº³Ì«á¤@¦~¡A¤GªÌªº§ë¸êª÷ÃB¤À§O爲46»õ©M38»õ¬ü¤¸¡C ¾¨ºÞ¦p¦¹¡A§ë¸êªÌ¤´µM«D±`ÂÔ·V¡C¤µ¦~§ë¦V©`¦Ì·s³Ð¥ø·~ªº§ë¸ê±N¥Ñ2002¦~ªº3.86»õ¬ü¤¸¡B2003¦~ªº3.25»õ¬ü¤¸¤U·Æ¨ì2 »õ¬ü¤¸¡A³Ìªñ¡A©`¦Ì·s³Ð¥ø·~¤¤ªºÂ¼·¡--¦~¾P°âÃB300 ¸U¬ü¤¸ªºNanosys ¤½¥q³Ìªñ©ñ±ó¤FIPO ¡A¤j¦h¼Æªº©`¦Ì¬ãµo¸êª÷³£¨Ó¦Û¤j¥ø·~¡C°¨§J»¡¡A22% ªº­·ÀI§ë¸ê³£§ë¦V¤F5 ®a¤½¥q--Nanosys ¡BQuantum ¡BMolecular Imprints¡BFrontier Carbon and Catalytic Solutions.³Q¦¬ÁʱN¬O³\¦h·s³Ð¥ø·~ªº©R¹B¡C
³ø§iÅã¥Ü¡A«ö§ë¸êª÷ÃB­pºâ¡A¬ü°ê¬O³Ì¤jªº©`¦Ì°ê®a¡C¬ü°êÁp¨¹¬F©²©M¦U¦a¬F©²±N¦b©`¦Ì¬ã¨s¤è­±§ë¤J16»õ¬ü¤¸¡A¬ù¥e¥þ²y¤½¦@¾÷ºc¦b©`¦Ì»â°ì§ë¸êªº35% ¡F¨È¬w©M¼Ú¬wªº§ë¸êÃB¤À§O¬O16»õ¬ü¤¸©M13»õ¬ü¤¸¡C

¬ü°êªº¤½¥q¦b©`¦Ì¬ã¨s¤W±N§ë¤J17»õ¬ü¤¸¡A¬ù¥e¥þ²y¨pÀç¾÷ºc38»õ¬ü¤¸§ë¸êªº46% ¡A¨È¬w©M¼Ú¬wªº³o¤G­Ó¼Æ¦ì¤À§O爲14»õ¬ü¤¸¡B36% ©M6.5 »õ¬ü¤¸¡B17%.¦b¦Û1976¦~¥H¨Ó±Â¤©ªº»P©`¦Ì§Þ³N¬ÛÃöªº88546 ¶µ§Þ³N±M§Q¤¤¡A¦³64% ¬O¥Ñ¬ü°ê±M§Q°Ó¼Ð¸p±Â¤©ªº¡C

­^°ê¬ì¾Ç®a«ØÄ³³W½d©MÀËÅç©`¦Ì産«~

8/2/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A­^°ê¬Ó®a¾Ç·|©M¬Ó®a¤uµ{¬ì¾Ç°|29¤éµo§G½Õ¬d³ø§i»¡¡A¬F©²À³·í¹ï©`¦Ì§Þ³N産«~¶i¦æ¦w¥þ®Ö¹ïÁ`©M³W½d¡A§â©`¦Ì産«~¹ï¤HÅé°·±d©MÀô¹Òªº¼ç¦b¦M®`­°¨ì³Ì§C­­«×¡C ©`¦Ì§Þ³N«üªº¬O¹ï¤j¤p¦b100©`¦Ì¥H¤Uªºª«½è¶i¦æ¾Þ§@¡A§Q¥Î¤Fª«½è¦b³o¤@¤Ø«×¤Wªí²{¥Xªº¿W¯S©Ê½è¡C©`¦Ì§Þ³N¨ä¹ê¦b¼Æ¤Q¦~«e´N¤w¦s¦b¡A¦ý©`¦Ì§Þ³N産«~ªñ¨Ç¦~¤~¶}©l¨B¤J¥«³õ¡C³¡¤À¹q¸£´¹¤ù¡B¨¾½Kªº¿Ç¤l¡BDVD¼½©ñ¾÷¡B¦Û¼ä¬Á¼þ¡B¨¾ÅÎÁ÷¤¤ªº¾B¥ú¾¯µ¥産«~¡A³£¬OÀ³¥Î©`¦Ì§Þ³Nªº¹ê¨Ò¡C

³o¶µ½Õ¬d¬O­^°ê¬F©²¦b¥h¦~©e°U­^°ê¬Ó®a¾Ç·|©M¬Ó®a¤uµ{¬ì¾Ç°|Áp¦X¶i¦æªº¡A¦®¦b©ú½T©`¦Ì§Þ³Nµo®iÀ³¥Îªº²{ª¬©M«e´º¡C³ø§i»¡¡A¥Ñ©ó¨T¨®§À®ð±Æ©ñ©M¯à·½®ø¯Ó¡A¦ÛµM¥Í¦¨ªº©`¦Ì·L²É¤w¦bªÅ®ð¤¤¦s¦b¦h®É¡C¥Ø«eªº°ÝÃD¬O¡A¤H­Ì¤£²M·¡¤H³y©`¦Ì·L²É¤Î©`¦ÌºÞ³Q¤HÅé§l¤J¡B³q¹L¥Ö½§§l¦¬¤Î¦bÀô¹Ò¤¤»W¿n¡A·|µ¹¤HÅé°·±d©MÀô¹Ò±a¨Ó¤°麽¦M®`¡C¦¹«e´¿¦³¬ã¨sÅã¥Ü¡A¤@¨Ç¤H³y©`¦Ì·L²É¬r©Ê­n¤j©ó©M¥¦¦PÄݤ@Ãþª«½èªº¸û¤jÁû²É¡C

½Õ¬d²Õ­t³d¤H¦w¡P¹DªL»¡¡G¡§¦PºØª«½èªº©`¦Ì¯Å·L²É©M´¶³qÁû²É¡A¨ä©Ê½è¦b«Ü¦h¤è­±³£¤£¦P¡A§Ú­ÌÀ³¹ï¨ä¥¿­±©M­t­±§@¥Î³£¦³©ÒÁA¸Ñ¡C¡¨¥L»¡¡A¥Ø«e¹ï©`¦Ì産«~ªººÊ±±ÁÙ¬O¤@¤ùªÅ¥Õ¡AÀ³·í¦b§â¥¼¨Óªº¤£½T©w©Ê©M­·ÀI©Ê­°¨ì³Ì§Cªº±¡ªp¤U¡A³v¨Bµo´§©`¦Ì§Þ³NªºÀ³¥Î¼ç¤O¡C ³ø§i«ØÄ³¡A¼Ú·ù©M­^°êÀ³·í¥ßªk±N©`¦Ì·L²É©M©`¦ÌºÞ¦C爲¡§·s«¬¤Æ¾Çª«½è¡¨¡A¥H«P¶i¬ÛÀ³¦w¥þ©Ê´ú¸Õ©M©úÅã¼Ð¥Üªº¹ê¬I¡C¦¹¥~¡A¬F©²ÁÙÀ³¦¨¥ß¿W¥ßªº¬ì¾Ç¦w¥þ©e­û·|¡A¹ï¯A¤Î¨ì´¶³q¦Ê©mªº©`¦Ì§Þ³N産«~¶i¦æÀË´ú¡AÃÒ©ú¹ï¤HÅéµL®`«á¤è¥i¶i¤J¥«³õ¡A¦p¨¾ÅÎÁ÷¤¤¤G®ñ¤ÆÜg©`¦Ì·L²Éªº¨Ï¥Î¡C³ø§iÁÙ«ØÄ³¡A©`¦Ì§Þ³N¬ÛÃö産·~À³¥X»O²Î¤@ªº¦w¥þÀËÅç²Ó«h¡C

©`¦Ì¬ì¾Ç»P©`¦Ì¬ì§Þªº¾÷·|»P¤£½T©w©Ê

7/29/2004, Nanotechnology and Nanoscience, ­^°ê¬Ó®a¨ó·|»P¬Ó®a¤uµ{¾Ç°|©ó¤C¤ë¤G¤Q¤E¤é¤½§G¤F¤H­Ì´Á¬ß¤w¤[ªº³ø§i¡A³ø§i¦WºÙ¬°¡§©`¦Ì¬ì¾Ç»P©`¦Ì¬ì§Þªº¾÷·|»P¤£½T©w©Ê¡¨¡A¸Ó³ø§i°Q½×¤F©`¦Ì¬ì§Þªº¼ç¦b­·ÀI»P§Q¯q¡A¨Ã¥B«ØÄ³¹ï©`¦Ì·L²É»P©`¦ÌºÞ¶i¦æ§ó¦hªº¦w¥þ´ú¸Õ¡C³ø§i¤º®e²[»\¤Q­Ó³¹¸`¡A¥]¬A«e¨¥¡F©`¦Ì¬ì¾Ç»P©`¦Ì¬ì§Þªº©w¸q¡F¬ì¾Ç»PÀ³¥Î¡F©`¦Ì»s³y¥H¤Î©`¦Ì¬ì§Þªº¤u·~À³¥Î¡F©ó°·±d¡BÀô¹Ò»P¦w¥þªº¥i¯à¤£§Q¼vÅT¡FªÀ·|»P¹D¼wijÃD¡F§Q®`Ãö«Y»P¤½¦@¹ï¸Ü¡Fªk³WijÃD¡Fµ²½×¡F«ØÄ³¥H¤Î°Ñ¦Ò¸ê®Æ¡C

The Royal Society  - excellence in scienceConical Flask, school children using high-tech lab equipment, ammonite by PeterSheldon, Volcano Monitoring by JohnMurray, earth, ROV Submersible by RachelJames¡@

¸Ó¥÷³ø§i»¡©ú¤F©`¦Ì¬ì§Þ©ó²{¦b»P¥¼¨Ó´£¨Ñ³\¦h§Q¯qªº¨Æ¹ê¡A¤£¹L¹ï¨ä¬ãµoÀ³¸Ó¶i¦æ¤½¶}ÅG½×¡C³ø§i±j½Õ©`¦Ì·L²É¹ï°·±d»PÀô¹Ò¼vÅTªº¤£½T©w©Ê¥²¶·§Y¨è¸Ñ¨M¡A¤]«ØÄ³¹ï©`¦Ì·L²ÉªºÃnÅS¶qÀ³¸Ó¥ßªk¡C°õ¦æ¦¹¶µ¬ã¨sªº¤u§@¹Î¶¤¥D®uAnn DowlingºÙ¡§¥Ø«e©`¦Ì·L²Éªº³W½d¦s¦bµÛ¸¨®t¡A©`¦ÌÁû²Éªº©Ê½è¤£¦P©ó¬Û¦P¤¸¯Àªº¤j¤Ø¤oª«½è¡A¤£¹L¥Ø«e¦b¶i¦æ©`¦Ì·L²Éªº»s³y®É¡A¨Ã¥¼µ¹¤©ÃB¥~ªº´ú¸Õ¡C¬ÛÃö³W½dÀ³¸Ó§óÄY®æ¡AÅý©`¦Ì·L²É¦b´ú¸Õ»P¼Ð¥Ü¤W³£¯à¥H·sªº¤Æ¾Çª«½è¨Ó¥[¥Hµû¦ô¡C¡¨

Nanotube

¸Ó¶µ³ø§i«ØÄ³­^°ê»P¼Ú¬w¥ßªk³æ¦ìÀ³¸Ó±N©`¦Ì·L²É»P©`¦ÌºÒºÞµø¬°·sªº¤Æ¾Çª«½è¡A¥t¥~¡A³ø§i¤]«ØÄ³¦b§ó¤F¸Ñ¨ä¼vÅT©Ê¤§«e¡A¾¨¥i¯àªºÁ×§KÄÀ©ñ¦¹¨Ç©`¦Ìª«½è¶i¤J¶g¾DÀô¹Ò¡A¦P®É­^°ê°·±d»P¦w¥þ§½¹ï©ó±µÄ²¤H³y©`¦Ì·L²Éªº¤u§@¤H­û¡AÀ³¸Ó¦Ò¼{¨î©w¸û§CªºÃnÅSµ¥¯Å¡C ³ø§i«ü¥X¡A¥Ñ©ó¯Ê¥FÃÒ¾ÚÅã¥Ü¤H³y©`¦Ì·L²É»P©`¦ÌºÒºÞ·|¾É­P¦MÀI¡A³y¦¨¤F¬Û·íªº¤£½T©w©Ê¡A©Ò¥HÀ³¸Ó¥Ñ¤@­Ó·sªº¸ó»â°ì¬ã¨s¤¤¤ß¨Ó±´¨s©`¦Ì·L²É»P©`¦ÌºÒºÞªº¬r©Ê¡B¬y¦æ¯f¾Ç¡B¦s¯dµ{«×»P¥Íª«²Ö¿n§@¥Î¡A¥H¤Î¨äÃnÅS³~®|¡A¦P®É¤]¶·¬ã¨s¯àºÊ´ú©`¦Ì·L²É»P©`¦ÌºÒºÞÀô¹Ò§t¶qªº»ö¾¹¡C

¨Ì¾Ú¸Ó¶µ¬ã¨s¡A©`¦Ì·L²É»P©`¦ÌºÒºÞ¦bÀ³¥Î©ó°Ó¥Î²£«~¦p¤Æ§©«~¤§«e¡A¤]À³¸Ó¥Ñ¿W¥ßªº¬ì¾Ç¦w¥þ©e­û·|µ¹¤©®Ö¥i¡C¦pªG©ó±M·~´Á¥ZµLªkÀò±o§¹¾ãªº¬r²z¼Æ¾Ú®É¡A·~¬ÉÀ³¸Ó¶i¦æ¸ÔºÉªº©`¦Ìª«½è¦w¥þ©Ê´ú¸Õ¡A¨Ã¥B¤½½Ñ©ó²³¡C ¬ã¨s¹Î¶¤¤]«ØÄ³¹ï©`¦Ì¬ì§Þªº¬ãµoÀ³¸Ó¶i¦æ¤½¦@¹ï¸Ü¡A¥HÁ×§K¥Á²³¥X²{®Ú²`¸¦©Tªº¦¨¨£©Î·¥ºÝ¤Æªº¥ß³õ¡C©ó¦¹¬ã¨s¶i¦æ¶¥¬q¦P®É®i¶}ªº¥«³õ¬ã¨sÅã¥Ü¡A¶È¦³29%ªº­^°ê¤H¤fÅ¥¹L©`¦Ì¬ì§Þ³o­Ó¦Wµü¡C

­^°ê¬F©²¦Û2003¦~¤»¤ë°_¡A´N©e°U­^°ê¬Ó®a¨ó·|»P¬Ó®a¤uµ{¾Ç°|¶i¦æ©`¦Ì¬ì§Þªº¬ã¨s¡C­^°ê¬ì§Þ³¡ªøDavid SainsburyÁnºÙ­^°ê¬F©²©ó¤µ¦~¦~©³·|¹ï¦¹¥÷¬ã¨sµ²ªG°µ¥X¥¿¦¡¦^À³¡C

©`¦Ì¶î®Æ«æ¬ß¼Ð·Ç¯Â¼ä¥«³õ

8/9/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡Aªñ¦~¨Ó¡Aª½±µ¥H©`¦Ì­ì§÷®Æ¥Í産ªº°ª¬ì§Þ¥\¯à¶î®Æ¡X¡X©`¦Ì¶î®Æªº¥X²{¡A¦¨爲¶î®Æ¦æ·~ªº¤@¤j¼öÂI¡C¦b¥«³õ¤W¡A©`¦Ì¶î®Æ¦]¨äÀu²§ªºÀô«O©Ê¯à¡B­@À¿¬~©Ê¡B¤â·P¡B¦Û¼ä©Ê©MµøÄ±®ÄªG¡A¶V¨Ó¶V¨ü¨ì¤¤°ªºÝ¼h­±®ø¶OªÌªº«C·ý¡C¦ý¥O¤H¿ò¾Ñªº¬O¡A¦]爲¯Ê¥F¬ÛÃöªº°ê®a¼Ð·Ç©M¦æ·~¼Ð·Ç¡A¡§©`¦Ì¡¨¼Ð·Ç¬É©w§xÃø¡A©`¦Ì¶î®Æ¦p¤µ¤w¦¨爲衆¦h°ê¤º¥~¶î®Æ¼t®a°Ó®aª£§@ªº¡§·§©À¡¨¡A¡§©`¦Ì¶î®Æ¡¨¤§¦W¦]爲³Q¹L«×ÀݥΡB¶Ã¥Î¦ÓÅý®ø¶OªÌ¯u°²²ö¿ë¡Aª½±µ¼vÅT©`¦Ì¶î®Æ®ø¶O«H¤ß¡C¡§©`¦Ì¶î®Æ¡¨産«~¡A¥¿¾D¹J¥«³õ®ø¶O«H¤ß¦M¾÷¡C

¼Æ¦Ê«~µPª§¥s¡§©`¦Ì¶î®Æ¡¨

¾Ú±x¡A¥Ø«e¶î®Æ¥«³õ¤W¡A¥H¡§©`¦ÌÀ𭱺£¡¨¡B¡§©`¦Ì¤ì¾¹º£¡¨¡B¡§©`¦Ì¶î®Æ¡¨爲産«~¦Wªº«~µP¤£¤U´X¦Ê­Ó¡A­Ó­Ó³£§j¦Û¤v¬O¯u¥¿ªº¡§©`¦Ì¶î®Æ¡¨¡B¡§©`¦Ìº£¡¨¡A¥Îªº³£¬O¥u¦³´¶³q¤HÀY¾vµ·¼e«×10¸U¤À¤§¤@¤pªº­ì§÷®Æ¡A³£¨ã¦³¥úIJ´C¡B¦Û¼ä¡B­@À¿¬~©Êµ¥¥\¯à¡AÀô«O©Ê¡B¤â·P©MµøÄ±®ÄªG³£¬O¤@¬y¡C

¹ê»Ú¤W¡A¾Ú°ê¤º©`¦Ì¶î®Æ®õ¤æ¡B¤¤°ê¬ì¾Ç°|©`¦Ì­º®u¬ì¾Ç®a±i¥ß¼w¤¶²Ð¡A©`¦Ì¶î®Æ§@爲¥Ø«e°ß¤@ªº¤@ºØ¥þ²y©ÊÀô«O¶î®Æ¡A¤w¤Þ°_¥@¬É¦U°êªº°ª«×­«µø¡C¥Ø«e°ê¤º¯à¯u¥¿¾Ö¦³©`¦Ì¶î®Æ§Þ³N¡B¥þ³¡À³¥Î©`¦Ì§÷®Æ爲­ì®Æ¥Í産¡§©`¦Ì¶î®Æ¡¨産«~ªº¼t®a¨ä¹ê¹é¹éµL´X¡A¬O¯àÀò±oÅv«Â§Þ³N³¡ªùų©wªº産«~§ó¬O¤Ö¤§¤S¤Ö¡C»P¶Ç²Î¶î®Æ産«~¬Û¤ñ¡A©`¦Ì¶î®Æ産«~ªº¦¨¥»¦Ü¤Ö­n°ª10%¥H¤W¡A¤j¦h¼Æ¼t®a爲Àò±o§ó¤j§Q¼í¡A©¹©¹¡§¬E¦ÏÀY½æª¯¦×¡¨¡C¦]爲©`¦Ì産«~¬O°ª·s産«~¡A°ê®a¤è­±¤@ª½¯Ê¥F¬ÛÀ³ªº¼Ð·Ç¡A´Nºâ¬O¦³Ãö³¡ªù·Q³W½d¥«³õ¤]¬OµL¾Ú¥i¨Ì¡C¥u¯à²´¬ÝµÛ°²«_産«~ªxÀݦ¨¨a¡C

°ê®a¼Ð·Ç¦³±æ¦~¤º¥X»O

¾Ú°ê¤º³Ì¦­¬ãµo©`¦Ì¶î®Æ産«~¡A¥Ø«e¤w¦³¡§©`¦Ì¶î®Æ²Ä¤@«~µP¡¨¤§ºÙªº¼s¦{¬P«a¤Æ¤u¶°¹Î¸³¨Æªø§d¾ð«G¤¶²Ð¡A¥L¤w±q¦³Ãö³¡ªù¤è­±±o¨ìÃÒ¹ê¡A¦b衆¦h°ª¬ì§Þ©`¦Ì¬ãµo¾÷ºc¡B¼t®a©M¦³Ãö³¡ªù§V¤O¤U¡A¦³Ãö¦U¦æ·~©`¦Ì産«~ªº°ê®aÁ`¼Ð·Ç±N¦³±æ¦b¤µ¦~¤º¥X»O¡A©¡®É¡A©`¦Ì¶î®Æ¤è­±¤]±N·|¦³±Mªùªº°ê®a¼Ð·Ç¡C¦b°ê®a¼Ð·Ç³W½d¤U¡A½Ö¬O¡§§õØP¡¨½Ö¬O¡§§õ¶f¡¨³£±N²{¥X­ì§Î¡A¸g¨ü¦í®ø¶OªÌ»P¥«³õ¦ÒÅ窺¡§©`¦Ì¶î®Æ¡¨¥«³õ¡AµLºÃ±Nªï¨Ó§ó¤jµo®i¾÷¹J¡C

±M®a±Ð¦p¦ó¿ë§O¡§©`¦Ì¶î®Æ¡¨

¦b°ê®a¦³Ãö¼Ð·Ç¥¼¥X»O¤§«e¡A®ø¶OªÌ­n«ç麽¿ë§O¥«³õ¤Wªº¡§©`¦Ì¶î®Æ¡¨©O¡C±`¦~»P¡§©`¦Ì¶î®Æ¡¨¥´¥æ¹Dªº°ê¤º¡§©`¦Ì¶î®Æ¡¨¼t°Óªº»âÀY¦Ï¡B¼s¦{¬P«a¤Æ¤u¶°¹Î¸³¨Æªø§d¾ð«G§i¶D°OªÌ¡AÃöÁä´N¬O­n¡§¤@¬d¡B¤G¬Ý¡B¤T»D¡B¥|¹êÅ硨¡C

¤@­n¡§¬d¡¨¬O­º¥ý­n¬d¸Ó産«~¦³¨S¦³³q¹L°ê®aÅv«Â³¡ªùªº§Þ³Nų©w¡A¦³¨SÀò±o¬ÛÃöªº§Þ³Nų©wÃҮѡB¬ì§Þ¼úÀy©MÅv«Â±M®aµû»ù¡C

¤G­n¡§¬Ý¡¨¡C¯u¥¿¨Ï¥Î©`¦Ì¶î®Æ¶î®Æªº¥­­±³£¥ú·Æ¼ä²b¡A¤âÆ[¤ÎµøÄ±®ÄªG¨}¦n¡C¦pªGµo²{¶î®Æ«áª««~ªí¥ÜÁÙ¦³¥W¥Y¤£¥­ªºªF¦è¡A¨º´N¤@©w¤£¬O¡§©`¦Ì¶î®Æ¡¨¶î¸Ëªº¡C

¤T­n¡§»D¡¨¡C¡§©`¦Ì¶î®Æ¡¨¬O¯u¥¿ªººñ¦âÀô«O¶î®Æ¡A§¹¥þ¤£²K¥[¥ô¦ó´§µoª«©M¦³®`²K¥[¾¯¡A®ð¨ý²M·s¡A¦Ó¥B¦b¥ú½u·Ó®g¤U®ð¨ý·|¶V¨Ó¶V²M·s¥B¤£·|´§µo¡C

¥|­n¡§°µ¹êÅ硨¡C©`¦Ì¶î®Æ¦Û¼ä©Ê¡B¦ÓÀ¿¼ä©Ê¡B§Ü¦¾¯à¤O±j¡B°®Àê§Ö¡A³q¹L¤@¨Ç²{³õ¤p¹êÅç§¹¥þ¯à¿ë§O¡C¤ñ¦p¶î¸Ë¤p¶ô§÷®Æ¬Ý¨ä°®Àê³t«×¡A¼â¾¥¥Ä´ú¨ä§Ü¦¾¯à¤O¡Aµ¥µ¥¡C

¥xÆW©_¬ü±N«Ø¥ß¨p¦³¤u·~¶é°Ï

8/27/2004, ¤é¸gBPºô, ¥xÆW©_¬ü¶°¹Î¤½§G¤F¦b¥x«n«Ø¥ß¶°¤¤²G´¹¹qµø¬ÛÃö¥ø·~ªº¨p¦³¤u·~¶é°Ïªº­p¹º¡C¥xÆW©_¬ü¥ú¹q¤½¥qÁ`µô¦ó¬L¶§ªí¥Ü¡A¤w¸gÀò±o»P¥x«n¬ì¾Ç¤u·~¶é°Ï¬Û¾Fªº250¸U¥­¤è¦Ì¤g¦a¡C¸Ó¤u·~¶é°Ï¹w­p¦b2005¦~²Ä3©u«×§¹¦¨¡A­p¹º§l¤Þ²G´¹¹qµø¼t°Ó¤Î²G´¹­±ªO¤¸¾¹¥ó¼t°Ó«e¨Ó§ë¸ê³]¼t¡C

¨´¤µ¬°¤î¡A¥xÆW¥D­n¥Ñ¬F©²¥D¾É¶}µo¶°¤¤°ª·s§Þ³N¥ø·~ªº¤u·~¶é°Ï¡C³q¹L¥Ñ¬F©²«Ø¥ß©MºÞ²z°ò¦³]¬I¨Ã¶°¤¤°ª·s§Þ³N¬ÛÃö¤u·~¨Ó§l¤ÞÀu¨q¤H§÷¨Ã¥B´£°ª¥b¾ÉÅé¡BIT¥H¤ÎÅã¥Ü¾¹µ¥¦yºÝ²£·~ªºÄvª§¤O¡C©_¬ü¶°¹Î±N±Ä¥Î¦P¼Ëªº¤èªk«Ø¥ß©MºÞ²z°ò¦³]¬I¡A¥H§l¤Þ²G´¹¹qµøªº¤W¹C¤Î¤U´å¥ø·~¡C©_¬ü¶°¹Î¤§©Ò¥H¨M©w¶}µo¤u·~¶é°Ï¡A¬O¥Ñ©ó¸Ó¶°¹Î»{ÃѨì­n·Q¨Ï²G´¹¹qµø¬ÛÃö¥ø·~ªºÄvª§¤O¶i¤@¨Bµo´§¥X¨Ó¡§´N¥²¶·¨Ï¬ÛÃö¥ø·~¶°¬ù¤Æ©M¶°¸s¤Æ¡¨¡C¥ø·~°Ñ¥[¸Ó¤u·~¶é°Ï«á¡A±N¥ií©w±ÄÁʤ¸¾¹¥ó¨Ã¥B´£°ª¤¸¾¹¥óªº¹B¿é®Ä²v¡C¥Ø«e¤w¸g¦³¡§¬ù20®a¡¨¥ø·~ªí¥Ü¦³¿³½ì¡A¨ä¤¤¤]¥]¬A¤é¥»ªº­I¥ú¼t°Ó¡C¸Ó¶°¹Î¥´ºâ¡§«Ø¥ß»P¤@±øÀs¥Í²£¹qµø¾÷ªº¤u¼t¬Û¤Ç¼Ä¤u·~¦a°Ï¡C¡¨

¸Ó¤u·~¶é°Ï»P¬F©²¶}µoªº¤u·~¶é°Ïªº°Ï§O¦b©ó¬F©²¥X¯²¤u·~¶é°Ïªº¤g¦a¡A¦Ó¸Ó¤u·~¶é°Ï¤g¦a«h»Ý­nÁʶR¡C¨ä¥¦±ø¥ó¡§»P¬F©²ªº¤u·~¶é°Ï¦Pµ¥¡¨¡C¸Ó¤u·~¶é°Ïªº§ë¸êª÷ÃB¡§¤j¬ù¬°200»õ·s¥x¹ô¡¨¡C±N¥Ñ¸Ó¶°¹Î¬°¹ê¬I¦¹¦¸­p¹º¦¨¥ßªº¥xÆWLinklinear Development Co., Ltd­t³d¶}µo¡C

¦³«Ý©`¦Ì¬ì§Þ¬ãµo¨Ó¸Ñ¨M¥þ²y¯à·½¦M¾÷

8/13/2004, Small Times, ¦Û±q¤HÃþ¶}©l§Q¥Î¥Û¤Æ¿U®Æ¦Ü¤µ¡A§Ú­Ì¤@ª½³£¹³¬Oº®Ây¤å©ú¤@¼Ë¡Aµo²{Âyª«¡A¶i¦æ®·®»¡AµM«á¦Y±¼¡C¦pªG¤@­Ó¦a¤è¨S¦³Âyª«¤F¡A§Ú­Ì´N¾E²¾¨ì¥t¤@­Ó¦a¤è¡C¤HÃþ¯u¥¿¦³¤å©ú¤D¬O·í¤HÃþ©w©~¤U¨Ó°È¹A¡AµM«áµo©ú¤F¤å¦r¡A¿ú¹ô©M¤å¤Æ¤§«á¡C¹ï©ó¶}³Ð§Ú­Ìªº¥¼¨Ó¡A§Ú­ÌÀ³¸Ó¾Ç²ß§Ú­Ì¶}©l°È¹Aªº¯ª¥ý¡A¦b§Ú­Ì¦³¯à·½»Ý¨Dªº¦a¤è¡A¯à°÷§ä¥X¼½ºØ¯à·½¨ÑÀ³ªº¤èªk¡C

ªº½T§Ú­Ì¦³¤@­Ó¯à·½ªº¦M¾÷¡C§Ú­Ì®ø¯Ó¯à·½ªº³t«×¤ñ§Ú­Ì§ä¨ì¯à·½ªº³t«×­n§Ö¡C¦Ó¥B³\¦h§Ú­Ì¶Rªoªº°ê®a³£¬O¤£¤Íµ½©Î¬O¬Fªv¤£Ã­©w¡Cªp¥B¸Õ·Q¡A¸gÀÙ§ï­²¶}©ñ«áªº¤¤°ê¡A¨ä¤¤¦³13»õ¤H¤f³£«Ü·Q­n¶}¨®©M­n¦³¹q¦B½c¡C¥L­Ìªº¯à·½­n±q­þ¸Ì¨Ó©O? ¦pªG¨Ñ»Ý¥¢¿Åªº¸Ü¡A¯à·½»ù®æ¤@©w¤W´­¡C¦Ó¦pªG»ù®æªº¤W´­¤´µMµLªk¿Eµo¥X§ó¦hªº¨ÑÀ³¶q¡A¨º»ò¨ÆºA´N·|Åܱo«D±`ÄY­«¡C¦A³Ìªñ´X¤Q¦~¤º¡A§Ú­Ì³£¨S¦³µo²{¥ô¦ó¥D­nªºªoÄq¡C

¦³³\¦h¤H³£»{¬°©`¦Ì¬ì§Þªº¬ãµo±N¦³¿ìªk¨Ó¸Ñ¨M¥þ²y¯à·½¦M¾÷ªº°ÝÃD¡CÂǵ۩`¦Ì¬ì§Þ¡A¯à·½¨Ï¥Îªº®Ä²v¡A¶§¥ú¢w¹q¤OªºÂà´«²v¡A¥Ûªo´£·ÒIJ´Cªº³]­p¡A¥H¤Î¯à·½ªºÀx¦s§Þ³N¡A¨Ò¦p¿U®Æ¹q¦À©Î¬O¤@¯ë¹q¦À¡A³£±NÀò±o§ï¶i¡C¦]¦¹²{¦b­±Á{ªº¬D¾Ô¤D¬O¦p¦ó¨Ó¬[ºc§Ú­Ìªº©`¦Ì¬ãµo­p¹º¡A¨Ó§Ö³t¦a§ä¥X¤S¦n¤S«K©yªº¸Ñ¨M¤è®×¡C¦¹½g¤å³¹ªº§@ªÌJim Von Ehr¬O¬ü°êZyvex¤½¥qªº³Ð©l¤H©M¥Ø«eªºÁ`µô¡A¥L¹ï¦¹Ä³ÃD¦³¤@µf¯S®íªº¨£¸Ñ¡A¸Ô±¡½ÐŪ¨ä­ì¤å¤å³¹¡C

image
§@ªÌ
Jim Von Ehr¬O¬ü°êZyvex¤½¥qªº³Ð©l¤H©M¥Ø«eªºÁ`µô¡A ¥Lªº¹q¤l«H½c¬Ojvonehr@zyvex.com.

©`¦Ì§÷®Æ¬ì§Þ:

¾×¦í¼ö¦Ó¥uÅý¥ú½u³q¹Lªº¬Á¼þ¶î¼h

8/10/2004, Scientific American, ¨Ì¾Ú10/08/04§÷®Æ¤Æ¾Ç´Á¥Z (Journal of Materials Chemistry) ªº³ø¾É¡A­^°ê§Qª«®ú¤j¾Ç»P­Û´°¤j¾Ç¾Ç°|ªº¬ã¨s¤H­û¬ãµo¤F¤@ºØ·sªº¬Á¼þ¶î¼h¡A¯à¾×¦í¼ö¦Ó¥uÅý¥ú½u³q¹L¡A¶î¼h§÷®Æ¬°¤G®ñ¤Æ³«»P¤Ö¶qªºÂëª÷ÄÝ¡C

Science Image: sunlight
¼v¹³¨Ó·½: NOAA/Department of Commerce

¤G®ñ¤Æ³«Á¡½¤¨ã¦³¼ö­PÅܯS©Ê¡A¥i¸g¥Ñ·Å«×½ÕÅÜÂàÅÜ¥ú¾Ç¬ï³z²v¡A¤]¥i³z¹LºUÂøÂë¡B໡Bà·»P¬tµ¥Âø½è½Õ¾ãÂà´«·Å«×¡C ­^°êªº¸ÕÅç¶î¼h©ó§C·Å®É¡A¤¹³\¥i¨£¥úÃФºªº¥ú½u»P¬õ¥~½u¬ï³z¡A·í·Å«×¶W¹LÄá¤ó29«×¡A¶î¼h§÷®Æ·|¤Ï®g¬õ¥~½u¿ç®g¡C§@ªÌ¤§¤@¡AIvan Parkin±Ð±Â«ü¥X¾¨ºÞ¤G®ñ¤Æ³«ªº¼ö¤Ï®g©Ê½è«D±`½T»{¡A¦¹§Þ³N§xÃø¤§³B¦b©óÂà´«·Å«×¡A¦pªG§÷®Æ¨ìÄá¤ó70«×¤~¶}©l¤Ï®g¬õ¥~½u¡A¤]¨SÔ£¦n³B¤F¡A¬ã¨sµ²ªGÅã¥ÜÂà´«·Å«×¯à­°¦Ü«Ç·Å¤§¤W¡A¨Ã¥B¥i°Ó·~¤Æªº»s³y¦¹ºØ¶î¼h¡C

¬ã¨s¦¨ªGÃöÁ䤧¤@¬°¶î¼hºUÂøª«¢wÂëª÷Äݪº³Ì¨Î¿@«×¬°1.9 %¡A¨ä¦¸¬°¯à¥H±`À£¤Æ¾Ç®ð¬Û¨I¿nªk (APCVD) ¦b¯B¦¡¥­ª©¬Á¼þ»sµ{¦P®É¶i¦æÁ¡½¤ªº¨I¿n¡AµL¶·¨Ï¥Î¨ì°ª¦¨¥»ªº¯uªÅ³]³Æ¡A¦Ó¥BÁ¡½¤¦¨ªø§Ö³t¡C §@ªÌ¤]«ü¥X«áÄò¬ã¨s­«ÂI¬°¼W¥[¶î¼hªº¸g¤[©Ê¡A¹w´Á¶W¹L¦Ê¦~¡F¨Ã§Æ±æ¯à§ïÅܶî¼hªºÃC¦â¡A¥Ø«e¬°¤£«ç»ò§l¤Þ¤Hªº¶À/ºñ¦â¡C

¥ÎRNA¨Ó·í¥¼¨Ó«Øºc©`¦Ì¾÷¾¹ªº©`¦ÌÆN¬[

8/25/2004, Nanotech Web, ¬ü°ê´¶´ç¤j¾Çªº¬ì¾Ç®a³Ìªñ¤w¸g¬ãµo¥X¤@ºØ·s§Þ³N¡A¦¹§Þ³N¥i¥H±q«Ê¥]¦¡ªº®ÖÁÞ®Ö»Ä (pRNA) ªº¦UºØ¤À¤l¤¤»s³y¥X³\¦h¤£¦Pªºµ²ºc§Îª¬¡C³o¨Ç¤£¦Pªºµ²ºc§Îª¬¤¤¥]¬A¦³ÂùÅé¡A¥|¦ìÅé¡A¤T¨¤Åé¡A±ìª¬Åé©M³\¦h¤£¦Pªº¤Tºû°}¦CÅé¡C´¶´ç¤j¾Çªº¬ì¾Ç®aPeixuan Guoªí¥Ü¡A¥L­Ìªº¬ã¨s¤u§@¦¨ªGÅã¥Ü¥X¡A¥L­Ì¦³¿ìªk±q¤£¦P§Îª¬©M¤j¤pªºRNAµ²ºc¤è¶ô¤¤¡A¨Ó±±¨î©M«Øºc¥X¤Tºûªº°}¦Cµ²ºcÅé¡C¦pªG¥L­ÌÄ~Äò²`¤J¬ã¨sªº¸Ü¡ARNA±N¦³¥i¯à¥Î¨Ó»s³y¥X¥¼¨Ó©`¦Ì¾÷¾¹ªºµ²ºcª«¡C


´¶´ç¤j¾Çªº¬ì¾Ç®aPeixuan Guo

¨ì¥Ø«e¬°¤î¡A¤j³¡¤À¦³ÃöÀ³¥Î¦b©`¦Ì¬ì§Þªº¥Íª«¤À¤lªº¬ã¨s¡A³£¬O¶°¤¤¦b¹ïDNA¤À¤l©M³J¥Õ½èªº¤è­±¡CµM¦Ó¤j®a³£©¿²¤¤FRNA¨ã¦³¥i¥H³Q±±¨î¦¨¦UºØÀ³¥ÎÆF¬¡§Îª¬ªºÀu¶Õ¡A¦Ó¤@¯ëDNA¤j³¡¤À³£³Q­­¨î¦bÂùÁ³±Ûªº§Îª¬¡CPeixuan Guoªí¥Ü¡ARNAµ²¦X¤FDNA©M³J¥Õ½èªº¦UºØÀuÂI¡A¦Ó¥B©`¦Ì¬ì§Þ¾Ç®a¥i¥H¥ô·N¦a¨Ó¾Þ±±§Q¥Î¥¦¡C¥¦©Ò¥i¯à§Î¦¨ªº¦UºØ¦h¥\¯àªºµ²ºcÅé¡A¤@¯ë¤]¬O¥i¥H«Ü®e©ö¦a³Q¥Í²£¡A¾Þ±±©M¥[¤u¡C

Peixuan Guo©M¨ä¬ã¨s¹Î¶¤©Ò¨Ï¥Îªº«Ê¥]¦¡ªº®ÖÁޮֻĤÀ¤l¡A¤D¬O±qphi29²Óµß¯f¬r¤¤ªºDNA«Ê¸Ë°¨¹F (DNA-packing motor)©ÒÀò¨úªº¡C³o¨Ç¤À¤l·|§Î¦¨¥X¤@¨Ç¤»­±Å骺Àôª¬ª«¡CÂǵ۹ï³o¨ÇpRNAªºµ²ºc³]­pµy¥[­×§ï¡A³o­Ó¬ã¨s¹Î¶¤´N¦³¿ìªk¨Ó»¤¨Ï³o¨Ç¤À¤l§ï²Õ¦¨³\¦h¤£¦Pªº·s§ÎÅé¡A¨ä¤¤¥]¬A¦³ÂùÅé¡A¥|¦ìÅé¡A¤T¨¤Åé¡A±ìª¬Åé©M³\¦h¤£¦Pªº¤Tºû°}¦CÅé¡C

RNA array
 ´¶´ç¤j¾Çªº¬ì¾Ç®aPeixuan Guo¹êÅç«Ç¤¤©Ò»s³y¥X¨Ó¦UºØRNA§Îª¬ªº¼v¹³¡C³Ì«e­±ªº¤T­Ó©â¶Hªº§Îª¬Åé¢w¢w³æÅé¡AÂùÅé©M¤T¦ìÅé¢w¢w§ó¶i¤@¨B¦a¥Î¤HÅé¤âÁu¤¬¬Û¾Ö©êªº¼ÒÀÀ¨Ó¸Ñ»¡ (½Ð°Ñ¨£¹Ï A, B©MC¤¤ªº¤º´¡¹Ï). Peixuan Guoªº¬ã¨s¹Î¶¤¤]¤w¸g¬ãµo¥X¤@ºØ¤èªk¥i¥H¨Ï³o¨Ç°ò¥»ªºµ²ºc§ÎÅé¶i¤@¨B¦aµ²¦X¦¨§ó½ÆÂøªº¤Tºûµ²ºcÅé¡A¨Ò¦p¦b¹ÏDªº°}¦CÅé¡C³oºØ°}¦CÅ馳¥i¯à§Î¦¨¤@¨Ç·L«¬ªºµ²ºcÆN¬[¡A©ó¨ä¤W¥i¥H¥Î¨Ó«Øºc¥X¤@¨Ç©`¦Ì¬ì§Þªº¤¸¥ó¡C¹Ï¹³¨Ó·½: Purdue University graphic/Guo Laboratories

¥Î¼ö³B²z¨Ó½Õ¸`©`¦Ì·L´¹²Õ¸ËÅ骺¾É¹q©Ê

8/3/2004, Nanotech Web, ·Rº¸ÄõªºNMRC©M¼w°êº~³ù¤jªº¬ì¾Ç®a­Ì¡A³Ìªñ¶}µo¥X¤@ºØ¥Î¼ö³B²zªº§Þ³N¡A¨Ó½Õ¸`¤@ºØª÷ÄÝ©`¦Ì·L´¹°}¦Cªº¾É¹q¯S©Ê¡C³oºØª÷ÄÝ©`¦Ì·L´¹²Õ¸ËÅé¡A¦b³o­Ó¬ã¨s¹Î¶¤³vº¥¼W°ª¨ä¼ö³B²zªº°h¤õ·Å«×¤U¡A¥i¥H±q¥»¨Ó§e²{¥Xªºµ´½tÅé¯S©Ê¡A³vº¥ÂಾÅܦ¨±µªñª÷Äݪº¯S©Ê¡C

·Rº¸ÄõªºNMRCªº¬ì¾Ç®aGareth Redmondªí¥Ü¡A³o¨Ç¸g¹L¤Ø¤o¿ï¾Ü©M¦³¾÷ª«¶w¤Æªº©`¦Ì·L´¹Åé¡A¨ä©Ò¨ã¦³ªº¿W¯Sªº¦Û§Ú²Õ¸Ëªº¯S©Ê¡AÅý§Ú­Ì¥i¥H»s³y¥X±Æ§Ç¾ã»ôªº¤Gºû©M¤Tºûªº°}¦C¡A¨ÓÀ³¥Î¦b¥¼¨Ó¥H©`¦Ì·L´¹¬°¬[ºc¡A¨ã¦³¥þ·sªº¥ú¾Ç©M¹q¾Ç¯S©Êªº©`¦Ì¹q¤l¤¸¥ó©M¹q¸ô¡CÁöµM¤j®a³£ª¾¹D³\¦h¥¼¨Óªº¥ú¹q¤¸¥óªº¯S©Ê¡A±N·|³Q©`¦Ì·L´¹¶¡ªº±µ¦X¾÷ºc©M©`¦Ì·L´¹­Ó§Oªº¯S©Ê©Ò±±¨î¡A¦ý¬O°w¹ï©`¦Ì·L´¹¶¡ªº±µ¦X¾÷ºc¹ï©`¦Ì·L´¹°}¦Cªº¹q¤l¯S©Êªº¼vÅT¡A«o¶È¦³¤Ö¼Æªº¬ì¾Ç®a¦³²`¤Jªº¬ã¨s¡C

Gareth Redmond©M¨ä¬ã¨s¦P¹±»s³y¥X¤@¨Çª½®|3.8©`¦Ìªº¤T¹`¤Æ¹Wªº©`¦Ì·L´¹°}¦C¡AµM«áÂǵÛÅý³o¨Ç´¹Åé¦b¥Ò­f·»²G¤¤¨I¿n¤§®É¡A¨Ï¨ä¶î¸Ë¤W¤@¼h¦³¾÷ª«ªºÃ­©w¼h¡C³o­Ó¹Î¶¤±µµÛ±N³o­Ó©`¦Ì·L´¹¶W´¹®æµ²ºcÅé¨î©ñ¦b¨â­Óª÷¤lªº¹q·¥¤§¶¡¡A¨ä¹q·¥¶¡ªº¤ÀÂ÷¶¡»Ø¤j¬ù70©`¦Ì¡C³o¨Ç´¹®æ¤¤¤¶©ó©`¦Ì·L´¹¶¡ªº¥­§¡¤ÀÂ÷¶ZÂ÷¤j¬ù¬O2.5©`¦Ì¡A¨ä¦b«Ç·Å¤Uªº§C°¾À£¹qªý¶W¹L1­ÓTeraOhm¡C

¦bÁ٭쪬ªp¤Uªº¼ö°h¤õ³B²z¥i¥H«Ü©úÅã¦a­°§C³o­Ó°}¦Cªº¹qªý¡C¨Ò¦p¦bÄá¤ó80«×ªº¼ö³B²z¤U¡A¨ä§C°¾À£¹qªýÅܦ¨100 MegaOhm¡C³o¤ñ°_¤@­Ó¥¼¸g¹L¼ö³B²zªº¤¸¥óªº¹qªý­n¤p¤W1000­¿¥H¤W¡C¦pªG¦b¤£¦Pªº·Å«×¤U¨Ó¤ÀªR³o­Ó´¹³B²z¹Lªº¤¸¥óªº¹q¬y¢w¢w¹qÀ£¯S©Ê¡A§Ú­Ì·|µo²{¨ä¯S©Ê´N¹³¬O¤@ºØMottµ´½tÅé¡C³o­Ó¹Î¶¤»{¬°³oºØ²{¶H¤D¬O¦]¬°°h¤õ³B²z¤w¸g´î¤p¤F©`¦Ì·L´¹¶¡ªº¤ÀÂ÷«×¡C¦bÄá¤ó100«×ªº¼ö³B²z¤U¡A³o­Ó°}¦Cªº¹qªý¤S´î¤Ö¤F1000­¿¡A¤U­°¨ì190 kOhm¡C¦pªG¶q´ú¨ä·Å«×©M¹qªýªºÃö«Y¡A§Ú­Ì¥i¥Hµo²{³o­Ó¤¸¥ó²{¦b«h¨ã¦³·L®zª÷Äݪº¯S©Ê¡C¦b°h¤õ·Å«×¦bÄá¤ó150«×®É¡A¨ä«Ç·Å¤Uªº¹qªý«hÅܦ¨1 kOhm¡A³o§¹¥þ´N¬Oª÷Äݪº¯S©Ê¤F¡C

Nanocrystal array
°ª¸ÑªR«×±½´y¹q¤lÅã·L³N¤Uªº¤@­Ó¨å«¬ªº©`¦Ì·L´¹¤¸¥ó¡A ¦¹¤¸¥ó³Q²Õ¸Ë¦b¨â­Óª÷¤lªº¹q·¥¤§¶¡¡A¨Ã¥B³Q¸m©ñ¦b¤@¶ô®ñ¤Æª¿ªº°òªO¤W¡C

¼w°êBYK¡XCHEMIE±À¥X¨âºØ¶ì½¦¥[¤u¥Îªº©`¦Ì²£«~

7/28/2004, Small Times, ¼w°êWeselªº¤@®a¤Æ¾Ç²£«~¤½¥q¡ABYK¡XCHEMIE¡A¬O¤@®a¶î¸Ë¡A¾¥¤ô©M¶ì½¦²K¥[¾¯ªº¥D­n¨ÑÀ³°Ó¡A³Ìªñ¥L­Ìµo¥¬¡A¦b¤Q¤ë¥÷ªºK 2004¶ì½¦²£·~¶T©ö®i¤¤¡A±N±À¥X¨âºØ¶ì½¦¥[¤u¥Îªº©`¦Ì¬ì§Þ²£«~¡C

³o¨âºØ§Y±N±À¥Xªº²£«~NANOBYK-3600©MNANOBYK-3601¡A´Á¶}µoªº¥Øªº¤D¬O­n¥Î¨ä¨Ó§ï¨}µµ¥~½u¶î¸Ë²£«~ªº­@¨í«×©M­@¿i«×¡C¦¹·s²£«~±N¥i¥H³QÀ³¥Î¦b¶ì½¦²£«~¤W­±¡A¨Ò¦p¶ì½¦¦aªO¡AÂǵۤ@¼hªí­±¶î¸Ë¨Ó¼W±j¨ä­@¨í«×©M­@¿i«×¡C³o¨âºØ²£«~ªº¬ãµo¤D¬OBYK¡XCHEMIE©MNanophase¬ì§Þ¤½¥q¤@°_¦X§@¥X¨Óªºµ²´¹¡C

©`¦Ì´¹¤ù©`¦Ì¹q¤l©`¦Ì¾÷¹q¨t²Î¬ì§Þ:

¥ú¤l¥æ´«§Þ³N¦³±æ¹ê²{ ¤Wºô³t«×´£¤É¦Ê­¿

8/20/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A³Ìªñ¶}µoªº¤@ºØ¥Î©ó½w¸Ñºô¸ô²~ÀVªº©`¦Ì§Þ³N¦³¥i¯à±N爲ºôÂέ̱a¨Ó¤@¦Ê­¿©ó¥Ø«eªº¤Wºô³t«×¡C

¥Ø«e¹M§G¥þ²y©M²`®I®ü©³ªº¥úÆl¯à°÷»´¦Ó©öÁ|ªº¹ê²{10 Gbps¨ì40 Gbpsªº¶Ç¼½³t²v ¡AµM¦Ó³Ì«á¤@¤½¨½Ãì¸ô¤Wªº¹q¤l¥æ´«§Þ³N«o¤j¤jªº«d®z¤F°ª³t¥úÅÖºô¸ôªº¹dÃB±a¼e¡C¦ý8¤ë11¸¹µo¦æªº¡m©`¦Ì§Ö°T¡n¤W¥Zµnªº¤@¤ù½×¤å´y­z¡A³q¹L¬Y¨Ç¤H¤u»E¦Xª«Öß±µ¦b¤@°_ªººÒ-60¤Ú§J²y (Buckyball)¡A¥i¥H§@爲¥ú¤l¥æ´«§Þ³Nªº¤@­Ó¹ê²{³~®|¡C

¥Ñ©ó¸ê®Æ±q¥úÅÖ¼Ò¦¡Âà´«¨ì¹q¤l®æ¦¡»Ý­n¸g¹L¾ã¦X©M­«¾ãªº¹Lµ{¡A¦]¦Ó±a¨Ó¶Ç¿é©Ê¯à¤Wªº·l¥¢¡C¬JµMµLªk±q¹q¤l¸ô¥Ñ¾¹¤è­±¤J¤â¡A¬ì¾Ç®a«K±N²´¥ú§ë¦V¤F¥ú¾Çªº¥æ´«§Þ³N¡C爲¦¹¡A¦h­Û¦h¤j¾Ç©M¥dº¸µÜ¹y¤j¾Çªº¬ã¨sªÌ­ÌÁp¦X¶}µo¤F¤@ºØ¯à¥Î©ó¥úÅ֥洫¾÷ªº·s«¬»E¦Xª«§÷®Æ¡C­Y¥ú¾Ç¥æ´«¾÷³Ì²×±o¥H°Ý¥@¡A´X¥G¤£·|産¥Í·l¯Óªº¥ú«H¸¹±N¯à¥H¸U»õ¤À¤§¤@¬íªº³t«×³q¹L¥æ´«°ð¡C

¾Ú±x¡A³oºØ·s§÷®Æªº°Ý¥@¤w¸g¹Gªñ¤F¶q¤l¤O¾Ç©w«ß©Ò´y­zªº²z½×·¥­­¡C¡§¥u­n©Ò¦³ªº³]³Æ©M¨t²Î¹ê²{¥ú¤l¤Æ¡A¨º麽¹q¤l¶Ç¿é©Ò¤Þ°_ªº²~ÀV¶Õ¥²±N¤£´_¦s¦b¤F¡C¡¨

¥ú¤l´¹Åé¥i¥H¥Î¨Ó±±¨î¶q¤lÂIµo¥úªº®É¶¡

8/23/2004, Nanotech Web, ²üÄõªº©`¦Ì¬ì¾Ç®a¤w¸g©ú¥X¡AÂǵ۱N¥b¾ÉÅé©Êªº¶q¤lÂI®I¤J¤@ºØ¥ú¤lªº´¹Åéµ²ºc¤¤¡A¥L­Ì´N¥i¥H¦³¿ìªk¨Ó±±¨î³o¨Ç¶q¤lÂIµo¥úªº®É¶¡¡C¥L­Ì±N¨ä¬ã¨s¦¨ªGµoªí©óNature 430 654¡C³o­Ó·sµo²{±N¥i¥H¥´¶}¶}µo¥X§ó°ª®Ä²vªº¤Ó¶§¯à¹q¦À©Mµo¥ú¤G·¥Å骺¤jªù¡C

³o­Ó¬ã¨s¤D¬O¥Ñ²üÄõTwente¤j¾Ç©MUtrecht¤j¾ÇªºWillem Vos¥H¤Î¨ä¬ã¨s¦P¹±©Ò¶i¦æªº¡C¥L­Ì±N²É®|4.5©`¦ÌªºÖ´¤ÆÂ𪺩`¦Ì²É¤l®I¤J¤@ºØ¥ú¤l´¹Åéµ²ºc¤§¤¤¡A¦¹¥ú¤l´¹Åé¤D¬O©Ò¿×ªº¤Ï«¬³J¥Õ¥Û (inverse opal) ¢w¢w¤]´N¬O¤@ºØ®ñ¤ÆÜgªº¯x°}µ²ºc¡A¨ä¤¤§Gº¡¤F·L¤pªº²y«¬ªÅ®ð¬}¡CÂǵ۱N³o¨ÇªÅ®ð¬}¶¡ªº¶¡¹j¦b240©`¦Ì¨ì650©`¦Ì¤§¶¡½Õ¸`ÅܤơA³o­Ó¬ã¨s¹Î¶¤´N¥i¥H±N±qÖ´¤ÆÂð¶q¤lÂI©Ò¦ÛµMµo®g¥X¨Óªº¥úªºµo®g³t²v½Õ§Ö©Î¬OÅܺC¡C¨Ò¦p¡A·íªÅ®ð¬}¶¡»Ø½Õ¨ì420©`¦Ì®É¡A´N¥i¥H²£¥Í¥X©ñ®g®É¶¡9.6©`¬íªº¥ú¡A¦Ó·í¶¡»Ø½Õ¨ì500©`¦Ì®É¡A´N¥i¥H±N¦¹¥ú©ñ®g®É¶¡¼W¥[¨ì19.3©`¬í¡C³o­Ó¬ã¨s¹Î¶¤¦b¨ä½×¤å¤¤ªí¥Ü¡A¥L­Ì¥H¤W©Ò¶q¨ìªº®É¶¡ÅܤơA¤D¬O¬ì¾Ç¬É­º¦¸ÃÒ¹ê¤F¨Ï¥Î¤Tºûªº¥ú¤l´¹Åé¥i¥H±±¨îµo¥úÅ骺©ñ®g®É¶¡¡C¥L­ÌÃÒ¹ê¤FÂǵۥú¤l´¹Å餤´¹®æ°Ñ¼ÆªºÅܤơA¥i¥HÀò±o±j«×¶W¹L¨â­¿¥H¤Wªº©ñ®g®É¶¡ªºÅܤơC

³o­Ó¹Î¶¤ªº¬ã¨s¦¨ªG¦P®É¤]¬MÃÒ¤F¤@­Óªø¤[¥H¨Óªº¤@­Ó²z½×¹w´ú¡A¦¹¹w´ú¤D¬O¡¨¥ú¤l´¹Å餧¤÷¡¨¢w¢w¬ü°êªºª«²z¾Ç®aEli Yablonovitch©ó1987¦~©Ò´£¥Xªº¡C¨º´N¬O¨Ì¾Ú¥L¦bBellcore®Éªº­pºâ«ü¥X¡A¥ú¤l´¹ÅéÀ³¸Ó¯à°÷§í¨î©M±±¨î¦Ûµo©Êªºµo¥ú¡C

Inverse opal
¤Ï«¬³J¥Õ¥Û (inverse opal) µ²ºcÅ骺±½´y¹q¤lÅã·LÃè¤Uªº¼v¹³¡C
³oºØ´¹Å骺©TºAª«½è¤§¶¡§t¦³¤@­Ó±Æ¦C¾ã»ôªºªÅ®ð¬}ªº°}¦C¡C(¼v¹³¨Ó·½: COPS)

Controlled emission
¦¹·Ó¤ù¤D¬O¤@¶ô¼e¬ù2Íù¦Ìªº¥ú¤l´¹Åé¡C¨ä¤¤©Òµo®g¥X¨ÓªºÂÅ¥ú¤D¬O¥Ñ±Æ¦C°ï½U¾ã»ôªºªÅ®ð²y§ÎÅé©Ò¤Ï®g¥X¨Óªº¥ú½u¡C(¼v¹³¨Ó·½: COPS)

·L¾÷¹q¬ì¾Ç®a§¹¦¨¤F­ì¤lÄÁªºÅ±³y

8/31/2004, National Institute of Standards and Technology, ¬ü°ê¬ìù©Ô¦h¦{ªº¤@­Ó¬F©²¬ã¨s¾÷ºc¡A¦b¬ãµo»s³y¥X¤@ºØ§ó¦h²£·~¥i¥H¥Î¨ìªº°ª·Ç½T«×­ì¤lÄÁ¡A¤w¸g¦V«eÀò±o¤F¤@­Ó«Ü¤jªº¶i®i¡C³o­Ó¾÷ºc¡A¬ü°ê°ê®a¼Ð·Ç©M¬ì§Þ¤¤¤ß (NIST) ³Ìªñµo¥¬®ø®§¡A¥L­Ì¤w¸g¶}µo¥X¤@ºØ¥H·L¾÷¹q¬°¬[ºcªº­ì¤l®ÉÄÁªº®Ö¤ß¬ì§Þ¡C¥L­Ì¨Ï¥Î·Lű³y§Þ³N¨Óű³y¥X¤@­Ó´¹¤ù¤j¤pªº­ì¤lÄÁ¡A¬°¥¼¨Óªº¤â«ù­p®É¤¸¥ó©M¨ä¥L¥ý«e¤£¥i¯àªºÀ³¥ÎçE¤F¤@±ø¥i¯àªº¸ô®|¡C

NIST physicist John Kitching holding the chip-scale clock
NISTªºª«²z¾Ç®a John Kitching®i²{µÛ¤@­Ó¥@¬É³Ì¤pªº­ì¤l®ÉÄÁªº®Ö¤ß¤¸¥ó¡C
³o­Ó "ª«²zªº¥]»q" ¨ä¤j¤p¤j¬ù¶È¦³¤@²É¦Ì¡C

NIST Chip-Scale Clock physics package
¼v¹³¤¤ªºª÷¤l²Ó½u¥i¥H¥Î¨Ó©M´¹¤ù«¬­ì¤l®ÉÄÁªº¹q¤l¹q¸ô³sµ²¡C(¼v¹³¨Ó·½: NIST)

­ì¤l®ÉÄÁ­p®Éªº·Ç½T«×«D±`°ª¡A³\¦h­ì¤l®ÉÄÁ¥i¥H«O«ù´X¦Ê¦~ªº·Ç½T®É¶¡¡C¦ý¬O¨ì¥Ø«e¬°¤î¡A­ì¤l®ÉÄÁÁÙ¬O»Ý­n«Ü¤jªºªÅ¶¡©M¯à·½¨Ó²£¥Í¥X¤@­Ó·Lªi³õ¡A¥Î¨ä¨Ó¿Eµo­ì¤l¡C³o¨Ï±o­ì¤l®ÉÄÁªºÀ³¥Î³Q­­¨î¦b³q°T½Ã¬P©Î¬O¤j«¬ªº¹q¸£³]¬I¤W­±¡A¦Ó¤£¯à³Q¥Î¦b¤â¾÷¡A¤â´£¹q¸£¡AGPS±µ¦¬¾¹©Î¬O¨ä¥L¥Ø«e§Ö³t¦¨ªøªº¹q¤l¸ê°T²£«~¤¤¡C

¬ü°ê°ê®a¼Ð·Ç©M¬ì§Þ¤¤¤ß (NIST) ªº¬ì¾Ç®a§Q¥Î¤F¤@ºØ©Ò¿×¿Ó½Õ¢w¢w²Õ¸s³´¨À (coherent¡Xpopulation trapping) ªº§Þ³N¨Ó¸Ñ¨M³o¨Ç°ÝÃD¡A³oºØ§Þ³N¤D¬O¥Î¥ú¦Ó¤£¬O¥Î·Lªi¡A¨Ó±N­ì¤l¿Eµo¥X¨Ó¡C¥L­Ìªº·s¤èªk±N¥»¨Ó»Ý­nªº¤j«¬·LªiµÄ«Ç¥h°£¡A¦Ó¥B±N¥¨¤jªº¯à·½®ø¯Ó­°§C¨ì¶È¶È»Ý­n¤@­Ó¤@¯ëªºAA¹q¦À¡C³oºØ§Þ³N¦P®É¤]¥i¥H¦b¤@¶ô¬Á¼þ©Î¬Oª¿´¹´¹¶ê°òªO¤W¡A§å¦¸¦aű³y¥X¨ä¥D­n¤¸¥ó¡C

BIOPHAN¤½¥q©MNASA¦X§@¶}µo¥i¥H´Ó¤J¤HÅ骺©`¦Ìµo¹q¾÷¨t²Î

8/20/2004, Small Times, ¬ü°êBIOPHAN¬ì§Þ¤½¥q©M¬ü°ê¤ÓªÅÁ`¸pªºAmes¬ã¨s¤¤¤ß¤w¸gñ¸p¤@­Ó¦X§@¦X¦P¡A­n¤@°_¨Ó¶}µo¥X¥i¥H´Ó¤J¤HÅ骺©`¦Ìµo¹q¾÷¨t²Î©Ò»Ý­nªº©`¦Ì¤uµ{§÷®Æ¡C

¡@¡@

³o®a¦ì©ó¬ü°ê¯Ã¬ù¦{Rochesterªº¤½¥q¡A¨ä¤À¤ä¾÷ºcTE-Bio©M¤ÓªÅÁ`¸pAmes¬ã¨s¤¤¤ß¦ì©ó¥[¦{Moffett Fieldªº©`¦Ì¬ã¨s¤¤¤ß±N¤@°_¦X§@¡A¸ÕµÛ­n¶}µo¥X§Q¥Î¥Íª«¼ö¯àªºµo¹q¨t²Î¡A¥H«K¥¼¨Ó¯à°÷À³¥Î¦b´Ó¤J¤HÅ骺Âå¾Ç¤¸¥ó¤W­±¡A¦P®É¬ü°ê¤ÓªÅÁ`¸p¤]·Q­n§ä¨ì¥¼¨Ó¦b¤ÓªÅ±´¯Á®É©Ò¥i¯à¥Î¨ìªºªø¹Ø©R©M§C¹q¤Oªº¸Ñ¨M¤è®×¡C

©`¦ÌºÞ, ©`¦ÌŽ, ©`¦ÌÅÖºû©M©`¦Ì²yªº¶i®i:

¤é¥»¬ì¾Ç®a»s¦¨·s«¬Âù¼h©`¦ÌºÞ¨ã¦³­@°ª·Å¯SÂI

8/18/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A¤é¥»«H¦{¤j¾Ç¤u¾Ç¨t±Ð±Â»·Ãæu«H»â¾Éªº¬ã¨s¤p²Õ³Ìªñ¦¨¥\¦X¦¨Âù¼hºÒ©`¦ÌºÞ¡A爲¦b©`¦Ì¤ô¥­¤W±±¨î¹q¬y¡A¶}µo¶W¤p«¬·Pª¾¾¹µ¥¹q¤l¸Ë¸m³þ©w¤F°ò¦¡C

¾Ú¡m¤é¸g産·~·s»D¡n29¤é³ø¹D¡A·sªº©`¦ÌºÞ¬OÂù¼hµ²ºc¡A¦b©`¦ÌºÞùؤS®M¤@­Ó©`¦ÌºÞ¡C·s«¬©`¦ÌºÞ¨ã¦³­@°ª·Åªº¯SÂI¡A¦b¥~³¡§â©`¦ÌºÞ¥[¼ö¨ì2000Äá¤ó«×¤§«á¡A¥u¦³¥~¼h©`¦ÌºÞÅܧΡA¤º¼hªº©`¦ÌºÞ¤´¥i«O«ù­ìª¬¡C »·Ãñб»¡¡A³o¤@¦¨ªG±N¹ï¬ã»s·s«¬·Pª¾¾¹¡B¹q´¹Åéµ¥¤j¦³À°§U¡C

©`¦Ì½u¤Æ¾Ç·PÀ³¾¹

8/23/2004, Eureka Alert, ¬ü°ê¥[¦{¤j¾ÇÀ¹ºû´µ¤À®Õ¤Æ¾Ç¨tªº¬ã¨s¹Î¶¤µo²{¥Ñ¾Y¡Bà»»PÖ´­ì¤l»s³yªº©`¦Ì½u¡A¼ÉÅS©ó¦³¾÷·»¾¯»]¨T®É¡A¨ä¹qªý­È·|§e²{200% ªºÅܤơC¬ã¨s¤H­û±µµÛ±N¦¹©`¦Ì½u¦w¸m©ó¨â­Ó¾É¹qÅ餧¶¡¡Aµ²ªG¥L­Ì»s³y¥X¤F¤@ºØÂ²©öªº¤Æ¾Ç·PÀ³¾¹¡C

¥[¦{¤j¾ÇÀ¹ºû´µ¤À®Õ¤Æ¾Ç¨t§U²z±Ð±ÂFrank Osterlohªº¬ã¨s¹Î¶¤±N¤Æ¾Ç°ò»P©`¦Ì½u³s±µ¡A¥L­Ì´N¥i¥H¹ï²{¦³ªº·PÀ³¾¹¶i¦æ­×¹¢¡A¨Ï¨ä·PÀ³¾¹¯à°÷¶q´ú¥X·»²G¤¤ªº»Ä«×¡CFrank Osterlohªí¥Ü¡A¥L­Ìªº¬ã¨s¹Î¶¤¥Ø«e¥¿¦b¬ã¨s¦p¦ó©µ¦ù³oºØ·PÀ³¾¹ªº¥iµ{¦¡¤Æ¯S½è¡A¨Ï¨ä¯à°÷¥Î¨Ó°»´ú¥X¬µÃĪº¦¨¤À©Î¬OÀô¹Ò¤¤ªº¦Ã¬Vª«¡A¨Ò¦p¶¼¥Î¤ô¤¤ªº¹]§t¶qµ¥µ¥¡C

Frank Osterloh»{¬°¡A¦]¬°©`¦Ì§÷®Æ¥»¨­¯à²Õ¦¨¥X¶È´X­Ó­ì¤l¤j¤pªºµ²ºc¡A¦Ó¥B¤@¯ë¶È­n´X­Ó¤Æ¾Ç¤À¤l´N¯à°÷IJµo¤ÏÀ³¡A¤]´N¬O»¡©`¦Ì§÷®Æªºª«²z©Ê½è¡A¹ï¥~¦b¤Æ¾ÇÀô¹Òªº¨Ç·L§ïÅܨ㦳«D±`¤jªº¤ÏÀ³±Ó·P«×¡A©Ò¥H©`¦Ì§÷®Æ«D±`¾A¦XÀ³¥Î©ó¤Æ¾Ç·PÀ³¾¹ªº¶}µo¡C§Q¥Î©`¦Ì¬ì§Þ±N¥i¥H»s³y¥X¥ì¨t¦Cªº¤Æ¾Ç·PÀ³¾¹¡A¥i¥H¥Î¨Ó¶i¦æ¹ïÀô¹Ò«~½èªººÊ´ú¡A­¹ª«©M¶¼¤ô¦w¥þªººÊ±±©Î¬O«O¥þ¤WªºÀ³¥Î¡C

Frank Osterlohªº¬ã¨s¹Î¶¤±N¨ä¬ãµo¦¨ªGµoªí©ó¬ü°ê²Ä228©¡°ê®aAmerican Chemical Society¦bPhiladelphiaªº¤j·|¤¤, Aug. 22-26¡C

§Q¥Î©`¦Ìµ²¨Ó¾É¤Þ¥ú½u

8/27/2004, Nanotech Web, §QÁöµM©`¦Ì½uªº¤¸¥ó¤w¸g³QÃÒ¹ê¥i¥H¥Î¨Óµo¥ú©M°»´ú¥ú¤l¡A¦ý¬O¥Î©`¦Ì½u¨Ó¾É¤Þ¥ú½uªº§Þ³N¡A¨ì¥Ø«e¬°¤î¤´µM¬O¨S¦³Àò±o¹ê»ÚªºÃÒ¹ê¡C²{¦b¦b¬ü°ê¥[¦{¬f§JµÜ¤j¾Ç©M¬ü°êLawrence Berkeley°ê®a¹êÅç«Çªº¬ì¾Ç®a¡A¤w¸gÃÒ©ú¤F¥L­Ì¥i¥H¨Ï¥Î®ñ¤Æª«·L´¹Å骺©`¦Ìµ² (nanoribbons) ¨Ó¦b©`¦Ì¤¸¥ó¶¡¾É¤Þ¥ú½u¡C

¥[¦{¬f§JµÜ¤j¾Ç©MLawrence Berkeley°ê®a¹êÅç«Çªº¬ì¾Ç®aPeidong Yangªí¥Ü¡A¹L¥h´X¦~¨Ó¬ì¾Ç¬É¤w¸g¶}µo¥X©`¦Ì¤Ø«×ªº¹p®g©M¥ú¤l°»´ú¾¹¡A¦Ó¨ä¤¤©Ò¯Ê¾Ñªº¤D¬O¤@ºØ¥i¥H³s±µ³o¨Ç³æ¿W¤¸¥óªº­n¯À¡C­n¹F¨ì³oºØ¥Øªº©Ò¯Ê¤Öªº§Y¬O¤@ºØ¦¸ªiªøªº¥ú¾Ç¾É¤Þ¤¸¥ó¡C¦]¦¹¥L­Ì´N¿ï¾Ü¤F³oºØ¶Wªøªº©`¦Ì½u¨Ó·í§@¥i¯àªº§÷®Æ¨Ó¹ï¨ä¶i¦æ¸ÕÅç¡Aµ²ªG¤]µo²{³oºØ§÷®Æ³ºµM¬O¤@ºØ«Ü¦nªº¥ú¾É¤Þª«¡A¦Ó¥B¨ä¥ú¾Ç·l¯Ó«D±`¦a§C¡C


¬ü°ê¥[¦{¬f§JµÜ¤j¾Ç©M¬ü°êLawrence Berkeley°ê®a¹êÅç«Çªº¬ì¾Ç®aPeidong Yang©M¨ä¬ã¨s¹Î¶¤

Peidong Yang©M¨ä¬ã¨s¹Î¶¤©Ò¨Ï¥Î¨Ó¾É¤Þ¥ú½uªº©`¦Ì§÷®Æ¤D¬O¤G®ñ¤Æ¿üªº©`¦Ìµ²·L´¹Åé¡C³o¨Ç©`¦Ìµ²ªºªø«×°ª¹F1500·L¦Ì¡A¦Ó¨ä¬q­±«h¬°ªø¤è§Î¡A¤j¤p±q15 x 5©`¦Ì¨ì2 x 1©`¦Ì¡C¨Ì¾Ú³o¨Ç¬ì¾Ç®a©Ò­z¡A¤j³¡¤Àªº©`¦Ìµ²ªº¼e«×©M«p«×¬ù¬°100¨ì400©`¦Ì¤§¶¡¡A³oºØ¤Ø¤o¦b¤@­Ó¦¸ªiªøªºªÅ¶¡¸Ì¡A¹ï¥i¨£¥ú©Mµµ¥~½u¥úªº¾É¤Þ«D±`¦³®Ä²v¡A¨ä¥ú¾Çªº·l¯Ó«D±`¤p¡CÁöµM¤G®ñ¤Æ¾Oªº©`¦Ìµ²·L´¹Åé§÷®Æ¥»¨­¬O«D±`¦a¯Ü¡A¦ý¬O¤×¨ä©Ò§Î¦¨ªº©`¦Ìµ²«o¨ã¦³«D±`°ªªº¬X³n«×¡C³o¨Ï±o®e©ö¾Þ±±¡A¥ú¾Ç¤Wªº³sµ²©M²Õ¸ËÅܦ¨¥i¯à¡C

Nanoribbons
¤G®ñ¤Æ¿üªº©`¦Ìµ²·L´¹Åé©Ò²Õ¦¨ªº©`¦Ìµ²¹ï¬õ¥ú¡Aºñ¥ú©MÂÅ¥úªº¾É¤Þ«D±`¦³®Ä²v¡C

½¬ªá®ÄÀ³¨Ï±o¥ú¥i¥H²¾°Ê¤ô¯]

8/5/2004, Nanotech Web, ¬ü°ê¨È§Q®á¨º¦{¥ß¤j¾Çªº¬ì¾Ç®aAntonio Garcia©M¨ä¬ã¨s¹Î¶¤­É§U¤F¤@ºØ¥Î©`¦Ì½u©Ò¶î¸Ë¥X¨Óªºªí­±¡A¦]µÛ¦¹ªí­±¤W©Ò¨ã¦³ªº½¬ªá®ÄÀ³ (lotus effect) ¡A¨Ï±o¥L­Ì¦¨¬°¬ì¾Ç¬É²Ä¤@­Ó¶È¨Ï¥Îµµ¥~¥úªº·Ó®g¡A´N¥i¥H²¾°Ê¤ô¯]ªº¬ã¨s¹Î¶¤¡C³oºØ·s¶}µo¥X¨Óªº§Þ³N¥¼¨Ó±N¥i¥HÀ³¥Î¦b¤@¨Ç·L¬yÅ餸¥óªº¶}µo¤W­±¡C


¨È§Q®á¨º¦{¥ß¤j¾Çªº¬ì¾Ç®aAntonio Garcia

³o­Ó¬ã¨s¹Î¶¤­º¥ý±Nª½®|20¨ì50©`¦Ìªºª¿´¹©`¦Ì½uÀH¾÷¦a¶î§G¦b¤@­Óª¿´¹ªºªí­±¤W¡CµM«á¥L­Ì¦A±N³o¨Ç©`¦Ì½u¶î¸Ë¤W³æ¼hªº¥ú¦âÁ³±Û©K³ä¤À¤l (photochromic spiropyran molecules)¡C³o¨Ç¦³¾÷¤À¤l¥»¨­¤D¬O©Ú¤ô©Êªº¡AµM¦Óµµ¥~½uªº»¯ªÀ·|¨Ï¨ä¥¢¥h©Ú¤ô©Ê¡C¨ä¹ê½¬ªá¸­¤l¤]¬O§Q¥Î¤@ºØÃþ¦üªºµ²ºc¨Ó±Æ©Ú¤ô¯]¡C½¬ªá¸­ªºªí­±¨ã¦³¤@ºØºë±Kªºµ²ºcÅé¡A¦Ó¥B¨ä¤W¦³²É®|¤j¬ù1©`¦Ìªº©Ú¤ô©ÊÄú´¹Å骺¶î¸Ë¡C

¤@Áû¤ôºw·í¨ä«e¶iªº±µÄ²¨¤«×¤p©ó¨ä«á°hªº±µÄ²¨¤«×®É¡A¥¦´N·|ªuµÛ¦¹±µÄ²ªí­±¦V«e²¾°Ê¡C¦pªG¹ï¨ä¤Wªº¥ú¦âÁ³±Û©K³ä¤À¤l¡A¥Hªiªø366©`¦Ìªºµµ¥~¥ú·Ó®g¡A´N·|±N¦¹¤À¤lÂàÅܦ¨±a·¥©Êªº¿Ë¤ô©Ê«¬ºA¡A¦]¦Ó´î¤p¤F¨ä±µÄ²¨¤«×¡C¦]¦¹§Ú­Ì¥i¥H¬Ý¨ì¥ô¦ó¥HÁ³±Û©K³ä¤À¤l¶î¸Ëªºªí­±¡A¥u­n¥Îµµ¥~½u·Ó®g¡A´N·|¨Ï¨ä¤Wªº¤ô¯]²¾°Ê¡C

Drop by drop
¦b¿Ã¥ú¬V®Æ·Ó®g¤Uªº¨âÁû¤ôºw¡C¥ªÃ䪺¤ôºw (¬Ý°_¨Ó¸û¶êªº¤ôºw) ¤D¬O©ñ¦b¤@­Ó¦³«D±`©Ú¤ô©Êª«½è¶î¸Ëªº©`¦Ì½uªí­±¤W¡C¥kÃ䪺¤ôºw¬Ý°_¨Ó¦³ÂI¤À§G¶}¨Ó¡A¤D¬O©ñ¦b¤@­Ó¦³¦P¼Ë©Ú¤ô©Êª«½è¶î¸Ëªº¤@¯ë¥­­±¤W¡C³o±i·Ó¤ùÅã¥Ü¥X¨ã¦³©`¦Ì½u¶î§Gªºªí­±¥i¥H³Ð³y¥XÃþ¦ü½¬ªá¸­ªºªí­±¡C¨È§Q®á¨º¦{¥ß¤j¾Çªº¬ì¾Ç®a­Ì¤w¸g¥i¥H¨Ï±o³oºØªí­±¨ã¦³¥ú¤ÏÀ³©Ê¡A¦Ó¥B¥i¥H¥ªÃ䪺¤ôºw¦]À³µÛ¥ú½uªº·Ó®g¦Ó²¾°Ê¡C
·Ó¤ù¨Ó·½: ¨È§Q®á¨º¦{¥ß¤j¾Ç¡C

±±¨î©`¦Ì½u¦¨ªøªº¤è¦V

8/4/2004, Nanotech Web, ¬ì¾Ç¬É­º«×¦³¿ìªk¨Ó±±¨î¤@ºØ´á¤ÆñS©`¦Ì½u¦¨ªøªº¤è¦V¡C¬ü°ê¥[¦{¬f§JµÜ¤j¾Ç©MLawrence Berkeley°ê®a¹êÅç«Çªº¬ì¾Ç®a­Ì¤w¸gÃÒ¹ê¡A¥L­Ì¥i¥HÂǵۧïÅÜ¥L­Ì¥Î¨Ó°ö¾i©`¦Ì½uªº°òªO¡A¨Ó±±¨î©`¦Ì½u¦¨ªøªº¤è¦V¡C¥[¦{¬f§JµÜ¤j¾Ç©MLawrence Berkeley°ê®a¹êÅç«Çªº¬ì¾Ç®aPeidong Yangªí¥Ü¡A¦³Ãö©`¦Ì½uªº°ö¾i§Þ³N¤W¡A¹ï¨º¨Ç»{¬°©`¦Ì½u¦¨ªøªº¤è¦V¤£¥i¯à³Q±±¨î¡A¦Ó¥u¯à°ö¾i¥X¦³¤°»ò¬O¤°»òªº¬ì¾Ç®a¦Ó¨¥¡A¥L­Ì²{¦b©ÒÀò±oªºµ²ªG±N·|¬O¤@­Ó·¥¤jªºÅå³Y¡C¹ï©`¦Ì½u¦¨ªøªº¤è¦V¯à°÷¦³©Ò±±¨î¬O¤j®a¹Ú´K¥H¨Dªº¡A¦]¬°¨ä¤¤©Ò¨ã¦³ªº«D§¡½è©Êªº°Ñ¼Æ¡A¨Ò¦p¾É¼ö«×¡A¾É¹q«×¡A§é®g²v¡AÀ£¹q·¥¤Æ«×©MÀW±a¶¡»Ø¡A±N¥i¥H¥Î¨Ó¹ï¬Y¤@ºØ§÷®Æ»s³y¥X¨Óªº©`¦Ì½u½Õ¸`¨äª«²z¯S©Ê¡C

Peidong Yang©M¨ä¬ã¨s¹Î¶¤¨Ï¥Îª÷ÄÝ¢w¢w¦³¾÷ª«¤Æ¾Ç»]®ð¨I¿nªk (metal¡Xorganic chemical vapour deposition, MOCVD) ¦b¨âºØ¤£¦Pªº°òªO¤W°ö¾i¨ä´á¤ÆñSªº©`¦Ì½u¡A¤@ºØ¬O¾Yªº®ñ¤Æ¾T³æ´¹Åé¡A¥t¤@ºØ«h¬O®ñ¤ÆÁ⪺³æ´¹¡C¦b¹w¥ý¥H¤@ºØÄ²´C¡A¨Ò¦pª÷¡AÂì©Î¬O»É¶î¸Ë¹Lªº°òªOªº°Ï°ì¤W¡A©`¦Ì½u´N·|¥H¤@ºØÃþ¦üÅÖºû¾NÄqªº´¹Åéµ²ºcª«ªº«¬ºA§Î¦¨¡C¦b¾Yªº®ñ¤Æ¾T³æ´¹Å骺 (100) ­±¤W¡A¦¹­±¨ã¦³Âù­«ªº¹ïºÙ¡A©`¦Ì½u·|¥H««ª½©ó°òªOªº¤è¦V¦¨ªø¡A¦Ó¥B·|¨ÌµÛ [11bar0] ªº´¹Åé¤è¦V¦¨ªø¡C³oºØ©`¦Ì½uªººI­±¬Oµ¥Ãä¤T¨¤§Î¡A¦¹¤T¨¤§Îªº©³½uªø«×¤¶©ó15¨ì40©`¦Ì¤§¶¡¡C¥t¥~¡A®ñ¤ÆÁâ³æ´¹ªº°òªOªº (111) ´¹­±¨ã¦³¤T­«ªº¹ïºÙ¡A¨I¿n¦b¨ä¤Wªº©`¦Ì½uÁöµMÁÙ¬O¥H««ª½©ó°òªOªº¤è¦V¦¨ªø¡A¦ý¬O«o·|¬O·|¨ÌµÛ [001] ªº´¹Åé¤è¦V¦¨ªø¡C ©Ò°ö¾i¥X¨Óªº©`¦Ì½uªººI­±¤D¬O¤»¨¤§Îªº¡C

Peidong Yangªí¥Ü¡A¨Ï¥Î¹p¦Pªº´á¤ÆñS§÷®Æ¡A¦b¤£¦Pªº°òªO¤W©Ò°ö¾i¥X¨Óªº©`¦Ì½u¡A¨ä¶¡©Ò©ñ®g¥X¨Óªº¥ú½u¨ã¦³¤@­Ó100 meVªºÂÅ¥ú°¾²¾¡C¥L­Ì¬Û«H³oºØµo¥ú®t²§¤D¬O¦¹¨âºØ©`¦Ì½u¨ã¦³¤£¦P´¹Å馨ªø¤è¦V¡C

Peidong Yang
¬ü°ê
¥[¦{¬f§JµÜ¤j¾Ç©MLawrence Berkeley°ê®a¹êÅç«Ç¬ã¨s©`¦Ì½uªº¬ì¾Ç®aPeidong Yang

Nanowire on lithium aluminium oxide
¦b¾Yªº®ñ¤Æ¾T³æ´¹Å骺 (100) ­±¤W¡A¦¹­±¨ã¦³Âù­«ªº¹ïºÙ¡A©`¦Ì½u·|¥H««ª½©ó°òªOªº¤è¦V¦¨ªø¡A
¦Ó¥B·|¨ÌµÛ [11bar0] ªº´¹Åé¤è¦V¦¨ªø¡C³oºØ©`¦Ì½uªººI­±¬Oµ¥Ãä¤T¨¤§Î¡C

Nanowire on magnesium oxide
®ñ¤ÆÁâ³æ´¹ªº°òªOªº (111) ´¹­±¨ã¦³¤T­«ªº¹ïºÙ¡A¨I¿n¦b¨ä¤Wªº©`¦Ì½uÁöµMÁÙ¬O¥H««ª½©ó°òªOªº¤è¦V¦¨ªø¡A
¦ý¬O«o·|¬O·|¨ÌµÛ [001] ªº´¹Åé¤è¦V¦¨ªø¡C ©Ò°ö¾i¥X¨Óªº©`¦Ì½uªººI­±¤D¬O¤»¨¤§Îªº¡C

©`¦ÌÂå¾Ç©M©`¦Ì¥Íª«Àô¹Ò¬ì§Þ:

°ê»Ú°Ó¥Î¾÷¾¹¤½¥q¬ãµo©`¦Ì¦¨¹³§Þ³N¨ú±o¬ð¯}

8/17/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A¬ü°ê°ê»Ú°Ó¥Î¾÷¾¹¤½¥q¢°¢³¤é«Å§G¡A¸Ó¤½¥q¬ã¨s¤H­û¦bºÏ¦@®¶¦¨¹³§Þ³N»â¨ú¨ú±o­«¤j¬ð¯}¡A±N¨Ï¥¼¨ÓªºÅã·LÃè¥i¥HÆ[¹î¨ì¥ßÅ骺¤À¤l¤º³¡µ²ºc¹Ï¹³¡A²M´·«×¹F¨ì©`¦Ìµ¥¯Å¡C

¸Ó¤½¥q»¡¡A¨ä¬ã¨s¤H­û³q¹Lª½±µ±´´ú©TÅ骫½è¤º³¡³æ­Ó¹q¤lµo¥Xªº·L®zºÏ«H¸¹¡A¨ÏºÏ¦@®¶¦¨¹³§Þ³Nªº¿ë§O²v¹F¨ì©`¦Ì¯Å¡C1©`¦Ì爲10»õ¤À¤§¤@¦Ì¡Aªø«×¬Û·í©ó5¦Ü10­Ó­ì¤l±Æ¦C¦b¤@°_¡C °ê»Ú°Ó¥Î¾÷¾¹¤½¥q»{爲¡A³o¶µ¦¨ªG±N¹ï±q³J¥Õ½è¨ìÃÄ«~¡B±q¿nÅé¹q¸ô¨ì¤u·~¶Ê¤Æ¾¯µ¥¦UºØª«½èªº¬ã¨s産¥Í­«¤j¼vÅT¡A¦]爲³o¨Ç¬ã¨s³£»Ý­n¸Ô²Ó¦aÁA¸Ñª«½èªº­ì¤lµ²ºc¡C ¨Ò¦p¡A¯à°÷ª½±µ¬Ý¨ì³J¥Õ½è¸Ô²Óªº­ì¤lµ²ºc¹Ï¡Aª¾¹D¬Y¨Ç­ì¤lªº½T¤Á¦ì¸m¡A¹ï¬ãµo·sªºÃÄ«~±N¦³À°§U¡C

°ê»Ú°Ó¥Î¾÷¾¹¤½¥q»¡¡A¤¦¡P¾|¦÷»â¾Éªº¸Ó¤½¥q©`¦Ì´ú¶q¬ã¨s¤p²Õ¨ú±oªº³o¶µ¦¨ªG¡A±N¥Ø«eÆ[¹î¤HÅé¾¹©x¥ÎªºÂåÀøºÏ¦@®¶¦¨¹³³]³Æªººë«×´£°ª¤F¬ù1000¸U­¿¡C³o¶µ¦¨ªGµoªí¦b±N¤_©ú¤Ñ¥Xª©ªº¡m¦ÛµM¡nÂø»x¤W¡C

¥H³J¥Õ½è¬°¬[ºcªºÂù¦V©`¦Ì­P°Ê¾¹

8/12/2004, Physics News Update, ¥H³J¥Õ½è¬°¬[ºcªº©`¦Ì­P°Ê¾¹ (protein-based nanoactuators) ²{¦b¦b¦òù¨½¹F¦{¥ß¤j¾Çªº¬ã¨s¤H­û¤w¸g¥i¥H¥Î¹q¼ö¤Oªº°T¸¹¨Ó§Ö³t¦a¨Ó±±¨î¥¦­Ì¡A¦Ó¥B¥i¥H¨Ï¨ä¶i¦æ°f¦Vªº°Ê§@¡C¤@¯ë¦b¤@ºØ¬¡ªº¥Íª«¤¤¡A¨ä¦Ù¦×²Õ´ªº¦¬ÁY©Î¬OÃP¦¢³£¬O¥Ñ¹B°Ê©Ê³J¥Õ¨Ó°õ¦æªº¡A³oºØ³J¥ÕºÙ¬°actomyosin¡C¬ã¨s³]­p©`¦Ì¤Ø«×¤¸¥óªº¬ì¾Ç®a¡A«Ü¦ÛµM¦a´N·|³ßÅw¨Ó¼ÒÀÀ¥é®Ä³o¨ÇÅX°Ê¦Ù¦×¤À¤lªº®Ä²v©M¤p¥©¡C³o¨Ç¬ãµo¤¤ªºÃöÁä°ÝÃD¤D¬O¦p¦ó³q¹L²³æªº¤èªk¡A¨Ó±±¨î³o¨Ç³J¥Õ½è°¨¹Fªº§Ö³t¿Eµo°Ê§@¡C

³o¤]´N¬O¦òù¨½¹F¦{¥ß¤j¾Çªº¬ã¨s¤H­û¤@ª½¦b¶i¦æªº¬ã¨s¡C¥L­Ì¥Î¥H³J¥Õ½è°¨¹F (protein motors) ¨ÓÅX°Ê©`¦Ì½u¡A¨Ï¨ä¶i¦æ½u©Ê¹B°Ê¡F¦pªG©`¦Ì½u¨ã¦³ºÏ©Ê¡A¯à¥H·LÀNº¸±´´ú­p (micro-Hall probe) ¦¹ºØ³õ·PÀ³¾¹ºÊ±±¨ä°Ê§@¡C ¦òù¨½¹F¦{¥ß¤j¾Çªº¬ã¨s¤H­û«Ø¥ß¤F¤@®M¬y¼Ñ (flow cell)¡A©ó¨ä¤¤motor molecules¯à¨Ï¥Î¤@±ø¿é¤J½u¥H¼ö­P°Ê¶i¦æ¥i±±»P°f¦V¤è¦¡ªº°Ê§@¡A¦¹ºØ¥H³J¥Õ½è¬°¬[ºcªº©`¦Ì­P°Ê¾¹ (protein-based nanoactuators) ¯à¼ÒÀÀ¦Ù¦×¹B°Ê¤À¤lªº®Ä²v»Pºò½o©Ê¡A¥Íª«ªº¦Ù¦×²Õ´ (muscle tissue) ¬O¥Ñ¦Ù°Ê²y³J¥Õ¡@(actomyosin)¦¹ºØ°¨¹F³J¥Õ (motor proteins) ¶i¦æ¦¬ÁY»PÃP¦¢°Ê§@¡C

¬ã¨s¤H­û»{¬°¯à»s³y¤@ºØ¹q±±¡B¦ý¥H¥Íª«¯à¶q´£¨Ñ°Ê¯àªºÂù¦V©`¦Ì­P°Ê¾¹¡A¥¼¨ÓªºÀ³¥Î½d³ò¥]¬A¥Íª«¤ÀªR´¹¤ù¡@(bioanalysis chips)¡@»P°ò¦]¶Ç°e (gene delivery)¡C

°Ñ¦Ò¤åÄm:

­ì¤l¤OÅã·LÃè±´°w¦yºÝ¤Wªº§ÜÅé

8/16/2004, Eureka Alert, ¬ü°ê¨È§Q®á¯Ç¦{¥ß¤j¾Ç¬ã¨s¤H­û´£ª@¤F­ì¤l¤OÅã·LÃ誺©Ê¯à¡A¯à¥H©`¦Ì¼h¦¸¿ëÃѤÀ¤lªº¤Æ¾Ç²Õ¦¨¡C¬ã¨s¤H­û±N§ÜÅé³sµ²¦b­ì¤l¤OÅã·LÃ誺±´°w¦yºÝ¤W¡A·í§ÜÅé»P¨ä¬Û¹ïÀ³ªº¯S©w³J¥Õ½è¤ÏÀ³®É¡AÅã·LÃ誺¿é¥XŪ¼Æ²£¥Í¤FÅܤơA¦]¦¹¦bAFM±½´y½d³ò¯à§ä¥X¯S©wª«½è¡C ¨Ó¦Û¬ü°ê¨È§Q®á¯Ç¦{¥ß¤j¾Ç»P¶ø¦a§QLintz¤j¾Çµ¥ªº¬ã¨s¸s¡A¥H "Single Molecule Recognition Imaging Microscopy" ¤@¤å¦b¤K¤ë¤Q¤»¤éªºProceedings of the National Academy of Sciencesµoªí¨ä¤W­z¬ã¨s¦¨ªG¡C

­ì¤l¤OÅã·LÃè¨Ï¥Î¤@­Ó°ª±Ó·P»PÅÖ²Óªº±´°w±½´y¸Õ¥óªí­±¡A¥i¥HÀò±o©`¦Ì¤Ø«×ªº¸Õ¥óªí­±§Î»ª¡C­pµe­º®u¬ã¨s­û¡A¨È§Q®á¯Ç¦{¥ß¤j¾Çª«²z¤Î¤Ñ¤å¨t±Ð±ÂLindsayÁnºÙAFM¨ã³Æ­ì¤l¼h¦¸ªº¸ÑªR«×¡A¤£¹LºI¦Ü¥Ø«e¬°¤î©|µLªk¿ëÃѯS©wªº¤Æ¾Ç²Õ¦¨¡C Lindsay±Ð±Â¥Î¤F¤@­Ó¦³½ìªº¤ñÀÀ§Î®e¥L­Ìªº¬ã¨s¦¨ªG¡ALindsayºÙ¡§­Y±N©Ò¦³ªº³J¥Õ½è¥~§Î·Q¹³¦¨Lego¿n¤ì¶ô¡A¶Ç²Îªº¹q¤lÅã·LÃè¶È¯à·Pı¨ì¦aªO¤WªºLego¿n¤ì¶ô¡A¤£¹LµLªk¤À¿ë¿n¤ì¶ô¤§¶¡ªº®t²§¡C¦ÓASUªº¬ã¨s¯àÅý§A§¤¦b¦aªO¤W¡AÆ[¹î¨ì¿n¤ì¶ô¸Ì­±¦³¬õªº¡Bºñªº»P¶À¦âªº¡C¦¹§Þ³N¯à¤À¿ë¼v¹³¸Ìªº¯S©w²Õ¦¨¡A©Ò¥H§A¯à¨ÌÀH¤@­Ó½ÆÂøªº³B²z¹Lµ{¡A¨Ã¥B¥H¤À¤lµ¥¯Å¹îı¨ä¤¤¤@­Ó²Õ¦¨ªºÅܤơC¡¨

¬ã¨s¤H­û¥H¤@ªÑ°ª¤À¤l±N§ÜÅé³sµ²¦b±´°w¤W¡A¥H½T«O±´°wªº±Ó·P©Ê¡A¨ä©Ò´£¨ÑªºÃ´³s¯àÅý§ÜÅé¥HÂ\°Ê¤è¦¡»P³J¥Õ½è¨üÅé¶i¦æ§ó¨Îªº±µÄ²¡CºÏ¿EÄaÁu¼Ù¨Ï±o±´°w¤W¤UÂ\°Ê¡A³y¦¨§ÜÅé»P¸Õ¥óªº¤ÀÂ÷»P¦Aµ²¦X¡AÅý±´°w«ùÄò²¾°Ê¡C ·í²Ó­M¸g¾ú¥Íª«¹Lµ{®É¡A¦¹ºØ§Þ³NªºÃöÁä¯à¤O¯àÅý¬ã¨s¤H­û¤F¸Ñ²Ó­M²Õ¦¨¦p¦ó¥H¤À¤l¼h¯Å¤è¦¡¶i¦æ¤ÏÀ³¡A¨Ò¦p²Ó­M²Õ¦¨¹ï¯S©w¤Æ¾Çª«©Î¤Æ¦Xª«ªº¤ÏÀ³¡A¨Ã¯à¥H¤À¤lªºÃm®É¹q¼v¤è¦¡±N³o¨Ç¤ÏÀ³´£¨Ñ¤©¬ã¨s¤H­û¡A¦¹¹ï²Ó­M»P¨ë¿E¤ÏÀ³¦³Ãöªº¤Æ¾Ç°ÊºA¾Ç¯àÀò­P§ó¦hªº¤F¸Ñ¡C


¤@±iÃÀ³N®aµ§Ä²¤Uªº­ì¤l¤OÅã·LÃ誺±´°w (¤£«ö¤ñ¨Ò) ¡A¹Ï¤¤»¡©ú¤F¤@­Ó¥Î¤@®Ú·L²Óªº»E¦Xª«ªº³¨½u©ÒÄa¦Qªº§ÜÅé¡A
¦p¦ó¨Ó»{¥X¨Ã¥B««³¨¨ä©Ò­n§ä¥Xªº¤À¤l¦ì§}¡C³oºØ·s¶}µo¥X¨Óªº§Þ³N¥¼¨Ó±N¥i¥H¤j¤j¦a¼W±j­ì¤l¤OÅã·LÃ誺¥\¯à¡C

Lindsay»{¬°¦¹ºØ·sªºAFM¤èªk¹ï·sÃĬãµo¬Û·í­«­n¡A¦b½¤ªí­±¿ë»{¯S©w³J¥Õ½èªº¯à¤OÅã¥Ü¯à¶i¦æ½ÆÂøªº¬ã¨s¡A¦p¦P¹ï¤HÃþ²Ó­Mªí­±¦U¦¡¦UÃþªº¨üÅé±´¨s¨ä§½³¡¤Æ¾Ç¤ÏÀ³¡A¦¹¦b¬ãµo·sÃĮɡA¯à´£¨Ñ°ò¥»»{ª¾¡C

§Q¥Î¿Ã¤õÂΪº¿Ã¥ú»Ã¯À¨ÓÅã¥Ü¥Íª«¤¤³J¥Õ½èªº¹B°Ê

7/28/2004, Washington University, School of Medicine, St. Louis, ¥Íª«Å餤°T®§ªº¶Ç»¼¸ô®|¡]signal pathway¡^ºÞ²zµÛ³\¦h­«­nªº¥Í¤Æ¥\¯à¡A²Ó­M¶g´Áªº¶i¦æ¡B·s³¯¥NÁµ¥µ¥§@¥Î³£»Ý­n¸g¥Ñ°T®§ªº¶Ç»¼¸ô®|¨Ó½Õ±±¡C¦Ó¦b°T®§¶Ç»¼¸ô®|ªº½Õ±±·í¤¤¡A³J¥Õ½è¤§¶¡ªº§@¥Î§êºt¤F¤@­Ó¬Û·í­«­nªº¨¤¦â¡AÁC»Ä¤Æ¡]phosphorylation¡^´N¬O¤@¨Ò¡C

¤£¹L°T®§¶Ç»¼¸ô®|ªº¹B§@¡A·|¨Ì²Ó­M©Ò³B²Õ´Àô¹Òªº¤£¦P¦Ó¦³©Ò§ïÅÜ¡A³o¬O¤£¯à¦bÅé¥~¹êÅ礤©¾¹ê§e²{¥X¨Óªº¤@­±¡C¦]¦¹¦³¤H¨Ï¥Î¥¿¤lÂ_¼hÄá¼v¡]PET¡^©Î¬O¥Íª«§N¥ú¡]bioluminescence¡^ªº¤è¦¡¡A¹Á¸Õ¥H«D«I¤J¦¡ªº¤èªk¨ÓÀò±o¥Íª«Å餺³J¥Õ½è¤§¶¡§@¥Îªº¹Lµ{¡C¦Ó¥Ø«e°»´ú³J¥Õ½è¤§¶¡§@¥Îªºµ¦²¤¥]¬A¤F¬¡¤Æ©Î§í¨îÂàĶªº¨BÆJ¡B¬¡¤Æ°T®§¶Ç»¼¸ô®|¡A©Î¬OÁÙ­ì³Q¤¤Â_ªº»Ã¯À¬¡©Ê¡C

¦b»Ã¯À¬¡©Ê¤è­±¡A­Y±N³æ¤@³J¥Õ½è¤Á¦¨¨â¥b¡A³o¨â­Ó¤ù¬q¨Ã¤£·|¦Û¦æ²Õ¦X¦Ó²£¥Í§@¥Î¡C¥u¦³¦b³o¨â­Ó¤ù¬q¯à°÷¸g¥ÑÃĪ«µ¥¨ä¥L§@¥Î¦Ó¦A«×¹Î¶ê®É¡A¤~·|¶i¦æ¥¿±`ªº»Ã¯À¥\¯à¡C¦ý¬O¿Ã¤õÂΪº¿Ã¥ú»Ã¯À¨ü­­©ó¨äNºÝ³¡¤À©Òµo¥XªºÂźñ¦â¥ú¡]Âźñ¦â¥ú¬ï³z¥Íª«Å骺®ÄªG¤£¨Î¡^¡F¤ô¥Àªº¿Ã¥ú»Ã¯ÀÀ³¥Î¦b¥Íª«Åé¤WªººØºØ­­¨î¡A©Ò¥H²{¦³ªº¿Ã¥ú»Ã¯À¨t²ÎµLªk§¹¥þº¡¨¬«D«I¤J¦¡³J¥Õ½è§@¥Î³y¼vªº»Ý¨D¡C

¤£¹L³Ìªñ¦b¬ü°êµØ²±¹y¤j¾Çªº³Õ¤h«á¬ã¨s­ûKathryn E. Luker©Ò»â¾Éªº¬ã¨s¤¤¡A«h§ï¶i¤F²{¦³ªº¿Ã¥ú»Ã¯À¤¬¸É³y¼v¨t²Î¡]luciferase complementation imaging, LCI¡^¡C ¥L­Ì­º¥ý»s³y¥X¤£¦P­«Å|ªø«×ªº¿Ã¥ú»Ã¯ÀNºÝ¤ÎCºÝ°t¹ï¡AµM«á¨Ï¥Î²Óµß¨ÓÆ[¹î³o¨Ç°t¹ïªº§@¥Îª¬ªp¡A¿ï¥Xµo¥ú«×³Ì±jªº¤T¹ï¡A±µµÛÆ[¹î³o¤T¹ï¿Ã¥ú»Ã¯À²Õ¦X¦b¥Íª«Å餤ªºªí²{¡C

¦b¦Ñ¹«¤è­±ªº¹êÅç¡A¥L­Ì¥Î¿ï¥Î¤F¨âºØ¦]¬°§K¬Ì§í¨î¾¯rapamycin¦Ó§@¥Îªº³J¥Õ½è¡A¤@ºØºÙ¬°mTOR¡]mammalian Target of Rapamycin¡^ªº³J¥Õ½è¡A¥t¤@­Ó«h¬OFKBP¡C¥L­Ì±NmTOR¤W¤@­Ó¸òFKBP-rapamycin½Æ¦Xª«¿Ë©M©Ê«Ü°ªªº°Ï°ì¢w¢wFRB¢w¢w»P¿Ã¥ú»Ã¯ÀªºNºÝ³¡¤Àµ²¦X¡F¿Ã¥ú»Ã¯ÀCºÝ³¡¤À«h»PFKBPµ²¦X¡Cµ²ªGÅã¥Ü¡A¥u¦³¦brapamycinª`¤J¦Ñ¹«Å餺®É¡A¿Ã¥ú»Ã¯À¤ù¬q¤~·|µ²¦X¦Óµo¥X¿Ã¥ú¡A¥t¥~¦b²Ó­M¤¤Æ[¹îÁC»Ä¤Æ¬ÛÃöªº¤ÏÀ³¤]±o¨ì«Ü¦nªº®ÄªG¡C

¦b¥L­Ìªº¤èªk·í¤¤¡A¿Ã¥ú»Ã¯À¤ù¬q¦bµ²¦X®É©Òµo¥Xªº¿Ã¥ú¬O­I´ºªº1200­¿¡A¶W¹L¥Ø«e²{¦³¨t²Îªºªí²{¡C³o¨Ï±oLCI³o­ÓÀË´ú¤èªkªºÆF±Ó«×¤j¤j¦a´£°ª¡A¤]Åý°»´ú¤@¨Ç¿Ë©M¤O¨S¨º»ò±jªº³J¥Õ½è§@¥Î¦¨¬°¥i¯à¡C³o­Ó¤èªk¥Ø«e¥¿¥Î¨Ó¶i¦æ§ó¦h¤£¦P³J¥Õ½è§@¥ÎªºÀË´ú¡A¤£¹L¥i¹w¨£ªº¬O¡A³o­Ó¤èªk±N¦¨¬°¤@­Ó¦bÃĪ«¿z¿ï¤W·¥¬°¦³¤Oªº¤u¨ã¡C

­ì©l¤åÄm¡GKathryn E. Luker, et al. Kinetics of regulated protein¡Vprotein interactions revealed with firefly luciferase complementation imaging in cells and living animals. PNAS published July 29, 2004, 10.1073/pnas.0404041101.

¬ì¾Ç®aµo²{¦Û³¬¯g©ó¥Íª«¾Ç¤Wªº¦¨¦]

7/27/2004, Carnegie Mellon University Press Release, ¬ì¾Ç®a´£¥X·sªº²z½×¨Ó¸ÑÄÀ¦Û³¬¯g (autism) ªº¦¨¦]¡A»{¬°¦Û³¬¯g¥i¯à¬O·½©ó¸£³¡¾ã¦X©Ê¥\¯àªº¤£¨¬©Ò­P¡C ´£¨ì¦Û³¬¯g¡A³Ì¥O¤H¦L¶H²`¨èªº²ö¹L©ó¹F´µ¥ÅÀN¤Ò°Ò¡]Dustin Hoffman¡^ ¦b«B¤H¡]Rain man¡^¤@¤ù¤¤©Ò¹¢ºtªº¨¤¦â¡C¾Ö¦³¥X¦âªº­pºâ¯à¤O¡A¤é±`¥Í¬¡¤@µ·¤£­e¡A¦ýµLªk»P¥~¬É·¾³q¡A¤]«ÜÃø§ä¨ì¤@¥÷¥i¥H¿à¥Hºû¥Íªº¤u§@¡C¦b³o¼Ëªºª¬ªp¤U¡A¦Û³¬¯g±wªÌ¦b¬Y¨Ç¤è­±Àu¶Vªºªí²{¡A¤Ï¦Ó¬°³oºØ¯f¯g²K¤W¤@©Ù¯«¯µ¦Ó¥O¤H·P¹Äªº¦â±m¡C

¦Û³¬¯gªº¦¨¦]¦Ü¤µ©|¥¼¦³©w½×¡A¤÷¥ÀªººÞ±Ð¡B¬V¦âÅ骺²§±`¡B¸£³¡·l¶Ëµ¥µ¥­ì¦]³£¦³¤H´£¥X¹L¡A¦ýÁÙ¨S¦³¤@­Ó²z½×¥i¥H§¹¾ãªº¸ÑÄÀ¦Û³¬¯g±wªÌ¦b¬Y¨Ç±¡ªpªí²{Àu²§¡A«oµLªk»P¥L¤H·¾³qªº²{¶H¡C ¬ü°ê¥d¤º°ò±ö¶©¤j¾Ç¡]Carnegie Mellon University¡^»P¤Ç¯÷³ù¤j¾Ç¡]University of Pittsburgh¡^¦X§@µoªí¤F¤@­Ó·s²z½×¡G¡u·¾³q¤£¨}²z½×¡v¡]Underconnectivity theory¡^¡A¬°¦Û³¬¯gªº¬ã¨s´£¨Ñ¤F¤@­Ó·sªºµø³¥¡C

¦b¥L­Ìªº¹êÅç·í¤¤¯S§O§ä¨Ó17¦ì±w¦³¦Û³¬¯g¦ý´¼°Ó¥¿±`ªº±wªÌ¡A¥H¤Î17¦ì¥¿±`¤H§@¬°¹ï·Ó²Õ¡C¹êÅ窺¤è¦¡¬O´úÅç¨ü¸ÕªÌ¹ï»y¥yªº²z¸Ñ¤O¡A¦P®É¨Ã¨Ï¥Î¥\¯à©ÊºÏ®¶³y¼v¡]fMRI¡^¨ÓÆ[¹î¨ü¸ÕªÌ¸£³¡¬¡°Êªº±¡§Î¡C ¥L­Ìªº¬ã¨sµo²{¡A¦Û³¬¯g±wªÌ¦b¤j¸£ºû¥§§J°Ï¡]Wernicke's area¡^ªº¬¡°Ê¸û¥¬Ã¹¥d°Ï¡]Broca's area¡^¨Ó±o¬¡ÅD¡Cºû¥§§J°Ï­t³d³B²zªº¬O¤@­Ó¥y¤l·í¤¤¡A­Ó§O³æ¦rªº·N¸q¡A³o¥i¥H¸ÑÄÀ¬°¦ó¬Y¨Ç¦Û³¬¯g±wªÌ¦³Àu²§ªº¯à¤O¨Ó³B²z­Ó§O³æ¦r¡C ¦Ó¥¬Ã¹¥d°Ï­t³dªº¬O¹ï¥y¤lªº²z¸Ñ¡A¥Ñ©ó¦Û³¬¯g±wªÌ¥¬Ã¹¥d°Ïªº¬¡°Ê¨Ã¤£¬¡ÅD¡A©Ò¥H¥L­Ì¦bÁA¸Ñ¤@¨Çµ²ºc½ÆÂøªº¥y¤l®É·|¾D¹J¨ì§xÃø¡C

¥t¤@­Óµo²{¬O¡A¦Û³¬¯g±wªÌ¸£³¡ªº¥Ö½è»y¨¥¨t²Î¡]cortical language system¡^¤¤¡A¦U¥Ö½è°Ï°ì¤§¶¡ªº¥\¯à©Ê³sµ²¸û¥¿±`¤H¨Ó±o¤£µo¹F¡A¥i¥H¦õÃÒ¦ó¥H¦Û³¬¯g¯f¤HµLªk³B²z¾ã¦X©Êªº¨Æ¥ó¡A³o¤]»P¤§«e¨ä¥L¬ã¨sµo²{¦Û³¬¯g±wªÌ¦b¸£³¡¥Õ½è³¡¤À¦³¯Ê³´ªº±¡ªp¤¬¬Û©IÀ³¡C¦P®É¤]µo²{¦Û³¬¯g±wªÌ¦b¸£³¡ªE³»°Ï°ì¡]occipitoparietal area¡^ªº¬¡°Ê¸û±±¨î²Õ¨Ó±o§C¸¨¡A©Ò¥H¦Û³¬¯gªº±wªÌ¸ûÃø·Q¹³¥X¤@¬q¤å¦r©Ò´y­zªº´º¶H¡C¯à°÷·Q¹³±o¥X¤å¦r©Ò´y­zªº¤º®e¡A´N¬O¤@ºØ¸£³¡¾ã¦X©Êªº¬¡°Ê¡C

®Ú¾Ú¡u·¾³q¤£¨}²z½×¡vªº¸ÑÄÀ¡A¥¿¬O¦]¬°¦Û³¬¯g±wªÌ¦b¸£³¡¾ã¦X¥\¯àºô¸ô¤W¦³¯Ê³´¡A¨Ï±o¥L­Ì¹ï¼Æ¦r¡B¤å¦r¡B©Î¬O¹ï¬Y¨Ç¨Æ¥óªº°O¾Ð¤O¦³·¥¨Îªí²{¡A¦ý¤]¨Ï±o¥L­ÌµLªk¶¶§Qªº¦P®É¶i¦æ¦h¼Ë¤u§@¡A©Ò¥H¨Sªk»P¤H¥¿±`ªº·¾³q¡A¤]­­¨î¤F¥L­Ì¦b¨ä¥L¾ã¦X©Ê¤u§@¤è­±ªºªí²{¡C Âǥѡu·¾³q¤£¨}²z½×¡v´N¥i¥H¸ÑÄÀ¦Û³¬¯g±wªÌ¤@­Ó³Ì¤jªº¯S¼x¢w¢w©t¿W¡AµLªk»P¥L¤H¶i¦æ¥¿±`ªºªÀ¥æ¦æ¬°¡C³o¬O¦]¬°ªÀ¥æ¦æ¬°»Ý­n¸£³¡·¥½ÆÂøªº¾ã¦X¡C¤@­Ó¤H¥²¶·¯à°÷¦P®É¸ÑŪ¥L¤H·L§®ªºªí±¡ÅܤơB¥Î¥y»ºµü¡A°t¦X·í¤Uªº±¡¹Ò¡A¤~¯à°µ¥X¬Û·íªºÀ³¹ï¡C¤£ºÞ¬O¹ï»y¥yªº²z¸Ñ©Î¬O¤@¯ëªºªÀ¥æ¬¡°Ê¡A³o¨Ç½ÆÂøªº¾ã¦X©Ê¬¡°Ê¹ï©ó¦Û³¬¯g±wªÌ¦Ó¨¥³£¬O¤@¥ó«Ü§xÃøªº¨Æ¡C

¥i±¤¦b²{¤µ³o­ÓªÀ·|¬[ºc·í¤¤¡AµLªk»P¤H·¾³qµLºÃ¬O­ÓÄY­«ªº¯Ê³´¡A¤]­­¨î¤F¦Û³¬¯g±wªÌ¥¿±`¥Í¬¡ªº¯à¤O¡C­Y¯à¯u¥¿¸Ñ¶}¦Û³¬¯gªº¦¨¦]¡A´N¥i¥H³]­p§ó¾A¦X¥L­Ìªº°V½m½Òµ{¡A¨Ï¥L­Ì¯à¿Ä¤J¥¿±`ªº¥Í¬¡¡A¦Ó¥B¤]¯àµo®i¥X§ó¦³®ÄªvÀø¦Û³¬¯gªºÃĪ«¡C

­ì©l¤åÄm¡GMarcel Adam Just, et al. Cortical activation and synchronization during sentence comprehension in high-functioning autism¡Gevidence of underconnectivity. Brain, 127, 1811-1821(2004).

¶Pº¸»X¨Ï¥À¿ËÅ@¤lµLÄß

8/1/2004, Eureka Alert, ­÷¨ÅÃþ»Û©Ê°Êª«·|¤£ÅU¥ô¦ó¥Í©R¦MÀI¦a«OÅ@¦Û¤vªº¤l¤k¡A¬ã¨sµo²{¡ACRF¡]Corticotropin-Releasing Factor¡^ ªº´î¤Ö·|­°§C¥À¿Ëªº®`©È»PµJ¼{¡A¨Ó«OÅ@¦o­Ìªº¤l¤k¡C³o¶µ¬ã¨s¥Zµn©ó³Ì·s¤@´Á¡A¤K¤ë¸¹ªºBehavoiral Neuroscience¡C

¦b¥Íª«¾Ç¤W¡A³oºØ¥À¿Ë¤£ÅU¤@¤Á«OÅ@¤l¤kªº¦æ¬°¡AºÙ¬°¥À©Ê«I²¤¦æ¬°¡]maternal aggression¡^¡C¤£¹L¤§«e«Ü¤Ö¦³¬ã¨s»¡©ú¦¹¥À©Ê«I²¤¦æ¬°­I«áªº¥Íª«¾÷¨î¨s³º¬O¤°»ò¡C¬ü°ê«Â´µ±d¨¯¤j¾Ç³Á­}»¹®Õ°ÏªºStephen Gammieªí¥Ü¡A³z¹L¬ã¨s¥L­Ì¤w¸gª¾¹D¡A»Û©Ê°Êª«¦b­÷¨Å´Á®É¡A®`©È©MµJ¼{ªº±¡ºü·|´î¤Ö¡C¤]³\´N¬O¦p¦¹¡A·|Åý¥À¿Ë­Ì§ïÅܨ䥿±`¦æ¬°¡A±N­ì¥»¥u·|¤Þ°_®£Äß±¡ºüªº¨ë¿E¡AÂàÅܦ¨§ðÀ»ªº¦æ¬°¡A¨ÃÂǦ¹«OÅ@¦Û¤vªº¤l¤k¡C

¬°¤FÃҹꦹ¶µ°²»¡¡AGammie©M¥Lªº¦P¨Æ«K¶}©l¬ã¨s¦Ñ¹«ªº¥À©Ê«I²¤¦æ¬°©M¸£¤¤CRFªº°ª§C¦³¦óÃöÁp¡CCRF¬O¸£¤ºªº¤@ºØÐ`肽¡A¥i¥H±±¨î¦æ¬°¡C ¦b¥À¹«¤À®Y«á²Ä¤»¤Ñ¡A¬ã¨s¤H­ûµ¹¥À¹«ª`®g¤TºØ¤£¦P¾¯¶qªºCRF·»²G©M¥Í²z­¹ÆQ¤ô¡]¤£§tCRF¡^§@¬°±±¨î²Õ¡Cª`®gªº±¡§Î¬O¨C¤Ñ¤@¦¸¨Ã³sÄò¥´¥|¤Ñ¡CµM«á§â¥À¹«©M¤p¹«©ñ¦b¤@°_¨Ã¥[¤J¤@­Ó¤½¹«¡C¥Ñ©ó¤½¹«¦³®É­Ô·|¥h¦Y¤p¹«¡A¦b¥¿±`±¡§Î¤U¥À¹«·|¼««ã¦a¥h§ðÀ»¨º¨Ç¦Y¤p¹«ªº¤½¹«¡C¬ã¨sªºµ²ªGµo²{¡A·í¨S¦³ª`®g©M¥uª`®g¤p¾¯¶qªºCRF®É¡A¥À¹«­Ì·|¦b45¬í¤º¶W¹L20¦¸§ðÀ»¤½¹«¡C¦Ó¤¤¾¯¶qªº¥À¹««h·|¦b¤K¬í¤º§ðÀ»¤»¦¸¡F°ª¾¯¶qªº¥À¹««o¤°»ò¨Æ¤]¤£°µ¡C


 ¦b¬ü°ê«Â´µ±d¨¯¤j¾Ç³Á­}»¹®Õ°Ï°Êª«¾Ç¨tªº§U²z±Ð±ÂStephen Gammieªº¹êÅç«Ç¤¤¡A¤@°¦¥À¦Ñ¹«¥¿¦b«OÅ@©MÁý¾iµÛ­è¥Í¥X¨Ó¤T¤Ñªº¤p¦Ñ¹«¡CStephen Gammie±Ð±Â¤@ª½³£¦b¬ã¨s¦Ñ¹«¤¤¥À©Ê§ðÀ»©Ê©M²üº¸»X¿@«×¶¡ªºÃö«Y¡C³oºØ²üº¸»X·|±±¨î°Êª«¹ï®£Äß©MµJ¼{ªº¤ÏÀ³¦æ¬°¡C·Ó¤ù¨Ó·½: Michael Forster Rothbart


¦bStephen Gammie±Ð±Âªº¹êÅç«Ç¤¤¡A¤@°¦¥À¦Ñ¹«¥¿¦b«OÅ@©MÁý¾iµÛ­è¥Í¥X¨Ó¤K¤Ñªº¤p¦Ñ¹«¡C³o¬O¤@±i±qÅ¢¤l©³³¡Æ[¬Ýªº·Ó¤ù¡C
·Ó¤ù¨Ó·½: Michael Forster Rothbart

Gammie®Ú¾Ú³o­Óµ²ªGªí¥Ü¡A­°§CCRF¿@«×¦ü¥G¬O§Î¦¨¥À©Ê«I²¤¦æ¬°ªº¥²­n±ø¥ó¡C¬ã¨s¤H­û»{¬°³o­Óµ²ªG©Î³\¥i¥H¸ÑÄÀ¬°¦ó²£«á¼~Æ{¯g¡]postpartum depression¡^ ªº¥À¿Ë·|©¿²¤¥L­Ìªº¤l¤k¬Æ¦Ü©ó­h«Ý¥L­Ì¡A¦]¬°²£«á¼~Æ{¯g¥i¯à©M°ªCRF¦³Ãö¡C©Î³\±N¨Ó¥i¥H³]­pªýÂ_©Î«ú§ÜCRF±µ¨ü¾¹ªºÃĪ«¨Ó¶i¤@¨B±±¨î¦]À£¤O¦Ó¤Þ°_ªºµJ¼{¡C

­ì©l¤åÄm¡GS.C. Gammie, A. Negron, S. M. Newman, and J. S. Rhodes. Corticotropin-Releasing Factor Inhibits Maternal Aggression in Mice. Behavioral Neuroscience (DOI: 10.1037/0735-7044.118.4.000)

Åöíw»P¹[Â÷¤l³q¹DªºÃö«Y

7/23/2004, Science, Ãö©óÅöíw¡]seizure¡^¡A¤@ª½¤£Â_¦a¦³·s²z½×³Q´£¥X¨Ó¸ÑÄÀ¥¦ªº¦¨¦]¡CÅöíw¦bÂå¾Ç¤Wªº©w¸q¬O¡A¸£³¡¯«¸g²Ó­M¥H¶W¹L¥¿±`²Ó­M¥|­¿ÀW²v¨ÓÄÀ©ñ¹q¯ß½Ä¡]fire electrical impulses¡^¡CÅöíwªº¯f¤H¦bµo§@¹L¤@¦¸«á¡A¦Aµo§@ªº¾÷²v´N«Ü°ª¡C¬°¤°»ò©O¡H¦b1982¦~¡AC. E. Ribak¦bJournal of Neuroscience¤W´£¨ìµo§@ªº­ì¦]¬O¥Ñ©ó§í¨î©Ê¯«¸g¤¸ªº¦º¤`¡]loss of inhibitory interneurons¡^¡F¦ý¥Ø«e³Ì¼s¬°±µ¨üªº²z½×«h¬O¶b¬ð¤ÀªK°²»¡¡]axonal sprouting hypothesis¡^¡C

C. Bernard¦b2004¦~ªºScience¤W´£¥X¤F¥t¤@­Ó¤£¦PªºÆ[ÂI¡G¥L»{¬°¦Aµo§@ªº­ì¦]©M¯«¸g²Ó­M¤WªºA«¬¹[Â÷¤l³q¹D¡]type A ¡VK+ channel¡^¡A¨ä¼Æ¶q´î¤Ö©M¥\¯à³Q§í¨î¦³Ãö¡C ¶b¬ð¤ÀªK°²»¡¬O2001¦~¥ÑJ. P. Wuarin, F. E. Dudek©Ò´£¥X¡C¦b¶b¬ð¤ÀªK°²»¡¤¤¡G·í¯«¸g²Ó­M¦b©¹¤U¶Ç»¼°Ê§@¹q¦ì¡]action potential¡^®É¡A¥i¥HÂǥѶb¬ð¤ÀªK¡]sprouted axon¡^§â¹q¦ì¶Çµ¹ªþªñ²Ó­Mªº¾ð¬ð¡]neighbor¡¦s dendrite¡^¡C·í¯«¸g²Ó­M¨ü·l¦A¥Í®É¡A­Y·s¥Íªº¶b¬ð¤£·Ó³W¯xªø©¹¯«¸g¶Ç¾É¸ô®|¡]signal pathway¡^ªºÂà±µ¯«¸g¤¸¡]relay neuron¡^¡A¦Óªø¦Vªþªñªº²Ó­M¾ð¬ð¡A´N·|§â¹q¦ì¶Ç¦^¨ì¯«¸gºô¸ôªº­ìÂI¡]network of origin¡^¡A³o­Ó²{¶HºÙ¬°¥¿¦V¦^õX¡]positive feedback¡^¡A¤]¬O¨ÏÅöíw²£¥Íªº­n¯À¡C

C. Bernard¦b2004¦~ªºScience«h¤S´£¥X¥t¤@­Ó¤£¦PªºÆ[ÂI¡G¥L»{¬°¦Aµo§@ªº­ì¦]©M¯«¸g²Ó­M¤WªºA«¬¹[Â÷¤l³q¹D¡]type A ¡VK+ channel¡^¡A¨ä¼Æ¶q´î¤Ö©M¥\¯à³Q§í¨î¦³Ãö¡C°Ê§@¹q¦ì¥Ñ¥»Åé¡]soma¡^µo¥X¡A¶Ç©¹¶b¬ð¡A¶Ç©¹¾ð¬ðªº³¡¥÷«Ü¤p¡A¦]¬°¦³A currentªº¦s¦b¡]A current´N¬O¾ð¬ð¤Wªºtype A ¡VK+ channel¥´¶}©Ò³y¦¨ªºion current¡^¡A©¹¤W¶Ç¨ì¾ð¬ðªº¹q¦ìºÙ¬°echo¡C­Y¥¢¥hA current¡A°Ê§@¹q¦ì¦^­µ¡]action potential reverberation¡^´N¯àµo¥Í¡AµL½×sprouting¬O§_²£¥Í¡C ¦ý¬OBernardÁÙ¤£ª¾¹D²Ä¤@¦¸ªºÅöíw¦p¦ó¨ÏA current´î¤Ö¡]downregulation¡^¡C ¤j³¡¥÷ªº¯«¸g²Õ´³£¾Ö¦³°j¸ô¡]recurrent connections¡^¡ABernardªº¬ã¨s¥i¥HÅý§Ú­Ìª¾¹D¬°¤°»ò¬Y¨Ç§í¨îA currentªºÃĪ«·|¦b¥¿±`¤H¨­¤W¤ÞµoÅöíw¡C¤]³\§Ú­Ì¤]¯à¤j´T­°§CÅöíwªº¦Aµo¥Í²v¡C

­ì©l¤åÄm¡GK. Staley et al. NEUROSCIENCE Epileptic Neurons Go Wireless. Science, Vol 305, Issue 5683, 482-483 , 23 July 2004

°ò¦]¬ðÅܬOªü´þ®üÀq¯gªº¥D¦]

7/26/2004, Science Now, ªü´þ®üÀq¯g¡]Alzheimer's Disease¡^¨ã¦³®a±Ú©Ê¡A¦ý¥Ø«e¤wª¾¨Ã¤£¬O¤@ºØ¿ò¶Ç¯e¯f¡C½T¤Áªºªü´þ®üÀq¯g¦¨¦]¦Ü¤µ¤´¤£²M·¡¡C³Ì·sªº¬ã¨sÅã¥Üªü´þ®üÀq¯g¥i¯à¸ò²É½uÅ骺¬ðÅܦ³Ãö¡C

¬ã¨s¤H­û¦Ü¤µ¤w¸gµo²{¬Y¨Ç©M¡u®a±Ú©Êªü´þ®üÀq¯g¡v¦³Ãöªº°ò¦]¡AµM¦Ó³o¨Ç¯S®í°ò¦]¹ï¡u±ßµo©Êªü´þ®üÀq¯g¡vªº¼vÅT¤´µM¨S¦³­«­nªºÃöÁp¡C¥[¦{¤j¾Çº¸ÆW¤À®Õ¡]University of California, Irvine¡^ªºDouglas Wallace ¤Î¨ä¦P¤¯µo²{¡A²É½uÅ餺DNA ªº¬ðÅÜ¥i¯à¬O¾É­P±ßµo©Êªü´þ®üÀq¯gªº°_¦]¡C¬ã¨s¤H­ûµo²{¡A¦b¤ñ¸û¥|¤Q­Ó¦~ÄÖ¬Û·íªº¥¿±`¤H©M¤G¤Q¤T­Óªü´þ®üÀq¯g¯f¤Hªº¸£³¡ÀËÅé«áµo²{¡A¦³65% ªºªü´þ®üÀq¯gªº¯f¤H¦b¸£³¡½Õ±±²É¸¢Åé°ò¦]ªí²{ªºDNA¤W¦³¬ðÅÜ¡C¬ã¨s¤H­û¦P®Éµo²{¡A¦­´Áµo¥Íªº¸£³¡°ò¦]¬ðÅÜ·|¾É­P¤j¶q²Ó­MÄâ±a¬ðÅܰò¦]¡A¨Ã¥i¯à¬O¾É­P¬Y¨Çªü´þ®üÀq¯g±wªÌ¸û¦­¦º¤`ªº­ì¦]¡C

«¢¦òÂå¾Ç°|¯«¸g¿ò¶Ç¾Ç®aRudolph Tanziªí¥Ü¡AÁöµM³o­Ó¬ã¨s¥O¤HÆf¥Ø¡A¦ý¬O¥Ñ©ó¼Ë¥»¼Æ¶q¹L©ó¯U¤p¡A¦Ó¥B°ò¦]¬ðÅܪº¤ñ¨Ò¡]65%¡^¨Ã¤£¬O«Ü°ª¡A©Ò¥H±ßµo©Êªü´þ®üÀq¯g©M¦¹²É¸¢Åé°ò¦]¬ðÅܪº¯u¥¿Ãö«Y¤´«Ý¶i¤@¨Bªº¬ã¨s¡C

­ì©l¤åÄm¡GCoskun, P.E. et al., Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. PNAS 101, p10726, 2004

¦p¦ó§Î¦¨¬V¦âÅ骺»E¦Xµ²ºc

6/3/2004, Howard Hughes Medical Institute, ¦b²Ó­M½Æ»sªº¹Lµ{¤¤¡A¬V¦âÅé¥ÑÂ÷´²ª¬ºA§Î¦¨°ª±K«×ªº»E¶°µ²ºc¬O¤@­Ó¬Û·í­«­nªºÀô¸`¡C¤Ö¤F³o­Ó¨BÆJ¡A½Æ»s¦¨¬°Âù¥÷ªº¬V¦âÅé¦b¤À°t¨ì¨â­Ó¤l²Ó­Mªºµ{§Ç¤¤´N¦³«Ü¤jªº¾÷²v·|µo¥Í¬V¦âÅé¤À°t¤£§¡ªº¿ù»~¡CÁöµM¥Ø«e¹ïDNA¦p¦ó§Î¦¨®Ö¤pÅé¡]nucleosome¡^ªº¤@¯Å¬V¦âÅéµ²ºc¦³¬Û·íµ{«×ªº»{ª¾¡A¦ý¬O¹ï©ó§ó°ª¼h¯Åªº¬V¦âÅéµ²ºc¬O¦p¦ó§Î¦¨ªº«o¯Ê¥F¤F¸Ñ¡C¦]¦¹¡A³o¥÷¬ã¨s¥H¤j¸z±ìµß¤¤ªºMukBEF³J¥Õ½è¡]ÄÝ©ó°Ñ»P¸û°ª¼h¯Å¬V¦âÅé¥]²Ï¹Lµ{ªºcondensin³J¥Õ½è¡^§@¬°¹êÅç¹ï¶H¡A¨Ó¸Õ¹Ï¤F¸Ñ¬V¦âÅé¥]²Ï¦¨»E¦XÅ骺¹Lµ{¡C

   group photo-click to enlarge
Howard Hughes Medical Institute
ªºDr. Bustamante¥H¤Î¨ä¬ã¨s¹Î¶¤

³z¹L¤@®M¯àª½±µÆ[´úDNA¨ü¤O©µ¦ù©M¿W¥ß¦¬ÁY¹Lµ{ªº»ö¾¹¡AHoward Hughes Medical Instituteªº¬ì¾Ç®aµo²{¥ÑMukBEF³J¥Õ½è¥]²Ï¦¨»E¶°ª¬ºAªºDNA¦b¨ì¹F¤@¯S©w©Ô¤O¡]¤j¬ù¬O17 * 10-12 ¤û¹y¡^¤§¤U·|¦³³sÄò©Ê¡B©µ¦ùªø«×Ãþ¦üªº©µ®i¡A¦Ó¥B¦bµL¥t¥~²K¥[MukBEF³J¥Õ½è©M¯Ê¤ÖATPªº±¡ªp¤U¡A³Q©ÔªøªºDNA¤]¯à¦Û°Ê¦^ÂШì³Q©Ôªø¤§«eªºªø«×¡C¨Ì¾Ú¤@³s¦ê¬ÛÃöªº¹êÅç¼Æ¾Ú¡AHoward Hughes Medical Instituteªº¬ì¾Ç®a´£¥X¤@­Ó¥Î¨Ó¸ÑÄÀDNA¦p¦ó§Î¦¨»E¶°µ²ºcªº¼Ò«¬¾÷¨î¡GMukBEF³J¥Õ½èªº¨âºÝªþµÛ¨ìDNA¤W¤§«á¡A§Q¥ÎÃþ¦ü§¨¤l¤@¯ë±i¦Xªº¤è¦¡¨Ó¨ÏDNAÁYµu©Î¦ùªø; ¦ÓMukBEF³J¥Õ½è¤§¶¡«h¬O§Q¥ÎATPªþµÛ¨ìDNA¤W©ÒÄÀ©ñªº¯à¶q¨Ó¤¬¬Û³sµ²¡C¦]¦¹¡AMukBEF³J¥Õ½è°ò¥»¤W´N¹³¤@±Æ¤¬¬Û³s±µªº§¨¤l¡Aªþ¦bDNA¤W¥H§¨¤l¤@ºÝ¶}¤f­«½Æ±i¦Xªº¤è¦¡¨Ó½Õ±±DNAªº¦ùªø©ÎÁYµu¡C

³o¶µ¶O®É¤T¦~ªº¬ã¨s¦¨ªG¤£¶È´£¨Ñ¤F¤@®M¦³½ìªº¾÷¨î¨Ó¸ÑÄÀDNA¦p¦ó¥]²Ï¦¨ºò±K»E¦Xµ²ºc¡A¤]¦³§U©ó¬ì¾Ç¬É¹ï²Ó­M¶i¦æ½Æ»sªº¸Ô²Ó¾÷¨î¦³§ó¶i¤@¨Bªº¤F¸Ñ¡C

­ì©l¤åÄm¡GCase, R. B. et al., ¡¥The bacterial condensin MukBEF compacts DNA into a repetitive, stable structure.¡¦ Science 305, 222-227 (2004)
Published online 3 June 2004 [DOI: 10.1126/science.1098225] (in Science Express Research Articles)

¤T¤d¤T¦Ê¸U¦~«e´Nºt¤Æ¥X¨Óªº§Ü·R´þ³J¥Õ

6/29/2004, Fred Hutchinson Cancer Research Center, ³Ìªñ¬ã¨sµo²{¡A¤HÅ餺¦³¤@ºØ³J¥Õ½è¯à°÷³y¦¨HIVªº°ª«×¬ðÅÜ¡A¨Ï¥¦µLªk¶¶§Q¼W´Þ¡A¦]¦Ó§í¨î¯f¬rªºÂX´²¡C¦ý³o­Ó³J¥Õ½è«o¦bHIVºt¤Æ¥X¨Óªº¤T¤d¨â¦Ê¸U¦~«e¡Ð¤]´N¬O¶Z¤µ¤T¤d¤T¦Ê¸U¦~«e¡Ð´N¤w¸g¥X²{¤F¡C

¤£¦PªºAIDS±wªÌ¹ï©óHIV·P¬Vªº±Ó·P©Ê¡]susceptibility¡^¥H¦Ü©ó¯fµ{¡]progression¡^¨Ã¤£¬Û¦P¡A³o»P·P¬Vªº¯f¬r«~¨t¤Î±wªÌ¥»¨­ªº°ò¦]²Õ¦¨¦³Ãö¡C¶V¨Ó¶V¦h¬ã¨sµo²{¡A¤HÃþ¬Y¨Ç°ò¦]·|¤j¤j¼vÅT¨ì¯f¬rªººt¤Æ¡F¨ä¤¤¤@­Ó¡A¬O¦W¬°apolipoprotein B¡Vediting catalytic polypeptide 3G¡]APOBEC3G¡^ªº°ò¦]¡C APOBEC3G¬O¤@ºØ­MáGÔr²æÓi酶¡]cytidine deaminase¡^¡A¨ã¦³DNA°Å¿è¡]editing¡^ªº¥\¯à¡A¯à±NHIV¤Î·áµU§K¬Ì¯Ê³´¯f¬r¡]simian immunodeficiency virus¡ASIV¡^cDNA¤¤ªº­MáGÔrÂàÅܦ¨§¿áGÔr¡]uracil¡^¡A±µµÛ¦b¯f¬rªº°ò¦]Åé¤W³y¦¨³\¦h³¾ÁTáIËï¡]guanine¡^Âন¸¢áIËï¡]adenine¡^ªº¬ðÅÜ¡C

HIVÄÝ©ó¤ÏÂà¿ý¯f¬r¬ì¡]Retroviridae¡^ºC¯f¬rÄÝ¡]Lentiviruses¡^¡CºC¯f¬rÄݪº¯f¬rµ´¤j³¡¤À¨ã¦³¤@­Ó¦W¬°Vif¡]virion infectivity factor¡^ªº°ò¦]¡A¨ä³J¥Õ½è²£ª«¯à»PAPOBEC3Gµ²¦X¡A¨Ã§â¥¦¥á¨ì³J¥Õ¸ÑÅé¡]proteasome¡^¤¤¤À¸Ñ±¼¡AÂǦ¹«OÅ@·s¥Í¦¨ªº¯f¬r¤£¨ü¼vÅT¡C¥Ñ©ó¥\¯à«ú§Ü¡AAPOBEC3G©MVif¦b¤Ñ¾Ü¤U¤¬¦³®øªø¡A±H¥D©M¯f¬r¹³¦bÁ|¦æ­x³ÆÄvÁɤ@¯ë¡AÂǵۤ£Â_²£¥Íªº¿ò¶ÇÅܲ§°µ¬°­x³Æ§ó·s¡C³o¼ËªºÄvª§¡A³q±`·|¥[³tª«ºØ¬ðÅܳt²v¡A¬ðÅܪº³¡¤À®e©ö³Q«O¦s¤U¨Ó¡A³o«KºÙ¬°¥¿¦V¿ï¾Ü¡]positive selection¡^¡C

¬ã¨sµo²{¡AAPOBEC3G¦bÆFªøÃþ°Êª«ªººt¤Æ¹Lµ{¤¤´¿¸g¹L«D±`¦h¦¸¥¿¦V¿ï¾Ü¡C³z¹L¤ÀªR·s¥@¬ÉµU¡BÂÂ¥@¬ÉµU¡B¤jµVµV¤Î¤HÃþµ¥12ºØÆFªøÃþ°Êª«ªºAPOBEC3G°ò¦]¡Aµo²{¥¦ªº¥X²{¥i°l·¹¦Ü¤T¤d¤T¦Ê¸U«e¡C¦ý³Ì¥O¬ã¨s¤H­ûÅå³Yªº¬O¡A¥¿¦V¿ï¾Ü¶}©l¦bAPOBEC3G¨­¤W§@¥Îªº®É¶¡»·¦­©óºC¯f¬r¥X²{ªº®É¶¡¡Ð«áªÌ¦ô­p³Ì¦­¤£¶W¹L¤@¦Ê¸U¦~«e¡C³oªí¥Ü¤T¤d¸U¦~¨Óµ¹¤©APOBEC3GÄvª§À£¤Oªº¹ï¤â¥t¦³¨ä¤H¡AHIV¬O«á¨Ó¤~¥[¤J¾Ô§½ªº¡F¤]¦]¬°¥[¤J®É¶¡µu¼È¡AAPOBEC3GÁÙµLªk¹ïHIV²£¥Í±M¤@¯}Ãa©Ê¡A¦Ó¬O¹ï¾ã­ÓºC¯f¬rÄݳ£¦³§@¥Î¡C

Áö¥Ø«e©|µLªk½T©w­þ¨Ç°ò¦]°Ñ»P¤F³o­Óºt¤ÆÄvª§¡A¤S¬O¸g¹L«ç¼ËªºÄvª§¾÷¨î¡A¦ý­Y¥[¥H²`¤J¦Ò¶q¬ã¨s¡A¬Û«H¹ï·R´þ¯f¬Æ¦Ü¬O¨ä¥L¯e¯fªºªvÀø¡A³£·|¦³²ö¤jªºÀ°§U¡C¦¹¥~¡A¦bµo²{APOBEC3G¤§«e¡ARNA/DNA°Å¿è¥u³Q»{¬°»P¿ò¶Ç±K½Xªº¦h¼Ë©Ê¦³Ãö¡F²{¦b¸g¥ÑAPOBEC3G¹ï§í¨î¯f¬rÁc­lªº¬ã¨s¡A¦³§U©ó§Ú­Ì¹ïÆFªøÃþ°Êª«Å餺®Ö»Ä°Å¿èªº¤F¸Ñ¡F¦Ó³oºØ¥HRNA/DNA°Å¿è·í§@§í¨î¥~¨Ó°ò¦]ªº¤èªk¡A¥i¯à¥¿¬OÆFªøÃþ¯ª¥ý©Ò¥õ¿àªº¨¾¿m¾÷¨î¡C

­ì©l¤åÄm¡G Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G. PLOS Biology 2(9):e275 (2004).

ÁA¸Ñ§Ü·R´þ¯f³J¥Õ½èAPOBEC³J¥Õ

6/24/2004, Eureka Alert, ¹ï©ó¯à¹ï§Ü·R´þ¯f¯f¬rHIVªº«g¬P¢w¢wAPOBEC3G¡]apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G protein¡^¤@±Ú¦³¤F§ó¶i¤@¨Bªº»{ÃÑ¡C

¥Ø«e´X¥G¥i¥H»¡¬O¥´¹M¤Ñ¤UµL¼Ä¤âªºHIV¨Ã«D¯u¥¿¤Ñ¤UµL¼Ä¡A¦b¤HÅ餤¤@ºØ¥s°µAPOBEC3Gªº³J¥Õ½è·|¦bHIV¶i¦æ¤ÏÂà¿ý¦¨cDNAªº¶¥¬q®É¡A³y¦¨¨äcDNA¤WÆP°òªº¬ðÅÜ¡]­MáGÔr¡]cytidine¡^ÂàÅܦ¨§¿áGÔr¡]uracil¡^¡^¡A¨Ï±oHIVªº·P¬V¤O¤U­°¡C¤£¹L¹D°ª¤@¤Ø¡AÅ]°ª¤@¤V¡A¨Ã«Dµ¥¶¢¤§½úªºHIV·|»s³y¤@ºØ¥s°µ¯f¬r·P¬V¦]¤l³J¥Õ¡]virion infectivity factor, Vif¡^ªºªZ¾¹¨Ó©è¿mAPOBEC3Gªº§ðÀ»¡C

·íµM¬ì¾Ç®a¤£·|¦]¦¹¦Ó®ð¾k¡A©Ò¿×ª¾¤vª¾©¼¡A¦Ê¾Ô¦Ê³Ó¡C¥Ñ©ú¥§Ä¬¹F¤j¾Ç¡]University of Minnesota¡^Reuben Harris©Ò»â¾Éªº¬ã¨s¤p²Õ©ó³Ìªñµoªí¤F¹ïAPOBEC¤@±Úªº¤ñ¸û¡C ¦b³o­Ó¹êÅç·í¤¤¡A¥L­Ì¤ñ¸û¤F¤HÃþªºAPOBEC®a±Ú¦¨­û¡A¥]¬A¤FAPOBEC3G¡]hA3G¡^µ¥¤CºØ³J¥Õ½è¡B¤p¹«ªºAPOBEC3¡]mA3¡^¤Î¤j¹«ªºAPOBEC1¡]rA1¡^¹ïHIV­P¯f¤Oªº§í¨î±¡§Î¡Cµ²ªGÅã¥Ü¡A¦b¯f¬r·P¬V¦]¤l³J¥Õ¦s¦bªºª¬ªp¤U¡AmA3»PrA1¹ï©óHIVªº§í¨î¤O³Ì¬°Àu²§¡A¨ä¦¸«h¬OhA3B¡C ¦Ó¦b¨S¦³¯f¬r·P¬V¦]¤l³J¥Õªº¦s¦b¤U¡AhA3G¹ï¯f¬rªº§í¨î¤OÁö¬O¤HÃþAPOBEC®a±Ú¦¨­û¤¤³ÌÀu¨qªº¡A¥i¥HÅý50¢H¥H¤WªºHIV§Ç¦C²£¥Í¬ðÅÜ¡F¦ý¬O¦b¯f¬r·P¬V¦]¤l³J¥Õ¦s¦b®É¡Aªí²{¤Ï¦Ó¤£¦phA3B¡C¦Ü©óhA3Fªºªí²{«h»PhA3G·¥¬°Ãþ¦ü¡C

¥t¥~¥L­ÌÁÙ´ú¸Õ¤F³o¨ÇAPOBEC³J¥Õ¨Ó¹ï¹«¥Õ¦å¯f¯f¬r¡]murine leukemia virus, MLV¡^ªº§í¨î¤O¡Cµ²ªGµo²{°£¤FhA3G¥H¥~¡A¨ä¥LAPOBEC³J¥Õ³£¨S¦³§í¨îMLVªº²{¶H¡A§Y¨Ï¬O¹ï§í¨îHIV­P¯f¤Oªí²{·¥¨ÎªºmA3¥H¤ÎrA1¤]¬O¤@¼Ë¡C¥Ñ©ómA3»PAPOBEC3G¦³30¢Hªº§Ç¦C¬Û¦ü¡A©Ò¥H¥L­Ì»{¬°MLV¥i¯àºt¤Æ¥X¤£¦P©óHIV¹ï§Ü¦Ñ¹«APOBEC³J¥Õªº¾÷¨î¡C ¦ýAPOBEC³J¥Õ´N¦p¦P¤@§âÂù­±¤b¡AReuben Harris»{¬°³oÃþ³J¥Õ½è³Ì°ò¥»ªº¥ô°È¥i¯à¬O¨¾¤î¡u¥~¨Óªº¡v®Ö»Ä´²§G¡A¸U¤@³oÃþ³J¥Õ½è¥¢±±ªº¸Ü¡A¤]³\·|¨Ï±o²Ó­M¤º¾ãÅé¬V¦âÅé¬ðÅܪº¾÷²v¼W¥[¡A±q¦Ó¾É­PÀù¯gªºµo¥Í¡C ¦Ó¥B¤£¬O¨C­Ó·R´þ¯f±wªÌÅ餺³£¦³APOBEC³J¥Õ§í¨îHIV­P¯f¤Oªº²{¶H¡C¹ï©ó¦ó¥H¦³¨Ç¤H¯à©è¿m·R´þ¯fªº«Iŧ¡A¦³¨Ç¤H¤£¯à¡A¦Ü¤µ©|¥¼¦³©w½×¡C¹ï§ÜHIV³oºØ¦l¶B¬¾·âªº¯f¬r¤´¦³¤@¬qº©ªøªº¸ô­n¨«¡C¦b¨S¦³¯à¹ý©³ªvÀø·R´þ¯f¤èªk¦s¦bªº·í¤U¡A¦³®Ä©è¿m·R´þ¯f§ðÀ»ªº¤èªk¤´¬O·R±¤¦Û¤vªº¨­Åé¡A¤£­n³x¤@®É¤§§Ö¦Ó¸¨¤JHIVªºÅ]´x¡C

­ì©l¤åÄm¡GKate N. Bishop, et al. Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins. Current Biology, published online June 24,2004.

ªvÀø¥Õ¦å¯fªº¬ã¨s¥X²{­«¤j¬ð¯}

7/26/2004, Science, Âå¾Ç¤W­ì¥»¹ï©óºC©Ê°©Åè©Ê¥Õ¦å¯fªºªvÀø¬O¥HGleevec³oÃþ­«ÂIÃĪ«ªvÀø¬°¥D¡A¦ý§ÜÃĩʪº°ÝÃD«ùÄòÂX¤j¡A¤@«×Åý¬ì¾Ç®a¬Û·í§xÂZ¡A¦p¤µ¦³¬ü°ê¬ì¾Ç®a¬ãµo¥X·s¤@¥NªºÃĪ«¡A¥i±æÓV¸Ñ¥Ø«eªºµ~¹Ò¡C

¥Õ¦å¯f¡]leukemia¡^¡A§Y«UºÙªº¦åÀù¡A¬O°ê¤º¤Q¤j°ªµo´c©Ê¸~½F¤§¤@¡AÄÝ©ó³y¦å¨t²Îªº´c©Ê¯e¯f¡A»P¤@¯ëªºÀù¯g¸û¬°¤£¦Pªº¬O¡A¨ä­P¯f­ì¦]¤´¦b©ó³y¦å²Õ´¤¤¬YÃþ²Ó­M¦b°©Åè©Î¨ä¥¦³y¦å²Õ´¤¤²§±`¼W´Þ¡A¨Ã¶i¤@¨B«I¥Ç¤HÅ餺¦U¤ºÅ¦²Õ´¡A¾É­P¥¿±`³y¦å²Ó­M¨ü¨ì§í¨î¡AÁ{§É¤W²£¥Íªº¯gª¬³q±`¥]¬Aµo¿N¡B¥X¦å¡B³h¦å©M¨xŦ¡BµÊŦ»P²O¤Úµ²¸~¤jªº±¡§Î¡A¨Ì¸~½Fµo®i±¡§Î¥i¤À¬°«æ©Ê»PºC©Ê¥Õ¦å¯f¡A­Y¦A¥Ñ²§±`²Ó­Mªº¨Ó·½¨Ó¤ÀÃþ¡A¤S¥i¦A­Ó§O²Ó¤À¬°°©Åè©Ê»P²O¤Ú²y©Ê¥Õ¦å¯f¡C¥Õ¦å¯fªº¦¨¦]¬O¦h­«©Êªº¡A¥i¯à¥]¬A¿ç®g½uªº¼vÅT¡A¦pªø±T¡B¼s®qµo¥Í®ÖÃz«áªº­Æ¦s©~¥Á¿©±w¥Õ¦å¯fªº¾÷²v´N¸û¥¿±`¤H°ª¥X¥|¦Ê­¿¥H¤W¡F¤]¥i¯à¬O¦³¾÷¤Æ¦Xª«ªº¼vÅT¡A¦p¤w¦³¬ã¨s³ø§i«ü¥X¡Aªø´Á±µÄ²¦³¾÷­f¡A¤]®e©ö¿©±w¥Õ¦å¯f¡F¤]¦³¥ý¤Ñ©Êªº¿ò¶Ç¦]¯À¡A¦p­ð¤ó¯g¡]Down syndrome¡^©Î¤w¦³®a±Ú¯f¥vªÌµo¥Í²v¤]¸û¤@¯ë¤H¬°°ª¡FÁÙ¦³¯f¬r·P¬Vªº¥i¯à¡A¦p²Ä¤@«¬¤HÃþT²O¤Ú²y²Ó­M©Ê¯f¬r¡]Human T-Cell Leukemia Virus Type I, HTLV-I¡^ªº¼vÅT¡A¦UÃþ«¬¥Õ¦å¯fªº¦¨¦]¤ÎÁ{§Éªí²{¬Ò¤£ºÉ¬Û¦P¡C

±´¨s¨ä¤À¤l¼h­±ªº­P¯f¾÷¨î¡A¥HºC©Ê°©Åè©Ê¥Õ¦å¯f¡]chronic myeloid leukemia, CML¡^¬°¨Ò¡A¦¹Ãþ±wªÌ¤j¦h¦s¦b¶O«°¬V¦âÅé¡ePhiladelphia chromosome¡A±M«ü¦ì¦b²Ä9¹ï¬V¦âÅ骺ABL­ì­PÀù°ò¦]¡]Abelson proto-oncogene¡^±µ¨ì²Ä22¹ï¬V¦âÅ骺Â_µõÂIÂO¶°°Ï¡]breakpoint cluster region¡ABCR¡A±M«ü²Ä22±ø¬V¦âÅé¤W¯A¤Î¶O«°¬V¦âÅé©ö¦ì²{¶Hªº°Ï°ì¡^°ò¦]¤W¡A§Î¦¨BCR-ABL´O¦X°ò¦]¡]BCR-ABL chimeric gene¡^ªº±¡§Î¡A³oºØ±¡§Î¤j¬ù¦b95¢HªºCML¯f±w¤¤³£¥i¥Hµo²{¨ì¡f¡A³oºØ­PÀù©Êªº°ò¦]¬ðÅÜ·|¾É­P¤@ºØ²§±`ªº¿Ä¦X³J¥ÕBCR-ABLªº²£¥Í¡A³oºØ³J¥Õ½è¥²¶·¥ý»PATPµ²¦X¨Ó¬¡¤Æ¡A±µµÛ«P¶i¹TÓi»Ä¿E酶¡]tyrosine kinase¡^¬¡©Êªº´£¤É¡A¦¹¿E酶¦b²Ó­M¶g´Á¤¤§êºtµÛ­«­nªº¨¤¦â¡A¤×¨ä¬O¥i¥H³z¹LRas²Ó­M°T®§¶Ç¾É¸ô®|¨Ï²Ó­M²£¥ÍCdk-Cyclin½Æ¦XÅé¡A±µµÛ¦¹½Æ¦XÅé¤S¥i±N¼Ðªº³J¥ÕÁC»Ä¤Æ¡A¾É­P¦p®Ö½¤ªº¤À¸Ñ¡B¬V¦âÅ骺°ª«×»E¶°¡B¯¼Áèµ·ªº§Î¦¨µ¥±¡§Î¡A¥H§Q©ó²Ó­M¤Àµõªºµo¥Í¡C¥Ñ©ó¹TÓi»Ä¿E酶¨ü¨ì°ª«×¦a¬¡¤Æ¡A²Ó­M¤Àµõªº±¡§Î´N¤£¦A¨ü¨ì­ì¥»¥¿±`ªº²Ó­M¾÷¨î©Ò½Õ±±¡A¨Ï²Ó­M¤£Â_¦a²§±`¼W´Þ¡A³Ì«á¾É­P¤HÅ餺¥Õ¦å²yªº¹L«×¼W¥Í¡A§Y¤Þ°_ºC©Ê°©Åè©Ê¥Õ¦å¯f¡C­È±o¤@´£ªº¬O¡A¹TÓi»Ä¿E酶ªº¤£¨ü½Õ±±¦P®É¤]¬O³\¦h¨ä¥¦¸~½Fªº§Î¦¨¦]¯À¤§¤@¡C

¬°ªvÀøºC©Ê°©Åè©Ê¥Õ¦å¯f¡A¤@¶}©l¬O¥H¤Æ¾ÇªvÀø¬°¥D¡A¦p¨Ï¥Î¤zÂZ¯ÀªvÀø¡A§Y¥i¹F½w©M¯f±¡ªº¥Øªº¡A¦ý­Y­n¹ý©³®Úªv¡A«h¥u¦³³z¹L°ª¾¯¶q¤Æ¾ÇªvÀø¦X¨Ö°©Åè²¾´Ó¤~¦³¥i¯à¹F¨ì¥Øªº¡CµM¦Ó¥Õ¦å²y¨ã¦³ªí­±§Ü­ì¡A§Y¤HÃþ¥Õ¦å²y§Ü­ì¡]Human Leukocyte Antigen, HLA¡^¡A­Y¨S¦³¹J¨ì¦å½t¬Ûªñªº®aÄݩΨ䥦HLA¬Ûªñªº°©Åè®½ÃØªÌ¡A¦]¬°±Æ¥¸¦]¯Àªº¦Ò¶q¡A³q±`¤£«ØÄ³±µ¨ü°©Åè²¾´Ó¡A¦Ó¥u¥H¤Æ¾ÇÃĪ«ªvÀø¬°¥D¡C¦b³\¦hªvÀø¥Õ¦å¯fªºÃĪ«·í¤¤¡A³Ì¨ü¤Hª`¥Øªº²ö¹L©ó¬ü°ê­¹«~º[ÃĪ«ºÞ¨î¸p¡]Food and Drug Administration, FDA¡^©ó2001¦~5¤ë10¤é§Y§å­ã¤W¥«ªºªvÀøºC©Ê°©Åè¥Õ¦å¯f¡]CML¡^ªºÃĤY Gleevec¡]¤SºÙ¬°STI-571©Îimatinib¡^¡AGleevec»P¨ä¥¦ÃĪ«¤£¦P¡A¨ä¨Ï¥Î·sªº¾÷¨î¨ÓªvÀøCML¡Aºë½T¦a§ðÀ»Àù²Ó­M¦Ó¤£ªi¤Î¥¿±`²Ó­M¡A¤]¦]¦¹²£¥Íªº°Æ§@¥Î¤]¸û¨ä¥¦ÃĪ«¤Ö±o³\¦h¡A¥Ñ©ó±wªÌªA¥Î¦¹Ãįà°÷¨ÏÀù²Ó­M¼Æ¶q¤j´T¤U­°¡A¹ï©ó¨u¨£­P©RÀù¯g¦³À¸¼@©ÊªºÀø®Ä¡A¤@«×³QºÙ§@¬O¡u­«¤j¬ð¯}ªº¤fªA§ÜÀùÃÄ¡v¡CµM¦Ó¡AÀù²Ó­MªºÅܲ§©Ê¡]Heterogeneity¡^«o¦ü¥G§JªA³oºØÃĪ«±a¨Óªº¼vÅT¡AªA¥Î³oºØÃĪ«·U¤[¡A·U®e©ö²£¥Í¹ï¦¹ÃĨã§Ü©ÊªºÀù²Ó­M®è¡A³o¤]¦]¦¹¤@«×¦¨¬°¬ì¾Ç®a«æ±ý¸Ñ¨Mªº°ÝÃD¤§¤@¡C

­n¸Ñ¨M³o­Ó°ÝÃD¡A´N¥²¶·¥ý¤F¸ÑGleevec¬O¦p¦ó¦¨¥\±±¨î¦í¯f±¡ªº¡CGleevec¤§©Ò¥H¯à°÷§í¨î¦íBCR-ABL¿E酶¡A¬O¥Ñ©ó¨ä¯à°÷»PABLªºATPµ²¦X¦ì³sµ²¡A¨ÏATPµLªk»PABLµ²¦X¡A¹F¨ì§í¨îªº¥Øªº¡AµM¦Ó¡A³o¥u¦³¦bGleevec»PABLªºªºµ²¦X¦ìºò±Kµ²¦Xªºª¬ºA®É¤~¦³¥i¯àµo¥Í¡A¥Ñ©ó³oºØ±ø¥ó¤Wªº­­¨î¡A¦]¦¹·íABLªºµ²¦X°Ïªº³J¥Õ½èµ²ºc¥Ñ¬ðÅܳy¦¨Åܲ§ªº®É­Ô¡AGleevec´NµLªk»P¨äºò±Kµ²¦X¨Ó¹F¨ì§í¨î¥Øªº¡C©Ò©¯ÀNµØ¥ð´µÂå¾Ç¬ã¨s°|¡]Howard Hughes Medical Institute¡^ªº¬ì¾Ç®aNeil P. Shahµ¥¤H¤w¸g°w¹ï¦¹¤@°ÝÃD´£¨Ñ¸Ñ¨M¤§¹D¡A¥L­Ìµo²{¨ìSRC-ABL§í¨î¾¯¦P¼Ë¥i¥H»PABLªºATPµ²¦X¦ì¬Ûµ²¦X¥H¹F¨ì§í¨î¥Øªº¡A¦ý¤£»Ý­nºò±Kµ²¦Xªº±ø¥ó¡A§YµL½×¦¹µ²¦X¦ì¬O§_µo¥ÍÅܲ§³£¤£¨ü¼vÅT¡A¨Ãµo²{BMS-354825´N¬O¤@ºØ«Ü¦X¾Aªº§í¨î¾¯¡C¦b°Êª«¹êÅ礤¡A¬°Á×§K±Æ¥¸¤ÏÀ³ªºµo¥Í¡A¥L­Ì¥H¿©±w­«¯g½Æ¦X§K¬Ì¤£¥þ¯g­Ô¸s¡]Severe combined immunodeficiency, SCID¡^ªº¦Ñ¹«°µ¬°¬ã¨sÃD§÷¡A±N¦UºØ¤£¦PºØÃþªºBCR-ABL¬ðÅܲӭM¡]¥H¹«Ãþªº«eB²Ó­M¬°¥D¡^°e¤J¦Ñ¹«Å餺¡A¨Ã±j­¢¦Ñ¹«¤fªA¤£¦P·L¶qªºBMS-354825¡Aµ²ªGµo²{¡A¤j³¡¤Àªº¬ðÅܲӭM³£¦]¦¹¨ü¨ì¤F§í¨î¡A¨ä¤¤¤]¥]¬A¨ãM351T³oÃþ CML§ÜÃĩʱ`¨£¯f¨Ò¤¤ªº¬ðÅܪº²Ó­M¡F¬°ÀË´úBMS-354825¹ï¤HÅé°©Åè¥ýÅX²Ó­MªºÀø®Ä¡A¥L­Ì¥H¸ÕºÞ¤º¶°¸¨§Î¦¨³æ¦ì´ú¸Õªk¡]colony forming unit (CFU) assays¡A«ü¯à°÷¦Û¦æ½Æ»s¬°¤@§¹¾ã¶°¸¨ªº³æ¤@²Ó­Mªº´ú¸Õªk¡^¨ÓÀË´ú³o¨Ç²Ó­Mªº¦s¬¡±¡§Î¡Aµ²ªGµo²{¤£¦ý¥i¥H§í¨î·|²£¥ÍBCR-ABL¿E酶ªº²Ó­Mªº¼W´Þ¡A¤j³¡¤Àªº¥¿±`²Ó­M¤]³£¤£¨ü¼vÅT¡A³oªí¥ÜBMS-354825¹ï©ó¼Ðªº²Ó­M¨ã¦³°ª«×ªº¿ï¾Ü©Ê¡A«ê¦n«O¯d¤FGleevecªº¡uºë½T¦a§ðÀ»Àù²Ó­M¦Ó¤£ªi¤Î¥¿±`²Ó­M¡vªº²z·Q¯S©Ê¡C¥L­Ìªº³Ì·s¬ã¨s¦¨ªG¤w¥Zµn©ó¡m¬ì¾Ç¡n¡]Science¡^Âø»x¤W¡C

­YBMS-354825¯à°÷¦b¤HÅé¹êÅ礤¤]¦³¬Û·íªºÀø®Ä¡A«hÀ³·í¯à°÷³q¹L¥Íª«µ¥»ù©Ê¡]bioequivalence¡A³q±`¥Î¥H°µ¬°ÀË´ú¤wµù¥UÃĪ«»P¥¼µù¥U·sÃĶ¡ªº®t²§ªº¿Å¶q¼Ð·Ç¡A­Y¨âªÌ¦b¤HÅ餺©ÎªvÀø³¡¦ìªº§l¦¬®ÄªG¬Û·í¡A«hªí¥Ü¨ã¦³¥Íª«µ¥»ù©Ê¡A§Y¨âªÌ¶¡¥i¥H´À¥N¨Ï¥Î¡C§Y¨Ï¨ä¤¤¤@ºØÃĪ«ªº§l¦¬³t²v»P¥t¤@ºØ®t²§¬Æ¤j¡A¦ý­YµLÀø®Ä»PÂå¥Î¦w¥þ¤WªºÅU¼{¡A¤]¥iµø¬°¨ã¥Íª«µ¥»ù©Ê¡^ªºÀË´ú¶i¦Ó¨ú¥NGleevec¦¨¬°§ó¾A¦X§@¬°ªvÀø¥Õ¦å¯fªºÃĪ«¡A¾¨ºÞ¥Ø«eµo²{¨ìBMS-354825¹ï©ó¨ãT315I³oÃþ¦P¼Ë±`¨£ªºCML§ÜÃĩʯf¨Ò¤¤ªº¬ðÅܪº²Ó­M¨S¦³ÅãµÛªº§í¨î¥\®Ä¡A¦ýBMS-354825¤£¦ýÀø®Ä¤£¿é­ìGleevecÃĪ«¡A¨ä¹ï©ó§ÜÃĩʳoºØ·¥¬°½ÆÂø´Æ¤âªº°ÝÃD§ó´£¨Ñ¤FµL»ùªº¸Ñ¨M¤è®×¡AµÛ¹ê¹ï§JªA¥Õ¦å¯f¤@ª½¤£¿ò¾l¤Oªº¬ì¾Ç®a­Ì¥´¤F¤@¾¯±j¤ß°w¡C

­ì©l¤åÄm¡GShah et al., Overriding Gleevec Resistance with a Novel ABL Kinase Inhibitor. Science 2004 305: 399-401

¥Îª«²z­«¤O¼Ò«¬¨Ó¹w´ú¯f¬r©Ê¯e¯fªº¶Ç¼½

8/5/2004, Eureka Alert, ¬ü°ê»«¦{¦{¥ß¤j¾Ç(Penn State University) ©øÂκ[¥Íª«¾Ç¨t§U²z±Ð±ÂDr. Bjornstadµ¥¤H®M¥Îª«²z­«¤O¼Ò«¬¨Ó¹w´ú³Â¯l(measles)µ¥¯f¬r©Ê¯e¯fªº¶Ç¼½¡C Dr. Bjornstadªí¥Ü¡A¦b¹L¥h©Ò¹w´ú¯f¬r©Ê¯e¯fªº¶Ç¼½¬O®Ú¾Ú¶ZÂ÷¨Ó°µ°²³]¡A¦Ó¯f¬r¬y¦æ¦aÂI©Òºò¾Fªº«°Âí±N¬O¤U¤@­Ó¯e¯f¤j¬y¦æªº¦aÂI¡C¦ý²{¤µ¡A¥L­Ì©Ò¬ã¨sªº¦¨ªG¹ï³o¶µ»¡ªkªí¥Ü½èºÃ¡A¥L­Ì¬Æ¦Ü±Æ°£ªÅ®ð¶Ç¼½¬O¯f¬r´²¼½ªº¤è¦¡¡C

®M¥Îª«²z¾Ç©M¹B¿é²z½×¡A¨ä¬ã¨s¤H­û¨Ï¥Î¤@ºØ¦ñÀHµÛ¥H¶ZÂ÷¬°°ò¦ªº¸gÅç­«¤O¼Ò«¬¨Ó©w¸q¯f¬r¶Ç¬V©Ê¯e¯fªºªÅ¶¡¶Ç¼½ºô¸ô.¡CDr. Ottar Bjornstadµ¥¤H¦b¤µ¦~¤K¤ëªº¬ü°ê¥ÍºA¾Ç·|¦~«×·|ij¡]the annual meeting of the Ecological Society of America¡^¤¤ªí¥Ü¡A¥L­Ìªº¬ã¨s¥¿¬O¥H¬y¦æ¯f¾Çµ²¦XªÀ·|¾Ç¥H¤Î¹B¿é²z½×ªº¼Ò«¬¨Ó±´°Q¯f¬r¯e¯f¶Ç¼½ºô¸ô¡C Dr. Bjornstad«ü¥X¡A¦³¨Ç¤H´N¹³§Ú¤@¼ËÁöµM¦í¦b¸ô©ö´µ«°ªþªñ¡A¦ý¬O¯Ã¬ù¥«¿O¥ú°{Ã{¼ö¤O¥|®g¡A¤ñ¸ô©ö´µ«°§ó¥[±o§l¤Þ§Ú¡C¯f¬r´N¦n¤ñ¤H¤@¼Ë¡A¤£¤@©wÂQ©¹¾Fªñªº«°¥«¡A¤Ï¦Ó·|¨ì¨ã¦³§l¤Þ¤Oªº¤j«°¥«µo®i¡CµM¦Ó«°¥«´N¦n¤ñ¦æ¬P¤@¼Ë¡A¶V¤j´N¶V¦³§l¤Þ¤O¡A¦ý¬O§l¤Þ¤Oªº¤j¤p¤]¦]¶ZÂ÷ªº¼W¥[¦Ó´î¤Ö¡C

¬°¤F´ú¸Õ¥L­Ì©Ò³]­pªº¼Ò«¬¡A¥L­Ì¨Ï¥Î­^°ê¹L¥h¾ú¦~¨Ó·P¬V«Äµ£ªº³Â¯l¬y¦æ¯f¾Ç¸ê®Æ¡A¸ê®Æ¤W§¹¾ã°O¸ü±q¦è¤¸1940¦~¨ì²{¤µ­^°ê¦U¦a°Ï«Äµ£¤Î¨C¶g©M¨C­ÓªÀ°Ï³Â¯l¬y¦æ©Ò½¯©µªº±¡§Î¡C­^°ê·í§½¤w¦³¤j¬ù¦³1,000 ­Ó«°¥«©M 450 ­Ó¶m§ø¦a°Ïªº³ø§i¨ÃÃÒ¹ê³Â¯lÃzµo¤j¬ù¨C¹j¨â¦~µo¥Í¤@¦¸¡C¦]¦¹¡A¥L­Ì¹Á¸Õ®M¥Î¥L­Ìªº¼Ò«¬¨Ó¹w´ú³o¨Ç±Mªù·P¬V¥®µ£ªº³Â¯l¶Ç¼½¸ô½u¡C ¥t¤@¤è­±¡A¥L­Ì¤]µÛ¤â±´°Q¥L­Ì³]­pªº¼Ò«¬¬O§_»P³¥¥Í°Êª«¯e¯f¬ÛÃö¡A»«¦{¦{¥ß¤j¾Ç¥Íª«¨t¬ã¨s¥ÍLaura M. Warlow¦P®É»PBjornstad±q¨Æ«Ø¥ß³¥¥Í°Êª«¼Ò«¬¬ÛÃö¬ã¨s¡A±´°Q¤ü½E¼ö¯f¬r¡]distemper¡^¦b³Â´³®ü°\¡]harbor seals¡^©Ò½¯©µªº±¡§Î¡AWarlowµo²{¡A³Âªá®ü°\¤£¹³¤HÃþ¤@¼Ë®e©ö³Q¤j«°¥«©ú«Gªº¿O¥ú©Ò§l¤Þ¡A¥L­Ì¤Ï¦Ó¬OÂQ©¹¨ã¦³Â×´I­¹ª«ªº¤j®üÅy¡C

Warlowªí¥Ü¡A³o¨Ç¦b®üÅy»E¶°¦¨¤@¤j¸sªº®ü°\ºÙ¬°haul-outs¡A³oºØ¸s¸¨ªº¤j¤p¥¿»P®üÅyªº¤j¤p¥H¤Î­¹ª«±µªñ¦³«Ü¤jªºÃö³s¡C¦Ó³Âªá®ü°\´N¹³«Äµ£¤@¼Ë¡A·|Âǥѫy¹Â©¼¦¹¤§«e¶Ç¬V¤ü½E¼ö¯f¬r¡A¦b¦è¤¸1988©M2002¦~´N´¿µo¥Í¨â¦¸¤ü½E¼ö¯f¬rÃzµo¡A¤j¶q±þ¦º¥_®üªº³Âªá®ü°\¡C¦ÓWarlow«h¬O§Q¥Î©w¦ì¨t²Î©MªÅ¤¤Äá¼vªº¤è¦¡¨ÓÁA¸Ñ®ü°\¹ê»Úªº¼Æ¥Ø¥H¶i¦æ1988¦~ªº¯f¬rÃzµoªº¬ã¨s¡CWarlow§â©Ò±oªº¸ê®Æ®M¥Î©Ò³]­pªº¶ZÂ÷¼Ò«¬©M­«¤O¼Ò«¬¶i¦æ¬ã¨s¡Aµo²{­«¤O¼Ò«¬¯à§Ö³t¦a¹w´ú¶Ç¬Vµ¹®ü°\ªº¤ü·Å¼ö¯f¬rªº½¯©µ±¡§Î¡C

¦b§¹¦¨¹w´ú·P¬V«Äµ£»P°Êª«¯f¬r©Ê¯e¯fªº¼Ò«¬¤§«á¡A¥L­Ì·Q§ó¶i¤@¨B±´°Q·P¬V¦¨¤H¯f¬r©Ê¯e¯fªº¶Ç¼½¸ô½u¡CDr. Bjornstad»¡¡A¥L­Ì¥Ø«e¦b¬ü°ê°ê®a½Ã¥Í¤¤¤ßªºJohn E. Fogerty°ê»Ú¤¤¤ß±q¨Æ½Ã¥Í¬ì¾Ç¤è­±ªº¬ã¨s¡A¥L­Ì·Q§â¼Ò«¬À³¥Î¦b¦¨¤Hªº¤H¤f¼Æ¥H¤Î¨ã¦³³¡¤À§K¬Ì¤Oªº¤H¤f¼Æ¡A¨Ó±´°Q¬y¦æ©Ê·P«_¯f¬r¦b¦¨¤Hªº¶Ç¼½¸ô½u¡C

­ì©l¤åÄm¡GGrenfell, B.T., Bjørnstad, O.N., & Finkenstädt, B. (2002) Endemic and epidemic dynamics of measles: Scaling predictability, noise and determinism with the time series SIR model. Ecological Monographs 72: 185-202

·P«_¶K¤ù¥i¥H¬@±Ï³\¦h¦Ñ¤H

8/5/2004, Nature News, ¥þ¥@¬É¨C¦~¬ù¦³50¸U¤H¦º©ó¬y¦æ©Ê·P«_¡A¨ä¤¤¤j³¡¤À³£¬O65·³¥H¤Wªº¦Ñ¦~¤H¡CÁöµM¦b¬ü°ê¡AÂå¥Í­Ì«ØÄ³©Ò¦³65·³¥H¤Wªº¦Ñ¦~¤H³£­n±µºØ¬y·P¬Ì­]¡A¦ý¹ï¦Ñ¤H­Ì°I°hªº§K¬Ì¤O¨Ó»¡¡A¬y·P¬Ì­]¯à´£¨ÑªºÀ°§U¹ê¦b¦³­­¡A¤@¥¹¦Ñ¤H­Ìªº»ó¡BªÍ¾D¨ü¬y·P¯f¬r·P¬V¡A´N¥i¯à·|¤ÞµoªÍª¢©Î¨ä¥L­P©Rªº¯e¯f¡C©¯¦nªñ¤é¨Ó¡A¬ü°êªºIOMAI¤½¥qµo©ú¤F¤@ºØ¥i¥H¼W±j¬y·P¬Ì­]§K¬Ì¤ÏÀ³ªº¥Ö½§¶K¤ù¡A³oºØ¶K¤ù¹ï©ó§K¬Ì¤O°I°hªº¦Ñ¦~¤H¨Ó»¡¡A¹ê¬°¤@¤jºÖ­µ¡F¦Ó³o¶µ§Þ³N¦b¼Ú¬w¤]¤w¸g¶i¤J¤FÁ{§É¹êÅ窺¶¥¬q¡C

¦ì©ó¬ü°ê°¨¨½Äõ¦{»\¤h³ù¥«ªºIOMAI¤½¥q±q±`¤Þ°_­¹ª«¤¤¬rªº¤j¸z±ìµß¡]Escherichia coli¡^¤¤¡A´£¨ú¥X¤j¸z±ìµßªº¬r³J¥Õ¡A¤§«á±N©M§t¦³³oºØ¬r³J¥Õªº½¦¥¬¡A¶K¦b±µºØ¬y·P¬Ì­]«áªº°w¤Õ¤W¡A·í¬r³J¥Õ³Q¥Ö½§¤¤±M¥q§K¬Ìªº²Ó­M¡]Äõ­²¨u¤ó²Ó­M¡FLangerhans cell¡^±µÄ²¤§«á«Kµo´§¨ä»²§Uªº¥\¥Î¡]§Ú­Ì±N¤§ºÙ¬°¦õ¾¯¡Aadjuvant¡A¥Î¥H¼W¥[¬Ì­]¤§§K¬Ì­ì©Ê½è¡^¡A¨ë¿E¨­Åé¹ï¬Ì­]²£¥Í§ó±jªº§K¬Ì¤ÏÀ³¡A¨Ï§Ú­Ìªº¨­Å馳§ó±jªº¤O¶q¥h¹ï§Ü¬y·P¯f¬r¡C

¬Ì­]ªº±µºØ¤è¦¡¥D­n¤À¬°¤fªA¡B¥Ö¤Uª`®g¤Î¦Ù¦×ª`®g¤TºØ¡A¨ä¤¤¤fªA³oºØ¤è¦¡³Ì²Å¦X©ó¥@¬É½Ã¥Í²Õ´¡]World Health Organization¡A²ºÙWHO¡^ªº²z·Q¬Ì­]³W½d¡A­ì¦]¬O³Ì®e©ö±µºØ¡A¦ý²{¤µªº¤fªA¬Ì­]¥u¦³¤p¨à³Â·ô¬Ì­]¤@ºØ¦Ó¤w¡C¥Ñ©óIOMAI¤½¥q¤@ª½¥H¨Ó­P¤O©ó¬ãµo¡y¸g¥Öªº§K¬Ì¡z¡]transcutaneous immunization¡A²ºÙTCI¡A¸g¥Ñ¥Ö½§¹F¨ì§K¬Ì®ÄªG¡^¡A¨Ï±o¬Ì­]ªº±µºØ¤è¦¡¦h¤F¤@ºØ¡A¦Ó¥B±µºØªº«K§Q©Ê¤£¨È©ó¤fªA¡CTCI³oºØ·sªº¬Ì­]±µºØ¤è¦¡¡Aµ²¦X¤FÃĪ«¬ï³z¥Ö½§¡A¤Î¥H¦õ¾¯¬°°ò¦ªº§K¬Ì¨ë¿E¤ÏÀ³¡]adjuvant-based immunostimulation¡^³o¤è­±ªºª¾ÃÑ¡AÁÙ¦³¸ê®ÆÅã¥Ü¥X¡A¯u¥Ö¤¤ªºÄõ­²¨u¤ó²Ó­M¦b¨­¬°§Ü­ì§e²{²Ó­M¡]antigen-presenting cell¡^ªº¥\¯àµo´§¤¤¥i¥H§êºt²z·Qªº¥Ø¼Ð¨¤¦â¡C

IOMAI¤½¥q±N¤W­zªº¬ã¨s¦¨ªG¡Aµoªí¦bJournal of Virology¡A¨ä¤¤°Êª«¹êÅ窺³¡¤À¡AÅã¥Ü¥X¤ñ¸û¦Ñªº¦Ñ¹«¡A¦b¬I¥´¬y·P¬Ì­]«á¦A¶K¤W¶K¤ù¡A¯à¦³®Ä«P¶i¬y·P¬Ì­]ªº¤ÏÀ³¡F¶K¤W¶K¤ùªº°Êª«¡A¤]¤ñ³æ¿W¬I¥´¬y·P¬Ì­]ªº°Êª«¡A¨¬¨¬¦h¤F50­¿§Ü·P¬VªºT²Ó­M¡C³o®a¤½¥qªº°ÆÁ`µôLarry Ellingsworth«ÅºÙ¡A¥L­Ì¤w¸g¹ï¶W¹L50­Ó·ç¤h¦Ñ¦~¤H¶i¦æ³oºØ¶K¤ùªº¤HÅé¹êÅç¡AÁöµMµ²ªG©|¥¼¤½¥¬¡A¤£¹L±qEllingsworthªººA«×¤¤Åã¥Ü¡A¥L»{¬°³o¶µ¬ã¨s¤j¦³¥i¬°¡C¥L­Ì¤U­Ó¤ëÁÙ­n¹ï¤@­Ó¤ñ¸û¦~»´ªº¸ÕÅç¤p²Õ¶i¦æÃþ¦üªº¹êÅç¡AEllingsworth¹ï¥¼¨Óªºµ²ªG¤]©ê«ùµÛ¬Û·í¼ÖÆ[ªººA«×¡C ´¿¸g¾á¥ô¹LIOMAI¤½¥qÅU°Ýªº¬ü°ê§ùÄõ¤j¾Ç§K¬Ì¾Ç®aJohn Clements¯S§O«ü¥X¡A³oºØ¥Ö½§¶K¤ù©Î³\¥i¥H¥Î¨Ó¼W¶i¨ä¥LºØÃþ¬Ì­]ªº§K¬Ì¤ÏÀ³¡A«Äµ£©Î¬O·R´þ¯f±w³oÃþ§K¬Ì¤£°·¥þªº¸sÅé¡A¤]¥i¯à±q³oºØ¥Ö½§¶K¤ù¤¤Àò¯q¡C

³\¦h¨ä¥Lªº¬ã¨s¹Î¶¤³£¦b§ä´M¤èªk¡A¥L­Ì¨Ï¥Î¦UºØ¦õ¾¯¡B¦UºØ¤èªk¨Ó¶Ç°e¬Ì­]¡A¥Î¨Ó´£¤É¬y·P¬Ì­]¨Ï¥Î¦b¦Ñ¦~¤H¨­¤Wªº®Ä¤O¡C¨Ò¦pª½±µ§â¦õ¾¯ª½±µ¥[¤J¬Ì­]¤¤¡A©Î¬O¥Î»óµÄ¼Q¾¯ªº¤è¦¡§â¬Ì­]°e¤JÅ餺¡C¨Æ¹ê¤W¡A¦³¨Ç¬Ì­]¤¤¦­´N¤w¸g¥]§t¦õ¾¯¡A¨Ï¥Î¤j¸z±ìµß¬r³J¥Õªº¤èªk¤]¤w¸g¦n´X¤Q¦~¤F¡A¦ý¬Oª½±µ§â¬r³J¥Õ¥[¶i¤fªA©Î»óµÄ¼QÅx¬Ì­]¤¤ªº§@ªk¤w¸g¼È®É³Q°±¤î¡A¦]¬°³oºØ§@ªk¥i¯à·|¤Þµo¤Ó¹L±j¯P¤Î¦MÀIªº§K¬Ì¤ÏÀ³¡CEllingsworth«ÅºÙ¡A¦pªG§â¨Ï¥Î¬r³J¥Õ³oºØ¤èªkÀ³¥Î©ó¥Ö½§¶K¤ù¡A¥u·|¤Þ°_»´·Lªº¤ÏÀ³¡C ­^°ê³·µáº¸¤j¾Ç¬ã¨s¬y·P¬Ì­]ªºRoy Jennings¤]»{¬°¥Ö½§¶K¤ù¬O¤@­Ó¦n¤èªk¡A¥L§ó¶i¤@¨B´£¥X¡A§Ú­ÌÀ³¸Ó³]ªk§ä¨ì¤@ºØ¥i¥Hª½±µ°e¤J»óµÄªº¦õ¾¯¡A¤~¯à°÷¯u¥¿ªº¨Ï¬Ì­]ª½±µ»P¬y·P¯f¬r¶i¦æ¹ï§Ü¡C

­ì©l¤åÄm¡GGuebre-Xabier M., Hammond S.A., Ellingsworth L.R. & Glenn G.M.. Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice. J. Virol., 78. 7610 ¡V 7618, (2004).

Cambrios¥H¥Íª«§Þ³N»s³y©`¦Ì¤¸¥ó

8/4/2004, Cambrios Company News, ¬ü°êCambrios Technologies¤é«e«Å§G¡A¤wÀò±o3®a­·ÀI§ë¸ê°Óªº180¸U¬ü¤¸­·ÀI§ë¸ê¡C ¸Ó¤½¥q¾Ö¦³§Q¥Î¥Íª«§÷®Æªº¦Û²Õ¸Ë¡]Self-asembly¡^²{¶H¨Ó»s³y·L«¬¹q¤l¤¸¾¹¥óªº§Þ³N¡C¡§§Ú­Ì¥i¥H¥Í²£»Ý­n·L²Ó§G½uªº¥b¾ÉÅé¡A¥H¤Î¨Ï¥Î¦UºØµL¾÷¤Æ¦Xª«»s³yª½®|¼Æ¦Ênm¥ª¥kªº©`¦ÌºÞ¡¨¡]¸Ó¤½¥q­º®u°õ¦æ©xMichael R. Knapp¡^¡C¦]¬°§Q¥Îªº¬O¥Íª«§÷®Æªº¦Û²Õ¸Ë²{¶H¡A©Ò¥H¤ÏÀ³¥i¦b§C·Å¤U¶i¦æ¡C»P²{¦³§Þ³N¬Û¤ñ¡A¥i¤j´T²¤Æ¥Í²£³]³Æ¡C³o¬O¸Ó¤½¥qÀò±oªº­ºµ§­·ÀI§ë¸ê¡A¤µ«á±N¥[ºò¶i¦æ°Ó·~¹B§@¡Aª§¨ú3¡ã4¦~«á¹F¨ì¹ê¥Î¤ô¥­¡C¥Ø¼Ð¬O¶}µo¥X¥Î©ó¶WÁ¡«¬¹qµøªº·s«¬§÷®Æ¡C

¸Ó¤½¥q¾Ö¦³»P¯S©wµL¾÷¤Æ¦Xª«¨ã¦³¿Ë©M©Êªº³J¥Õ½è¡]ÁY®ò»Ä¡^¤Î¨äDNAÆP°ò§Ç¦Cªº¬ÛÃö¼Æ¾Ú®w¡C¥i»PFe¡BAu¡BGa¡BAs¡BCaµ¥ªºµL¾÷¤Æ¦Xª«¦³¿ï¾Ü©Ê¦a¶i¦æµ²¦XªºÁY®ò»Ä¡A¦b¯S©w±ø¥ó¤U¨Ï¥¦­Ìµo¥Í¤ÏÀ³¡A´N¥i¥H³q¹LÁY®ò»Äªº¦Û²Õ¸Ë±NµL¾÷¤Æ¦Xª«±Æ¦C¾ã»ô¡C¾Ú¸Ó¤½¥qªí¥Ü¡G¡§ÁY®ò»Ä¥Ñ8¡ã20ºØ®ò°ò»Äºc¦¨¡Aªø«×¥i¶i¦æ½Õ¾ã¡A¤ñ¦p»¡¥i±N¨äªø«×³]©w¦b1nm¥ª¥k¡¨¡C¨Ï¥Î³oºØÁY®ò»Ä¥i¥H»s³y¥X¨Ï¥ÎºÒ¥H¥~§÷®Æªº©`¦ÌºÞ¥H¤Î«p«×¦b1nm¥ª¥kªºÁ¡½¤¡C´£¨Ñ­·ÀI§ë¸êªº3®a¤½¥q¤À§O¬O¬ü°êARCH Ventures¡B¬ü°êAlloy Ventures©MOxford Bioscience Partners¡C

¥i»P¯S©wµL¾÷¤Æ¦Xª«¬Ûµ²¦XªºÁY®ò»Ä¬O³q¹L©Ò¿×ªº¾½µßÅé®i¥Ü¡]Phage Display¡^ªkµo²{ªº¡C¦b¸Ó¤èªk¤¤¡A³q¹L¦³·N¦a¨Ï§Üµß¯Àªº°ò¦]µo¥ÍÅܲ§¡A°ö¾i¥X§t¦³¤£¦P¯S©Êªí­±³J¥Õ½è¡]ÁY®ò»Ä¡^ªº§Üµß¯À¡C¶È¬D¿ï¥Xµ²¦X¦b¥Ø¼Ð¤Æ¦Xª«ªí­±ªº§ÜµßÅé¡A¶i¦æ¤j¶q°ö¾i¡A¨ÓÀò¨ú¸ÓÁY®ò»ÄªºDNA¡C³q¹L³oºØ¤èªk»s§@»P¯S©w¤Æ¦Xª«¨ã¦³¿Ë©M©ÊªºÁY®ò»Äªº¼Æ¾Ú®w¡C ¾½µßÅé®i¥Üªk¬O¦bÃÄ«~ªº¬ã¨s¶}µo¤¤¨Ï¥Îªº¤@ºØ²Õ¦X¤Æ¾Ç¡]Combinatorial Chemistry¡^§Þ³N¡ACambrios¤½¥q³Ð©l¤H¤§¤@¡B¬ü°ê³Â¬Ù²z¤u¡]MIT¡^°Æ±Ð±ÂAngela Belcher±N¸Ó§Þ³NÀ³¥Î©ó¥b¾ÉÅé¡BºÏ©Ê§÷®Æ¡Bª÷ÄÝ¡B®ñ¤Æª«¤Î³³²¡»s«~µ¥»â°ì¡A¦¨¥\¹ï¥i»PµL¼Æªº¤Æ¦Xª«¶i¦æ¯S²§µ²¦XªºÁY®ò»Ä¶i¦æ¤F¤ÀÂ÷¡C



»s³y¥X¥H¦ÛµM¬°®vªº§÷®Æ: Àj³½¥~´ßªºÅã·Lµ²ºcÅé¡C



·L´¹Å骺ªí­±¯S®í¿ï¾Ü©Ê¡C¿ï¾Ü¥X¤@¨Ç peptides¥i¥H¥Î¨Ó¤À¿ë¥X¤Æ¾Ç¤W©Mµ²ºc¤Wªº®t²§¡A
¦p¤W­±³o¨Ç³z¹L¿Ã¥ú§Þ³N©M¹q¤lÅã·L¾ðªº¼v¹³©ÒÅã¥Ü¥X¨Óªºµ²ªG¡C

 

¥¿­tÁLÂ÷¤l§Þ³N¥i·À¬¡99.7%ªº©I§l¾¹©x¯f¬r

7/29/2004, ¤é¸gBPºô, ¤é¥»¥_ùجã¨s©Ò»P®L´¶¤wÃÒ¹ê³q¹L¡§¥¿­tÁLÂ÷¤l¡]Plasma Cluster Ion¡^¡¨§Þ³N¥i¥H·À¬¡¿ß«aª¬¯f¬r¡A³o¬O®L´¶7¤ë27¤é«Å§Gªº¡C¸Ó¤½¥q¦b»P¥_ùجã¨s©ÒÂå¾Ç¤¤¤ßÂå°|ªº¹a¤ì¹F¤Ò»P¤pªL¾Ë©¾¶i¦æ¹êÅç®É¡A40¤ÀÄÁ¤º·À¬¡¤F99.7%ªº¯B´å¯f¬r¡C¿ß«aª¬¯f¬rÄÝ«aª¬¯f¬rÃþ¯f¬r¡C«aª¬¯f¬r¬°ª½®|60nm¡ã220nm²y§Î¡A¥i·P¬V¤H¡B¿ß¡B³¾¡Bª¯¡B¹«µ¥¡C·P¬V«á¡A°Êª«ªº©I§l¾¹©x¡B¸z¹D¡B¨xŦµ¥¾¹©x¥X²{¯e¯f¡A¤H«hªí²{¬°©I§l¾¹©x¯e¯f¡C¡§§Ú­Ì»{¬°10%¡ã30%ªº·P«_³£¬O¥Ñ³o¤@¯f¬r¤Þ°_ªº¡¨¡C

©Ò¿×¥¿­tÁLÂ÷¤l§Þ³N¡A¬O«ü¥ÑªÅ®ð¤¤ªº¤ô¤À¤l»P®ñ¤À¤l¥Í¦¨¥¿¡B­tÂ÷¤l¡A¤j¶qÄÀ©ñ¨ìªÅ®ð¤§¤¤¡A·À¬¡¯B´åÅðµß¡B¬y·P¯f¬r¡B螨ÂιL±Ó­ìµ¥ªºªÅ®ð浄¤Æ§Þ³N¡C®L´¶©ó2000¦~¶}µo¤F³o¤@§Þ³N¡A¥Ø«e¥¿Áp¦X¥þ²y¦U¦aªº¬ã¨s¾÷ºc¹ï¨ä¥\®Ä¶i¦æÅçÃÒ¡C ¦b¥_ùجã¨s©Ò»P®L´¶¤½¥q¶i¦æªº¹êÅ礤¡A·Ç³Æ¤F¨â°¦®e¶q1¥ß¤è¦Ìªº½c¤l¡A¿ß«aª¬¯f¬r¥H­¸ªj§Î¦¡¼Q®g¦b½c¤¤¡A¥u¦b¤@°¦½c¤lùئw¸Ë¤F¥¿­tÁLÂ÷¤lµo¥Í¤¸¥ó¤ñ¸û·À¬¡®ÄªG¡Aµ²ªGÃÒ©ú¦bµo¥ÍÂ÷¤l§@¥Îªº½cùØ¡A40¤ÀÄÁ¤º·À¬¡¤F99.7%ªº¯f¬r¡C

¹ï©ó·À¬¡ªº­ì²z¡A®L´¶»{¬°¡G¡§»PÂ÷¤lµo¥Íªº¤Æ¾Ç¤ÏÀ³±q¯f¬rªºÄ²¨¤³¡¹Ü¨«¤F²B­ì¤l¡A±q¦Ó¯}Ãa¤F·P¬V¥²»ÝªºÄ²¨¤¡¨¡C¤w³Q·À¬¡ªº«aª¬¯f¬r¡A§Y¨Ï¶i¤JÅ餺¤]¤£·|·P¬V¡C ¥t¥~¡A¸Ó¤½¥q¥Ø«e¥¿¦b¹ï¨Ï¥Î¥¿­tÁLÂ÷¤l§Þ³N·À¬¡¾É­P·s«¬ªÍª¢¡§­«¯g«æ©Ê©I§lºî¦X¯g¡]SARS¡^¡¨ªº«aª¬¯f¬r¬ìSARS¯f¬rªº¥\®Ä¶i¦æÅçÃÒ¡C

¹q¸Ñ¤ô©M¹q¸ÑÃú¥i°£µß¡B°£¯ä¡B§Ü¹L±Ó­ì

7/27/2004, ¤é¸gBPºô, ¤T¬v¹q¾÷7¤ë22¤é«Å§G¡A¤w¸gÃÒ¹ê±N¦Û¨Ó¤ô¹q¸Ñ«á±o¨ìªº¹q¸Ñ¤ô¡BÃú¤Æ¹q¸Ñ¤ô§Î¦¨ªº¡§¹q¸ÑÃú¡¨¨ã¦³°£µß¤Î°£¯äµ¥§@¥Î¡C¤µ«á¸Ó¤½¥q±N¨Ì¦¸±À¥X¨ã¦³¹q¸Ñ¤ô¡B¹q¸ÑÃúµo¥Í¥\¯àªº·Å­·¥[¼ö¾¹¡B°£Àã¾¹»PªÅ®ðÐ䤯¾¹µ¥¡C

©Ò¿×¹q¸Ñ¤ô¡A«üªº¬O±N¦Û¨Ó¤ô¹q¸Ñ«á±o¨ìªº§t¦³¦¸´â»Äªº¤ô¡A¨ã¦³·¥°ªªº°£µß§@¥Î¡C¤T¬v¹q¾÷´¿©ó2001¦~±À¥X§Q¥Î³oºØ¹q¸Ñ¤ô¡BµL»Ý¬~º°¾¯§Y¥i¬~±¼»´·L¦Ãº{ªº¬~¦ç¾÷¡A¨Ã¦¨¬°ºZ¾P°Ó«~¡C¨Ï¥Î¶WÁnªi®¶¤lµ¥¨Ï³oºØ¹q¸Ñ¤ô°_ªw¡B¥Í¦¨Ãúª¬¹q¸Ñ¤ô¡§¹q¸ÑÃú¡¨«á¡A¦bªÅ®ð¤¤¤]¥i¥HÀò±o¦P¼Ëªº°£µß§@¥Îµ¥¡C

¤T¬v¹q¾÷¦¹¦¸¦A¦¸ÃÒ¹ê¤F¹q¸Ñ¤ô¨ã¦³­°§C螨ÂιL±Ó­ì¬¡©Ê¡Bªá¯»¹L±Ó­ì¬¡©Ê¡Bµo¥Í¯ä¨ýª«½è¿@«×ªº§@¥Î¡A¹q¸ÑÃú¨ã¦³°£µß¡B§í¨î¯B´åÅðµß¡B°£¯ä¡B­°§C螨ÂιL±Ó­ì¬¡©Êªº§@¥Î¡C ¨ä¤¤¹ï©óªá¯»¹L±Ó­ì¡A¦b»P¤j¨ÁÂå¬ì¤j¾Ç¦@¦P¹ê¬Iªº¬ã¨s¤¤¡A§ü¾ðªá¯»±µÄ²¹q¸Ñ¤ô60¤ÀÄÁ«á¡A¦A¦V7¦W§ü¾ðªá¯»¹L±Ó¯g±wªÌ¶i¦æ¥Ö¤Uª`®g¡A´ú¶q¬õ´³»P¥Ö¯lªº¤j¤p«áµo²{§¡¥¼¥X²{¥Ö½§¤ÏÀ³¡AÃÒ©ú¤F¹q¸Ñ¤ô¥i¥H­°§C§ü¾ðªá¯»ªº¹L±Ó­ì¬¡©Ê¡C ¥t¥~¡A¤À§O¦b¶}±Ò¡BÃö³¬¥Í¦¨¹q¸Ñ¤ô®É¨Ïµo¥X¨å«¬»G±Ñ¯ä¨ýªº¥Ò²¸¾J¡]METHYL MERCAPTAN¡^³q¹L¤ô½c¡AÃö³¬¹q¸Ñª¬ºA®É¥Ò²¸¾J³q¹L¤ô½c«á¿@«×¬°4¡ã6ppm¡A¶}±Ò¹q¸Ñª¬ºA«á¿@«×­°§C¨ì1ppm¥H¤U¡AÃÒ©ú¤F°£¯ä®ÄªG¡C

¦b¹q¸ÑÃúªº®ÄªGÅçÃÒ¤¤¡A¹ï¬Û·í©ó6±i¶ò¶ò¦Ìªº©Ð¶¡¼Q©ñ¹q¸ÑÃú¡A¬ù¤@­Ó¤p®É«á¹ï¯B´åÅðµßªº´Ý¯d²v¶i¦æ´ú¶q¡Aµo²{´Ý¯d²v´î¤Ö¨ì¥¼¼QÃú®Éªº1%¥H¤U¡C¦b¦V©ñ¦³º¯³z·Ï¨ý¥¬¤Çªº½c¤¤°e­·®É¥[¤J¹q¸ÑÃúªº¤ñ¸û¹êÅ礤¡A°e¤J¹q¸ÑÃú«áªº¯ä®ð¤ñ¥¼°e¤J¹q¸ÑÃú®É´î¤Ö¤F1/2¡C ¸Ó¤½¥q±N¤À§O±q8¤ë1¤é°_¶}©l¾P°â¨ã¦³¹q¸ÑÃúµo¥Í¥\¯àªºªÅ®ð°£Àã¾¹¡§ABC-HM28¡¨¡B9¤ë1¤é¶}©l¾P°â¨ã¦³¹q¸Ñ¤ôµo¥Í¥\¯àªº¥[Àã¾¹¡§CFK-VX50E¡BCFK-VX 70E¡¨»P¥þ¦Û°Ê¬~¦ç¾÷¡§ASW-MZ700¡BASW-MZ800¡¨¡B10¤ë1¤é¶}©l¾P°â¥[Àã³³²¡­·®°¦¡¹q·x¾¹¡§RSF-DC400¡¨¡C

©`¦Ì·s§Þ³N, ·sµo²{©M²£«~:

©`¦ÌªA¸Ë¤£¥Î¬~ ©_§®ªA¸Ë¤µ¤Ñ¦³¬ù

8/19/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A¤£¥Î¬~º°¾¯¤]¯à²M¼äªº¦çª«¡B¥i¥Î°µ¨¾¤ô¦a¹Ïªº¥é¯uµ·­±®Æ¡K¡K°ª¬ì§ÞªºªA¸Ë­±®Æ±N¥O¤H¦Õ¥Ø¤@·s¡C¤µ¤Ñ¡A¤@§å°ª¬ì§ÞªA¸Ë­±®Æ±N±q¹êÅç«Ç¨«¤W¢â«¬¥x¡AÅý¤½衆¡§¶K¨­¡¨·P¨ü¨ì¬ì¾Çªº¹ê´f¡C

¾Ú¥_¨Ê­º¬ì¶°¹Î­t³d¤H¤¶²Ð¡A­º©¡¡§­º¬ìªM¡¨·s¤k¸Ë³]­p¤jÁɤ£¦P©ó±`¨£ªº®É¸Ë¡A¨ä«GÂI爲°ª¬ì§Þ­±®Æ¡C¨ä¤¤¬Û·í¤@³¡¤À爲­º¦¸±q¹êÅç«Ç®³¥X¨Óªº¬ì¬ã¦¨ªG¡C°Ñ¥[µû¿ïªº­±®Æ¦h¹F¦Ê¾lºØ¡C¨ä¤¤¨Ó¦Û¥_¨ÊªA¸Ë¾Ç°|ªºÂLµ·­±®Æ¬O¨ã¦³°ê»Ú¥ý¶i¤ô¥­ªº¬ì¬ã¦¨ªG¡A¤wÀò¨â¶µ°ê®aµo©ú±M§Q¡A¨ã¦³¤â·P¦n¡B§ÜÀR¹qµ¥¯SÂI¡C·sªº©`¦Ì­±®Æ«h¨ã¦³¦Û²M¼ä¥\¯à¡Aªg¤Wªo¦Ã¥Î¤ô¨R¬~§Y¥i¡A³oºØ©`¦Ì­±®ÆÁÙ¦³§Üµß©Ê¯à¡C±M·~¤H¤h¬ã»sªº¶W²ÓÅÖºû§÷®Æ¤]¦³¯«©_ªº¥\¯à¡G¨ä§÷®Æºë²Ó¡A¬Æ¦Ü¥i¥N´À¯È±i¡A»s¦¨­x¥Î¨¾¤ô¦a¹Ï¡C

¾Ú±x¡A·s­±®Æ¨Ó¦Û¤¤¬ì°|¡B¸Ñ©ñ­xÁ`¸Ë³Æ³¡©M¥_¨ÊªA¸Ë¾Ç°|µ¥³æ¦ì¡C¤U©P¤é¡A¼Ò¯S±N¨­µÛ³o¨Ç°ª¬ì§Þ産«~¦b°ê»Ú¶º©±µn¤W¢â«¬¥x¡C

ĵ¹î¦³±æ¬ï¤W©`¦Ì¨¾«B¨îªA

8/19/2004¡A¤¤°ê®ý¦¿¬Ù©`¦Ì¬ì§Þºô¡A¬Ý¦ü´¶³qªº¦çªA¡A¤@ªM¤ô­Ë¤W¥h«o¯à§Î¦¨¤ô»Èºu°Ê¯ëªº®ÄªG¡A¤ô¯]¸¨¦a¦çªA¤´¬O°®ªº¡C¬Q¤Ñ¡A°OªÌ¦b­º©¡¡§­º¬ìªM¡¨·s¤k¸Ë³]­p¤jÁɪº®i¥Ü»O¤W¬Ý¨ì¤F³oºØ¥Î©`¦Ì§Þ³N³B²z¹Lªº­±®Æ¡C¥Ø«e³oºØ§Þ³N¥¿¦b¦Ò¼{¥Î¦bĵªA¡B­x¸Ë¤W¡A¥Î¤£¤F¦h¤[ĵ¹î¡B­x¤H­Ì´N¯à¬ï¤W¨¾ªo¡B¨¾¤ô¤S­@żªº©`¦Ì¨îªA¤F¡C

³o¶µ¥Ñ¥@¬ö©`¦Ì¯¼Â´¬ì§Þµo®i¦³­­¤½¥q©M¤¤¬ì°|¤Æ¾Ç©Ò¬ã¨s¶}µoªº¶WÂù²¨©`¦Ì¤¶­±§Þ³N¤w¸g¶i¤J産·~¤Æ¡A¤@¦Ì´¶³qªº­±®Æ¥[¤u¦¨©`¦Ì­±®Æ¡A¥u­n20¦h¤¸¥[¤u¶O¡C³B²z¹Lªº­±®Æ¦³¶W²¨¤ô¡B²¨ªoªº©_²§©Ê¡A¦P®É¡A³B²z«áªº­±®Æ«O«ù­ì¦³Â´ª«ªº¥ô¦ó¯S©Ê»P¯S¼x¡A¤£§t¹ï¤HÅ馳®`ªº¤Æ¾Ç¦¨¤À¡C²{¦b¥¿¦b¶i¦æ¹êÅ窺¬O§â©`¦Ì§Þ³NÀ³¥Î¦b¨îªAªº»s§@¤W¡C

¥H¥þ¹³§Þ³N¬ã§Pµ§¸ñ¯u°°

8/11/2004, Scientific American, ¬ì¾Ç®a¬ãµo¤F¤@ºØ¹ï§Üµ§¸ñ°°³yªº·s¤u¨ã¡A¥H¥þ¹³§Þ³N(hologram-based technique)»s§@¤F¤â¼g¥óªº¤Tºû¼v¹³¹Ï¡A¥H¬ã§Pµ§¸ñªº¯u°°¡C §Y¨Ï¬O¦P¤@­Ó¤H¨Ï¥Î¦P¤@¤äµ§¼g¥XªºÃ±¦W¤]µLªk§¹¥þ¤@­P¡A¤£¹L¦³¨Ç¯S¼x¤´·|«O«ù¬Û¦ü¡A¨Ò¦pµ§¶¶¤è¦V¥H¤Î½u±ø­«Å|¤è¦¡¡C

Science Image: handwriting

¥H©¹ªº¤â¼g¤ÀªR®v¬O¥H¤Gºû¤è¦¡¬ã§P¼ã¯óªºµ§¸ñ¡C¸q¤j§Qù°¨²Ä¤T¤j¾ÇGiuseppe Schirripa Spagnolo»P¨ä¦P¨Æ¥H¹p®g¥ú±½´y¤å¥ó¡A²£¥Íñ¦Wµ§¹ºªº¥þ¹³¹Ï¡A¸g¥Ñ¼v¹³³B²z (image processing) »PµêÀÀ¹ê¹Ò (Virtual Reality) §Þ³N¡A«Ü®e©öªº§ä¥Xµ§¹º¥æ¤eÂIªº¬ð°_³B¡CSchirripa Spagnolo«ü¥X§ä¨ì¦¹¨Ç¬ð°_³B¤§«á¡A§Y¥i»´©öªº½T©w¤â¼g¥óªºµ§¹º¶¶§Ç¡A¥H¬ã§Pµ§¸ñ¯u°°¡C §@ªÌ¦b¤E¤ë¸¹ªºJournal of Optics A¤å³¹±Ô­z¤F¨ú¼Ë¤Î´ú¸Õ¤èªk¡A¦¹§Þ³Nªº¦¨¥\²v±µªñ90%¡C

µL³zÃ誺Ánªi»EµJ§Þ³N

7/15/2004, Physical Review Focus, ¥[®³¤j¬ì¾Ç®aµo²{Ánªi¦bÁn¤lª«½è (phononic material) ¤¤¤]¦³­t§é®g²{¶H¡C¹L¥h¤Q¦~, ¬ã¨s¤H­û­P¤O©óµo®i¤@ºØ©Ò¿×ªºÁn¤lª«½è¡A³oºØª«½è¥i¥H¥Î¨Óªý¹j±¼¯S©wªiªøªºÁnªi¡CUniversity of Manitoba¡ACanadaªºJohn Page¤Î¨ä¦P¹±±Nª½®|0.8²@¦ÌªººÒ¤ÆÂë¯]¤l®û¦b¤ô¤¤°ï±Æ¦¨¤Tºû°}¦C¡A§Î¦¨¤@­ÓÁn¤l´¹Åé¡C¤j¬ù1MHz¥ª¥kªºÁnªi¡A¤]´N¬Oªiªø¤j¬ù±µªñ¯]¤lªºª½®|¡AµLªk¬ï³z³o­Óµ²ºc¡C Pageªí¥Ü¡A³o¬O¥Ñ©ó¯]¤lªº¤j¤p¤Î¨ä±Æ¦Cµ²ºc¨Ï±o©Ò¦³´²®gªºÁnªi­è¦n³£²£¥Í¯}Ãa©Ê¤z¯A¡C

¦b2004¦~7¤ë9¤éµo¦æªºPhysical Review Letters¤¤¡A¬ã¨s¤H­û§óµoªí¤F¤@­Ó¥O¤HÅå³Yªºµ²ªG¡C·íÁnªi¦b1.6MHz®É¡A¥H¤pªi·½²£¥ÍªºÁnªi¬ï¹LÁn¤lª«½è«á¤´µM·|«ùÄò¦aÂX´²¶}¨Ó¡C ¦ý¬O¦b1.57MHz®É¡AÁnªi«o¬O´Â¤£¦Pªº¤è¦V¶Ç¼½¡A¤]´N¬OÁn¤lª«½è¨ÏÁnªi­«·s»EµJ¦¨¤@ÂI¡C

acoustic focusing patterns¡@¡@acoustic focusing patterns
¤@­Ó°ª®p©M¤@­Ó¤p¥C¡C ¤@­Ó¥ú¤l´¹Å骺¥­ªO¥i¥H±N1.57 megahertzªºÁnªi»EµJ¦¨¤@­Ó°ª®p (¨£¥ª¹Ï¹³) ¡A
µM¦Ó°w¹ï¤@­Óµy·L°ªÀW²vªºÁnªi«h¬Ý¤£¨ì³o¼Ëªº®ÄÀ³(¨£¥k¹Ï¹³)¡C¹Ï¹³¨Ó·½: Phys. Rev. Lett. 93, 024301 (2004)

Page¸ÑÄÀ¹D¡A§Î¦¨³oºØ­t§é®g²{¶Hªº¦¨¦]¸ò1MHzªºÁnªiµLªk³q¹L´¹Å骺­ì¦]¤@¼Ë¡C ¥u¬O¦b³oºØ±¡ªp¤U¡A¦b¤j³¡¤Àªº¤è¦V³£²£¥Í¯}Ãa©Ê¤z¯A¡A°£¤F´Â¦V»EµJÂIªº¤è¦V¥~¡C¦bÁn¤lª«½è¤W¡A¥u­nÁnªiªºÀW²vµy·L¦a§ïÅÜ¡A¤z¯Aªº¹Ï¼Ë´N·|¦³«Ü¤jªºÅܤơC ¤£¹³¦b¤@¯ëªºª«½è¤W¡A¤z¯A¹Ï¼ËªºÅܤƬOº¥º¥¦aµo¥Íªº¡C ¬ã¨s¤H­û¤]´£¥X¤F¤@®M°T¸¹³z¹LÁn¤l´¹Åé¶Ç¼½ªº²z½×¼Ò«¬¡A¨Ã¥B»P¹êÅçµ²ªG¬Û·í§k¦X¡C

¶WÁnªi¼v¹³³q±`¨Ï¥Î³zÃè§Îª¬ªºª«½è±NÁnªi»EµJ¡CPageªí¥Ü¡AÁn¤l´¹Åé±N¥i¨Ï¸ÑªR«×§ïµ½¨ì±µªñ¶WÁnªiªiªøªº½d³ò¡A ¤]´N¬O¤j¬ù1²@¦Ì©Î§ó¤p¡A³o¬O¶Ç²Îªº¶WÁnªi¼v¹³©ÒµLªk¹F¨ìªº¡C ¦]¦¹, ¦¹ºØª«½è¦bÂå¾Ç¤Î¤uµ{¤W³£¥i¥H¦³«Ü¦nªºÀ³¥Î¡C

·i§g¤@Ū¶µ¥Ø:

®æºô¹q¸£¨t²Î¥¢®Ä¼Ò¦¡

8/4/2004, Science Daily, ¬ü°ê°ê®a¼Ð·Ç»P§Þ³N§½ (NIST) ±Ò°Ê¤@­Ó·s­p¹º¡A¥H¤F¸Ñ®æºô¹q¸£ (computer grid) ¨t²Î¹ïÀþ®§¸UÅÜÀô¹Òªº¼vÅT¡A½T©w¨t²Î®e©ö¥¢®Äªºµ{«×¡A¦P®É§ä¥X¯à¨³³t°»´ú¥¢®Ä¨Ã¥B­×´_°ÝÃDªº¤èªk¡C 1998¦~¬ü°ê¥[¦{¬f§JµÜ¤j¾Çµo°_ªºSETI@homeªº­pµe¡A¥þ¥@¬É­p¦³¶W¹L2300¸U¥xªº­Ó¤H¹q¸£³z¹Lºô»Úºô¸ô³s±µ¡Aºc¦¨¤@­ÓµêÀÀªºÃe¤j¹Bºâ¸ê·½¡A§Q¥Î­Ó§O¹q¸£ªº¶¢¸m®É¶¡¹Bºâ¤Ñ¤å¼Æ¾Ú¡C¦¹§Y¬°®æºô­pºâ (grid computing) À³¥Î½d¨Ò¡AÃþ¦üªº®æºô­pºâÀ³¥Î©|¥]¬A·R´þ¯f¬ã¨s­p¹º¡B³J¥Õ½è§éÅ|°ÝÃD¤ÀªR¡BÀù¯g¬ã¨s¤ÀªRµ¥¡C

National Institute of Standards and Technology. Working with industry to develop and apply technology, measurements and standards

®æºô­pºâ§Þ³NÂǵۺô»Úºô¸ô±N¦¨¤d¤W¸Uªº¹q¸£³s±µ¦b¤@°_¡A¶i¦æ¤@­Ó³æ¤@¹Bºâ¡A¹q¸£¬ì¾Ç®a±o¥H¶i¦æ¥H©¹©Ò¤£¯à¹Bºâªº°ÝÃD¡A¹ï°ò¦]Åé¡B¤uµ{³]­p»Pª÷¿ÄªA°È¦¹¨Ç»â°ìªº°ÝÃD¯à´£¨Ñ§Ö³tªºµª®×¡C ®æºôªì´Áªº¬ãµo¥Øªº¬O¶i¦æ¶W¹q¸£ªº³sµ²¡A¥Î¥H­pºâÃþ¦ü®ð­Ô¼ÒÀÀ¦¹ºØ·¥«×½ÆÂøªº°ÝÃD¡AÀH«á®æºô­pºâªº°Ó·~À³¥ÎÁؼW¡C¦³¨Ç§ë¸ê¤½¥q¤w¸g¨Ï¥Î®æºô¹q¸£¶i¦æª÷¿Ä¥«³õªº§Y®ÉÅܤƤÀªR¡A»sÃĤ½¥q¤]¶}©lÀ³¥Î®æºô¹q¸£§JªA·sÃĬãµo©Ò¹J¨ìªº­pºâ¯à¤O¬D¾Ô¡C

®æºô¹q¸£¨t²Î»P¥­¦æ¹Bºâ¹q¸£¨t²Î¦³«Ü¤jªº®t²§¡A¥­¦æ¹Bºâ¹q¸£¨t²Îªº¹q¸£ÂO¶°©ó³æ¤@³õ©Ò¡A¨Ò¦p¶°¤¤¦b¤@­Ó¹êÅç«Ç¸Ì¡A¨Ï¥Î¤@­Ó¬Û¦Pªº³nÅé¡A¥ô¦ó®É¨è¥u¶i¦æ¬Û¦Pªº¤u§@¡A©Ò¦³ªº¹q¸£¦P®É¶}¾÷¡A¦P®É°Ñ¤©¹Bºâ¡C¦Ó®æºô¹q¸£¨t²Îªº¹q¸£¤À´²©ó©Ò¦³¥i¯àªº¦ì¸m¡A¹q¸£ªº¥i¨Ï¥Î®É¶¡¤]ÀH®É¦Ó²§¡A¤£¹L¦¹Á|¥i¥R¶O§Q¥ÎÃe¤j¥B¶¢´²ªº¹q¸£¸ê·½¡C·íµM«áªÌ­Y­n§ó¦³®Ä²vªº§¹¦¨¤u§@¡A»Ý­n§ó¦nªººÞ²z¡C

®æºô¹q¸£¨t²Î¤ñ¥­¦æ¹q¸£©Î¶W¯Å¹q¸£¬°¯Ü®z¡A§ó®e©ö¥¢®Ä¡C¨Ò¦p¾D¨ü¹q¸£¯f¬rªº§ðÀ»¡B¤u§@­t²üªº¬ðµM§ïÅÜ¡B©Úµ´ªA°Èºô¸ô§ðÀ»¡Bºô¸ô¤¤Â_µ¥µ¥¡C¥Ñ©ó°Ó·~À³¥Îªº¦¨ªø¡A©Ò¥H®æºô¨t²Îªº«OÅ@¥H¤Î¥i¾a«×ªº«OÃÒ±N§ó¬°­«­n¡C ¬ü°ê¬ü°ê°ê®a¼Ð·Ç»P§Þ³N§½¬°¤F§ó²M·¡®æºô¹q¸£¨t²Î¹ïÀþ®§¸UÅÜÀô¹Òªº¼vÅT¡A½T©w¨t²Î®e©ö¥¢®Äªºµ{«×¡A¦P®É§ä¥X¯à¨³³t°»´ú¥¢®Ä¨Ã¥B­×´_°ÝÃDªº¤èªk¡C©ó2004¦~¦¨¥ß¤F¤@­Ó·sªº¬ã¨s­p¹º¡A±N¬ãµo¤@®M¹q¸£¼Ò¦¡¥H½T»{®æºô¹q¸£¨t²Î®e©ö¥¢®Äªºµ{«×¡A¨Ã´Á±æ©ó©ú¦~¦~ªì§Y¯à§¹¦¨¦¹®M¼Ò¦¡¡C

¬ì¾Ç´Á¥Z¥Xª©¬É§¹¥þ§K¶OªºÂ૬´Á

8/1/2004, The United Kingdom Parliament, Science and Technology Committee, ÀHµÛºô»Úºô¸ôªº´¶¤Î¡A­°§C¤Fªýê°T®§¶Ç¼½ªºÃ¿ÆX¡A¦UºØ¸ê°Tªº¨ú±o¤éÁͤè«K¡A¦]À³ºô»Úºô¸ô¦Ó½Ï¥Íªº¹q¤l´Á¥Z´N¬O¤@¨Ò¡C¹ï©ó«D­^¬ü°ê®aªº¬ã¨sªÌ¨Ó»¡¡A¹q¤l¥þ¤å´Á¥Z©Ôªñ¤F¬ã¨sªÌ»P¥@¬Éªº¶ZÂ÷¡C¦³¤F¹q¤l´Á¥Z¤§«á¡AÅý¬ã¨sªÌ¯à¤@¸Ñµ¥«Ý¬ì¾Ç´Á¥Z§¤²îÄÆ¬v¹L®ü¦Ó¨Óªº¬Û«ä¤§­W¡C¤£¹L¡A¹q¤l´Á¥Zªº¥X²{¤£¥u¹Å´f¤F¬ã¨sªÌ¡A¤]®¨®¨¦a§ïÅܬì¾Ç´Á¥Z¥Xª©¬Éªº¥ÍºA¡C

Portcullis image and link to site home pageThe United Kingdom Parliament

­^°ê¤Uij°|¬ì§Þ©e­û·|¡]the House of Commons Science and Technology Committee¡^¦b¤µ¦~¤C¤ë¥÷ªº®É­Ô´£¥X¤@¥÷³ø§i¡A©e­û·|¦b³ø§i¤¤´£¨ì²{¤µªº¬ì¾Ç´Á¥Z¥Xª©¨î«×¤£¯àº¡¨¬»P¤é­Ñ¼Wªº¬ã¨s»Ý¨D¡A¦Ó¥B¬ì¾Ç´Á¥Z»ù®æªº´£¤É·N¨ýµÛ¨¿Ån¤é¯q²ÛÀߪº¹Ï®ÑÀ]¥²¶·ªá§ó¦h¿ú¨Óºû«ù¨Ï¥ÎªÌªº»Ý­n¡C¦]¦¹©e­û·|©ó³ø§i¤¤«ØÄ³¡A©Ò¦³­^°êªº¤j¾Ç¥H¤Î¬ã¨s¾÷ºc³£À³¸Ó­n´£¨Ñ§Y¨Ï¥B§K¶Oªº½u¤W¥þ¤å½×¤å¡A¦P®É¥Ñ¦U¬ã¨s©e­û·|¡]Research Council¡^¥H¤Î¬F©²©Ò¸ê§Uªº¬ã¨s¤]³£À³·í¤ñ·Ó¿ì²z¡C¨Ã¥B¬°¤F¹ªÀy§K¶O¤½¶}½×¤åªº¦æ°Ê¡A¸Ó³ø§i¤¤¨Ã«ØÄ³¦U­Ó¬ã¨s©e­û·|¸ê§U¬ã¨sªÌµoªí½×¤å¡C

¦b¤j¦è¬vªº©¼©¤¡A¬ü°êªº²³Ä³°|ij­û¤]«ØÄ³¬ü°ê°ê®a½Ã¥Í¬ã¨s°|¡]National Institutes of Health, NIH¡^©ÒÃÙ§Uªº¬ã¨s¡A¦bµoªí¬ã¨s½×¤åªº¦P®É±N½×¤å°Æ¥»°e¨ì¤½¦@Âå¾Ç¤¤¤ß¡]PubMed Central¡^¡A¥B¤½¦@Âå¾Ç¤¤¤ß·|¦b½×¤å¤½¶}µoªíªº¤»­Ó¤ë«á´£¨Ñ½×¤åªº­ì©l½Z¡F©Î¬O¥Ñ¬F©²­t¾á¬ã¨sªÌµoªí½×¤åªº¶O¥Î¡A¨Ï¤½¦@Âå¾Ç¤¤¤ß¥i¥H°¨¤W¦bºô¸ô¤W¤½¶}½×¤å­ì©l½Z¡AÅý¤j®a¯à¦bºô¤W§K¶O¥B§Y®É¦a¨ú±o¡C ³o¨Ç®ø®§¹ï©ó¶}©ñ¨ú¾\¦¡´Á¥Zªº¾ÖÅ@ªÌ¨Ó»¡¤£³×¬O¥´¤F¤@°O±j¤ß°w¡A¦ý¹ï©ó¶Ç²Î´Á¥Z¥Xª©°Ó¥H¤Î·|¦Û¦æ¥Xª©´Á¥Zªº¦U­Ó¬ì¾Ç¨ó·|¨Ó»¡«h¬O´¸¤ÑÅRÆE¡C

¬ì¾Ç¨ó·|¥Xª©´Á¥Z¥HÀò¨ú§Q¼í¨ÓÁ|¿ì¬ã°Q·|µ¥¬¡°Ê¤w¦æ¤§¦³¦~¡A¦Ó¶Ç²Î´Á¥Z¥Xª©°Ó¦b¹q¤l´Á¥Z­·¦æ¤§«á¡A½u¤W»{ÃÒ¶O¡]subscription¡^§ó²K¥[¤F¥L­Ì¤@µ§¤£¤Öªº¦¬¤J¡A¤@¥¹³o¨Ç«ØÄ³³Q±Ä¯Ç¨Ã±À¦æ¡A¶Õ¥²·|¦M¤Î¥L­Ìªº¦¬¤J¡C¬ü°ê¹êÅç¥Íª«¾Ç¾Ç·|Áp·ù¡]the federation of american societies for experimental biology¡^´N«ü¥X¡A²{¤µ¤w¦³³\¦h´Á¥Z¦b½×¤åµoªí«áªº¥b¦~¦Ü¤@¦~¤§¤º§K¶O´£¨Ñ½×¤å¥þ¤å¡C

¬°¤F°t¦X¶}©ñ¨ú¾\¦¡´Á¥Zªº¥Xª©¡A¬ã¨sªÌ¥²¶·¥I¶O¥Hµoªí½×¤å¬O¶Õ¦b¥²¦æ¡A¤£¹L³o¼Ëªº¨î«×ÁÙ¥²¶·¸g¹L¶i¤@¨BªºÅçÃÒ¡A¦pªG¬F©²»Ý­nÃÙ§U¬ã¨sªÌµoªí½×¤å¡AÁٻݭnµû¦ô¬F©²·|ªá¤W¦h¤Ö¿ú¨Óµoªí³o¨Ç½×¤å¡C¥t¥~ÁÙ¦³¦p¦U¤jÃļt³oÃþ§K¶O¨Ï¥ÎªÌ¡]free rider¡^ªº°ÝÃD¡AÃļt¤@¦V¬O´Á¥Zªº¤j¶R®a¡A¦ý¬O«Ü¤Öµoªí¾Ç³N©Êªº½×¤å¡C¤@¥¹´Á¥Z¥Xª©«¬¦¡Âର¶}©ñ¦¡¡A´N¬O¤è«K³o¨Ç¤£·|§ë®ç³ø§õªºÃļt¨ú±o³Ì·sªº¬ì¾Ç¬ã¨sµ²ªG¡C

¤½¶}½×¤å­ì©l½Zªº±¹¬I¤]¤Þ°_¨ä¥L°ÝÃD¡G¨s³º­ì©l½ZÁÙ¬O´Á¥Zµn¥Xªº½×¤å¤~¬O¸Ó¹êÅ禨ªG¯u¥¿¤½»{ªºª©¥»¡H­Y¬O³Ì²×¤½¦@Âå¾Ç¤¤¤ß³£·|¤½¶}½×¤å¥þ¤å¡A¨º»ò¬ã¨sªÌ¨ì©³¦³¨S¦³¥²­n¦b´Á¥Z¤Wµoªí½×¤å¡HÁÙ¦³ºû«ù¤@¥÷¹q¤l´Á¥Z©Ò»Ý­nªº¶O¥Î¥H¤Î·|­±Á{¨ìªº§Þ³N°ÝÃDµ¥µ¥¡AºØºØªºÄ³ÃD³£¥²¶·°µ§ó¶i¤@¨Bªº¬ã¨s¡C ¤£ºÞ«ç¼Ë¡A³o¨Ç®ø®§ªº½T¤j¤j¦a¾Ù°Ê¤F¬ì¾Ç´Á¥Z¥Xª©¥@¬É¡C¤£¥i¿Ð¨¥¦a¡A¬ì¾Ç´Á¥Z¥Xª©¬É¥¿­±Á{¤@³õ­²©R©Êªº¹B°Ê¡C¶Ç²Îªº´Á¥Z¥Xª©°Ó¡B¦U­Ó¬ì¾Ç¹ÎÅé¡B»Ý­nµoªí½×¤åªº¬ã¨sªÌÁÙ¦³¹Ï®ÑÀ]¡A¦b³o³õ­²©R·í¤¤¦p¦ó¤£·l¤Î¦Û¤vªº§Q¯q¤S²Å¦X¬F©²ªº¬Fµ¦¡A±N·|¬O­Ó´Æ¤âªº°ÝÃD¡C

°Ñ¦Ò¤åÄm:

U.K. Lawmakers Urge Prompt Access to Published Papers... Science,305,458-459(2004).
Seeking Advice on 'Open Access', NIH Gets an Earful. Science,305,764(2004).

¬ì¾Ç®aµo²{ÀH¾÷¹p®g

7/30/2004, Physical Review Focus, ¸q¤j§Qªº¬ã¨s¤H­û¬Û«H¥L­Ì¤w¸g§ä¨ìÀH¾÷¹p®g (random laser) ¥i¥Hµo¥XµL¤è¦V©Ê¦ý«o¨ã³æ¦â©Êªº¥ú·½ªº­ì¦]¤F¡C¤@¯ë¹p®gªº§Î¦¨¬OÅý¥ú¦b¨ã¦³¼W¯q¤¶½èªº¦@®¶µÄ¤¤¨Ó¦^®¶Àú¡A³z¹L¨ü¿E¿ç®g¨Ï¥ú±j«×¤£Â_©ñ¤j¡A¨Ã¨ã¦³¦P½Õ©Ê¤Î³æ¦â©Ê¡C¦ý¦pªG§â¼W¯q¤¶½è®³¨ì¦@®¶µÄ¥~¡A¨Ã±N¤§¿i¦¨¯»ª¬¡A«hÅܦ¨¤@­ÓÀH¾÷¹p®g¡C¦¹®É­Y¥Îµu¯ßªi¥ú·Ó®g¿Eµo¡A«h³o¯»¥½±N·|µo¥ú¡C ¦pªG¥ú¤l¦b¯»¥½¤¤³Q´²®g«Ü¦h¦¸¡A«h·|»¤µo¥X§ó¦hªº¥ú¤l¡C³Ì«á·í¥ú¤l²æÂ÷¯»¥½®É¡A¨äªiªø½d³ò·|¤ñ¤@¯ëªº¹p®g¥ú (´Xªñ³æ¦â¥ú) ÁÙ­n¼e«Ü¦h¡C


¦¹ÀH¾÷¹p®g¤D«D¤@¯ëªº¹p®g¡CÃþ¦ü³oºØÀH¾÷ªº¹p®g¤D¬O¥ÎÍù¦Ì¯Åªº²yÅé»s³y¥X¨Óªº¡A¦Ó¥B·|µo¥XÃþ¦ü®gªº¥ú¡C
·sªº¬ã¨sµ²ªGµo²{¡A¦¹ÀH¾÷¹p®g©Ò´²µo¥X¨Óªº³æ¦â¥ú¤D¬O¥Ñº¢¯d¦b¦¹§÷®Æ¤¤«D±`¤[ªº¤Ö¼Æ¥ú¤l©Òµo¥Xªº¡C(¼v¹³¨Ó·½: D Wiersma)

µM¦Ó¡A¦pªG§ó¶i¤@¨B±N¿Eµo¥úªº±j«×¼W±j¡AÀH¾÷¹p®g©Òµo¥Xªº¥úªºªiªø«h·|¥u³Ñ¤U´X­Ó«D±`³æ¦âªºªiªø¡C³o¨Çªiªøªº¦ì¸m·|ÀHµÛ¤£¦Pªº¿Eµo¯ßªi¦Ó§ïÅÜ¡A¦Ó¥B¬OµLªk¹w´úªº¡C¤£¹³¤@¯ëªº¹p®g¡A¥úªºªiªøªº¦ì¸m¥i¥Ñ¦@®¶µÄªº¼e«×¨Ó¨M©w¡C¦b¦¹¤§«e¤]´¿¦³¤@¨Ç¬ã¨s¤H­û´£¥X²z½×¨Ó¸ÑÄÀ³o²{¶H¡AµM¦Ó¨ä¥Lªº¤H«h©|©ê«ùÃhºÃªººA«×¡C

¦b2004¦~7¤ë30ªºPhysical Review Letters¤¤ European Laboratory for Nonlinear Spectroscopy in Florence and the Italian National Institute for the Physics of MatterªºDiederik Wiersma¤Î¨ä¦P¹±´£¥X¤F¤@­Ó¼Ò«¬¡A¥L­Ì»{¬°¡AÁöµM¤j³¡¤Àªº¥ú¤l¦b¼W¯q¤¶½è¤¤¥HÀH¾÷º©¨B (random walk) ªº¤è¦¡¤Ï¼u¤j¬ù¤Q¦¸«h·|Â÷¶}ª«½è¡CµM¦Ó¦³¤Ö¼Æªº¥ú¤l«o¥i¦bª«½è¤¤¤Ï¼u100-1000¦¸¡A¥L­ÌºÙ³o¨Ç¥ú¤l¬O "©¯¹Bªº¥ú¤l"¡C ¦Ó³o¨Ç¤Ö¼Æªº©¯¹B¥ú¤l¦bÂ÷¶}ª«½è®É«h·|¦ñÀHµÛ¤j¶q¬Û¦Pªiªøªº¦P½Õ¥ú¤l¡A¦ô­p500¦¸ªº¤Ï¼u¡A¤@­Ó¥ú¤l±N·|³Q©ñ¤j¦¨1012­Ó¥ú¤l¡C¥L­Ì¥H¹êÅç¤Î¹q¸£¼ÒÀÀ¨ÓÅçÃÒ³o­Ó¼Ò«¬¡A¨Ã±o¨ì¬Û·í«´¦Xªºµ²ªG¡CNorfolk State University in VirginiaªºMikhail Noginovªí¥Ü¡A¨S¿ù¡A³o­Ó¼Ò«¬¦b¬Y¨Ç¨t²Î¤W¥i¥H¸ÑÄÀÀH¾÷¹p®gªº®ÄÀ³¡CµM¦Ó¥L§ó§Æ±æ¯à¦³§ó¦hªº¹êÅç¨Ó´ú¸Õ³o­Ó¼Ò«¬ªº¾A¥Î½d³ò¡C

¬ì¾Ç®aµo²{»y¨¥·|¶ì³y«ä·Q

8/20/2004, Scientific American, ²ï¤h¤ñ¨È¦W¨¥¡G¡§ª´ºÀ¤£¥sª´ºÀ¡A¥çµL·l¨äªÚ­»¡C¡¨¤£¹Lª´ºÀ©ÎROSE³o­Ó¦r²´¬O§_·|¼vÅT¤H­Ì¹ïªá¦·ªº·Pª¾©O¡HBenjamin Lee Whorf ´£­Òªº»y¨¥¾Ç²z½×»{¬°»y¨¥·|¼vÅT«ä·Qªº¥»½è»P¤º®e¡C­ô­Û¤ñ¨È¤j¾Ç¾ÇªÌ¹ï¨È°¨»¹¤@­Ó³¡¸¨¶i¦æ¤F¼Æ¦~ªº¼Æ¦r»{ª¾¬ã¨s¡A¬ã¨sµ²ªG¤ä«ùWhorfªº°²»¡¡A§Y»y¨¥¥i¯à¶ì³y«ä·Q¡C

­ô­Û¤ñ¨È¤j¾Ç¦æ¬°¾Ç¬ã¨s­ûPeter Gordonªº¬ã¨s¹ï¶H¬°¤@­Ó©t¥ßªº¨È°¨»¹³¡¸¨Pirahã¡A³¡¸¨±Ú¸s¤H¼Æ¤Ö©ó¨â¦Ê¤H¡CPirahã±Ú¤H©ó­pºâ¼Æ¦r®É©Ò¨Ï¥Îªº­p¼Æ¨t²Î«Ü¯S®í¡A¥H1¡B2¨Ó­pºâ¼Æ¦r¡A¶W¹L3ªº¼Æ¶q¶ÈºÙ¤§¬°¡§³\¦h¡¨¡A¥L­Ì¨S¦³»y¨¥¯à´y­z¤j©ó3ªº¼Æ¦r¡C¬°¤F´ú¸ÕPirah㪺­p¼Æ¨t²Î¬O§_­­¨îPirahã±Ú¤H¹ï§ó¤j¼Æ¶qªº»{ª¾¡AGordonµ¹¤F¨Çºâ¼Æ§@·~¡A¨Ò¦pGordon ­n¨ü´ú¹ï¶H¬Ý¬Ý¦a¤WÂ\ªº¹q¦À¡AµM«á»P¬ÛºÙªº¼Æ¶q³sµ²¡C·í¼Æ¶q¤£¶W¹L3®É¡APirah㦨¤Hªº­p¼Æªí²{¤£¿ù¡A¼Æ¶q¼W¦Ü8¦Ü10®É¡A·Ç½T«×­°§C¡A§ó¤jªº¼Æ¶q®É¡APirahã±Ú¤H¸g±`µª¿ù¡A¤]´N¬OµLªk­pºâ¤j¼Æ¥Ø¡C

Science Image: piraha man
(
¼v¹³¨Ó·½: P. GORDON)

Benjamin Lee Whorf©ó1930¦~¥N¥½´Á´¿´£¥X¤@­Ó»á¨üª§½×ªº°²»¡¡A»{¬°»y¨¥¯à¨M©w§Ú­Ì«ä¦Òªº¤è¦¡©ÎªÌ§Ú­Ì¯à«ä¯Áªº½d³ò¡C¤ß²z¾Ç®a¡B¤HÃþ¾Ç®a»P»y¨¥¾Ç®aªø´Á¥H¨Ó§Y¤@ª½ºÃ´b°Êª«¡B¤p«Ä©Î¬Y¨Ç¤å©ú§Y¨Ï¯Ê¥F´y­z¼Æ¶qªº¤å¦r¡A¬O§_¤´¨ã³Æ¼Æ¦r·§©À¡C¨Ì¾ÚPeter GordonªºÆ[¹îµ²ªG¡AÅã¥Ü»y¨¥¯à©w¸q»{ª¾¡A¦Ü¤Ö©ó°Q½×¼Æ¦r®É¬O¦p¦¹¡C

¤£¹L³o­Ó»â°ì¸Ìªº¨ä¥L¾ÇªÌ¦³¤£¦Pªº·N¨£¡ARutgers¤j¾Ç¤ß²z¾Ç®aCharles Gallistel»{¬°Pirahã±Ú¤H¶È¶È¬OµLªk¿ë»{¥Xª««~ªº¼Æ¶qµ¥©ó¨ä¥L¼Æ¶q(Charles Gallistel ¥i¯à¹ïGordonªº´ú¸Õ¤èªk¦³·N¨£)¡CCharles Gallistel¥D±iPirahã±Ú¤H½T¹ê¾Ö¦³·Q¹³©Ò¦³¼Æ¦rªº¤Ñ¥Í¡B«D¨¥»yªº¯à¤O¡APirah㪺»y¨¥¶È¶È±N¤§ºë²¦Ó¤w¡C

«¢¦ò¤j¾Ç¤ß²z¾Ç®aSusan Carey«ù¬Û¤Ïªº¬Ýªk¡A¦o»{¬°¤H­Ì¯Ê¥F­p¼Æ¶W¹L«D±`¤p¼Æ¦rªº¤Ñ¥Í¯à¤O¡APirahã³B²z¼Æ¦rªº§xÃøÃÒ©ú¤F¦oªº½×ÂI¡CCarey »P¨ä¥Lªº¬ã¨s¤H­û¬Û«H¤p«Ä¤l¥H¤Î¤@¨Ç°Êª«¤Ñ¥Í¨ã³Æ¨âºØ°ò¥»ªº­p¼Æ¤è¦¡¡A­º¥ý¨âªÌÂǵ۫O¯d¼v¹³ªº°O¾Ð¯à»{¥X1,2©Î3­Óª«Åé¡A¨ä¦¸¯à¦ô­p¸û¤jªº¼Æ¦r¨Ò¦p¤j¬ù20¡ACarey¬Û«HPirah㤴¨Ì¿à¦¹ºØ¤Ñ¥Íªº­p¼Æ¨t²Î¡C

Johns Hopkins¤j¾Ç»{ª¾¤ß²z¾Ç®aLisa Feigenson»{¬°»y¨¥¯àÅý¤H­Ì¥h«ä¦Ò§¹¥þ·sªº¨Æª«¡A©ó¦¹®×¨Ò¡A»y¨¥ªº¯Ê¥F¦ü¥Gªý¤îPirahã±Ú¤H¥h«ä¯Á§ó¤jªº¼Æ¦r¡C¤£¹LFeigenson «ü¥X©ó¨ä¥Lªº¨Ò¤l¡A³Ì·sªº¬ã¨s¤´µLªk¸Ñ¨M»y¨¥¬O§_·|¶ì³y«ä·Qªºª§½×¡C

ª¼¤Hťı¸û±Ó¾Uªº¬ì¾Ç¤ÀªR

7/30/2004, Nature Science Update, ª¼¤H­µ¼Ö®aªº¤~µØ¬v·¸¬O¤@¦Aµo¥Íªº¥©¦X©O¡HÁÙ¬O¥Ñ©ó±Mª`ªº¾®¶°©O¡H¥[®³¤j¬ì¾Ç®a­Ìµo²{¡G¦~¥®¥¢©úªºª¼ªÌ¹ï©ó¼Ö­µÅܤƪº¹îı¯à¤O½T¹ê»·»·±j©ó«á¤Ñ¥¢©úªÌ¤Î´¶³q¤H¡C¥[®³¤j¬ì¾Ç®aPascal Belin»P¨ä¬ã¨s¹Î¶¤µoªí©ó2004¦~¤C¤ë¡m¦ÛµM¡n´Á¥Z(Nature 430¡G309)ªº¬ã¨s¦¨ªG«ü¥X¡G¦~¥®¥¢©úªºª¼ªÌ¹ï©ó¼Ö­µÅܤƪº¹îı¯à¤O½T¹ê»·»·±j©ó«á¤Ñ¥¢©úªÌ¤Î´¶³q¤H¡C

¦b¥L­Ìªº¬ã¨s¤¤¡A±N¨ü¸ÕªÌ°Ï¤À¬°¤T¤j¸sÅé¡G²Ä¤@¸s¬°¤C¦ì¦~¥®(¤G·³¥H«e)¥¢©úª¼ªÌ¡A²Ä¤G¸s¬°¤C¦ì¦~ªø(¤­·³¨ì¥|¤Q¤­·³¶¡)«á¥¢©úªÌ¡A²Ä¤T¸s«h¬°¤Q¤G¦ìµø¤O¥¿±`¨ü¸ÕªÌ¡C±µµÛ¡A¬ã¨s¤H­û­n¨D³o¨Ç¨ü¸ÕªÌ¾®Å¥¤@¨t¦C¥Ñ¨â­Ó³sÄò¥B­µ°ª¤£¦Pªº¼Ö­µ²Õ¦¨ªº­µ¹ï¡A¨Ã¹ï¦U­µ¹ï¤¤¼Ö­µªº°ª§CÅܤƶi¦æ§PÂ_¡C ¹êÅ礤¡A¬ã¨s¤H­û±N­µ°ª®t¬°1/8­Ó¤K«×­µ(¬Û·í©ó150­µ¤À­È©Î1.5­Ó¥b­µ)¡A­µ­È(µoÁnÅé¾_°Ê®É©µÄò®É¶¡ªºªøµu)¬°333²@¬íªº­µ¹ï°µ¬°°Ñ·Ó¡C³q¹L¹ï°Ñ·Ó­µ¹ïªº¨â­Ó¯S¼xÅܶq¤À§O¶i¦æ¥|¦¸¹ï¥b»¼´î¡A64­Ó¹êÅç­µ¹ï³Q¤À¬°8²Õ¡A¨C²Õ¥]§t8­ÓÀW²v¤£¦P§í´­¬Û²§ªº­µ¹ï¡C¹êÅçµ²ªGÅã¥Ü¡GµL½×¬O¹ïµyÁa§Y³uªº¼Ö­µÅܤÆ(³Ìµu­µ­È¡G20.8²@¬í)¡AÁÙ¬O·¥¨ä²Ó·Lªº­µ¶¥ªi°Ê(1/128­Ó¤K«×­µ)¡A¬Û¸û©ó«á¤Ñ¥¢©ú©Îµø¤O¥¿±`ªº¨ü¸ÕªÌ¡A¦~¥®¥¢©úªºª¼ªÌ³£§ó¯à·Ç½T¦a¿ëªR¡C

Pascal Belin±À´ú¡G¥X¥Í®Éªº¤j¸£¤¤­t³dµøÄ±¡Bťı»P¨ä¥L·Pıªº¯«¸g¨t²Î³£¬O¬Û¤¬Ápôªº¡A¥u¬O¦bµo¨|ªº¹Lµ{¤¤¡A¤j¸£¤¤¦UºØ·P©x¶¡ªºÁpô·|³vº¥®ø¥¢¡CµM¦Ó¡A¦pªG¦~¥®¥¢©ú¡A«h³oºØ·P©x¶¡Ápô²{¶H«h·|³Q«O¯d¤U¨Ó¡A¦p¦¹¤@¨Ó¡A¤j¸£¤¤ªºµøÄ±¥Ö½è¤]¥i¥H¨ó§U³B²zÁn­µ«H®§¤F¡C

­ì©l¤åÄm¡GNeuropsychology: pitch discrimination in the early blind. Nature. 2004 Jul 15;430(6997):309.

¾Ç­µ¼Öªº¤p«Ä·|§óÁo©ú

8/19/2004, American Psychological Society, ¥[®³¤j¬ì¾Ç®a¸g¥Ñ¹êÅç¤ñ¹ï¡A½T»{¾Ç­µ¼Öªº¤pªB¤Í¯à¼W¥[´¼¤O¡C¸ÕÅç¹ï¶H144¦W6·³¤p«Ä¡F4­Ó´ú¸Õ²Õ¡GÁä½L­µ¼Ö½Ò¡Bºq°Û½Ò¡BÀ¸¼@½Ò¡B¤@­ÓÔ£³£¤£¾Çªº¹ï·Ó²Õ¡F´ú¸Õ®É¶¡¡G¤@¦~¡F´ú¸Õ¥Ø¼Ð¡G´¼°Ó»P¹ÎÅé¾AÀ³¯à¤O¡C´ú¸Õµ²ªGÅã¥Ü«e¨â²Õ¤pªB¤Íªº´¼°Ó¸û«á¨â²Õ¼W¥[¬°¦h¡C

¦h­Û¦h¤j¾Ç¤ß²z¾Ç¨tE. Glenn Schellenberg³Õ¤h¬ã¨s¾Çµ£½Ò¥~¬¡°Ê¹ï´¼¤O»PªÀ·|µo®iªº¼vÅT¡A¥L§ä¤F144­Ó¤»·³¨àµ£¥ô·N¤À¦¨¥|­Ó¬¡°Ê²Õ¡GÁä½L½Ò¡Bºq°Û½Ò¡BÀ¸¼@½Ò¥H¤Î¤@²Õ¤°»ò³£¤£¾Ç¡C­µ¼Ö½Ò¤À¦¨Áä½L»Pºq°Û¨â²Õ¡A¥Øªº¦b©óÂk¯ÇÆ[¹îµ²ªG¡FÀ¸¼@»PÔ£³£¤£¾Çªº¤@²Õ«h¥R¬°±±¨î²Õ¡A¥H´ú¸Õ­µ¼Ö½Òµ{¹ï¨ä¥L»Ý­nÃþ¦ü§Þ¥©ªºÃÀ³N½Òµ{¥H¤Î§¹¥þ¤£¾Çªº¼vÅT¡A½Òµ{®É¶¡¬°´Á¤@¦~¡C¥Ñ¨àµ£°Ñ¥[½Òµ{«e«áªº´¼°Ó´úÅçÅã¥Ü¡A¾ÇÁä½L»Pºq°Û¨àµ£ªº´¼°Ó¸û¥t¨â²Õ¼W¥[¬°¦h¡F¾ÇÀ¸¼@ªº¤p«Ä¦bªÀ·|¦æ¬°¾AÀ³¤WÅã²{¤F§ïµ½¡A¾ÇÁä½L»Pºq°Ûªº¨àµ£©ó¦¹«h¥¼¨£§ïÅÜ¡C

¤£¹L¤÷¥À¿Ë¦b±Ç¸y¥]°e¤p«Ä¤W­µ¼Ö½Ò¤§«e¡A­nª`·NScienceDaily ªº³ø¾É§¹¥þ¤Þ¥ÎAmerican Psychological Society (APS) ºô¯¸ªº³ø¾É¡AAPS¼ÐÃD¬O¡§New Research Provides the First Solid Evidence that the Study of Music Promotes Intellectual Development¡¨¡A ¤å³¹¤¤ªº¤@¬q´£¨ì¡§The results of this study revealed that increases in IQ from pre- to post-test were larger in the music groups than in the two others¡¨¡A¦ü¥G¾Ç­µ¼Ö·|Åܱo¸ûÁo©ú¡C¤£¹L½×¤å­ì¤å¡§Music Lessons Enhance IQ¡¨ªºµ²½×¦p¬O»¡¡A¡§The findings indicate that music lessons cause small increases in IQ, but comparable nonmusical activities do not have similar consequences. By contrast, drama lessons had favorable effects on social behavior that were not evident in the music groups.¡¨¡A¦b´¼°Ó¤W¶È¦³¤p´T¼W¥[¡F¦Ó¥B½×¤å¤¤ªº¼Æ¾ÚÅã¥Ü¡AÁä½L²Õ¨àµ£¦b¾Ç²ß«e«áªº¾ãÅé´¼°ÓÅܤƬ°102.6-108.7¡Aºq°Û²Õ¨àµ£ªº¾ãÅé´¼°ÓÅܤƬ°103.8-111.4¡AÀ¸¼@²Õ«h¬°102.7-107.7¡A¨S¦³¾Ç²ßªº¤@²Õ¬°99.4-103.3¡C­Y¹ï¦¹¨Ç¼Æ¾Ú¨úln­ÈÆ[¹î¨ä±×²v¡A«h¶Èºq°Û²ÕªºÅܤƵy¤j¦Ó¤w¡C¥t¥~§@ªÌ¤]´£¨ì¤W¾Ç¨ü±Ð¯à¼W¥[´¼°Ó¡A¤p¯Z¨î¯S§O¦³®Ä¡A©Ò¥H¹³´ÑÃÀ¡B¬ì¾Ç¬ã²ß¡B¾\Ūµ¥½Ò¥~¬¡°Ê¥i¯à·|Àò±o¬Û¦üªº¦n³B¡C ©Ò¥H­Y¶È¬°¤FÅý¤p«ÄÅܪºÁo©ú¦Ó¾Çµ^¡A¤£¦p³­¤p«Ä¾\Ū¤]¯àÀò±o¬Û¦Pªº®ÄªG¡A¦Ó¥B§ó¯à¼W¶i¿Ë¤lÃö«Y¡C

¤HÃþªº¹Ø©R¶V¨Ó¶Vªø

7/6/2004, Science Daily, ¦Ò¥j¾Çªº¬ã¨sµo²{¥Û¾¹®É¥Nªº¤HÃþ¹Ø©R¤j´T©µªø¡A¨Ï±o¤HÃþ¦³ªøªÌ¶Ç©Ó¸gÅç¦Ó¦b¤å¤Æ¤W¦³©Ò­²·s¡C¦~ªøªÌ²Ö¿n¤F¤£¤Ö¥Í¬¡ªº´¼¼z¡C¦Óªø¹Ø¤]¬O¤HÃþ¦³§O©ó¨ä¥L¤j·áªº¥D­n¯S¼x¡C¤HÃþ¾Çªø´£¥X¤F¼ÆºØ²z½×¨Ó¸ÑÄÀ¬°¦ó¤Ñ¾Ü¯à°÷³y¦¨³oºØ®t²§¡C¤@­Ó²z½×´N¬O¡u¯ª¥À°²»¡¡v¡A¥D±i¹Ø©Rªº¼Wªø¥i¥HÅý¯ª¥À±o¦p·ÓÅU¨à®]¡A¼W¥[¥L­Ìªº¥Í¦s²v¡CµM¦Ó¬ì¾Ç®a¤@ª½¯Ê¥FÃÒ¾Ú«ü¥X¦­´Á¤HÃþªº½T¤ñ¨ä¥L¤HÃþ¯ª¥ý¬¡±o§ó¤[¡C

±K¦è®Ú¤j¾Çªº¤HÃþ¾Ç®aRachel Caspari©M¥[¦{¤j¾ÇªeÃä¤À®Õªº§õ©|ÁHÀËÅç¤F¨Ó¦Û¥|ºØ¤HÃþ¯ª¥ýªº768­Ó­ÓÅ骺¤ú¾¦¡A¥L­Ì¥Í¬¡¦b¤T¦Ê¸U¦Ü¤@¦Ê¤­¤Q¸U¦~«eªº«n¤è·á¡]australopithecines¡^¥H¤Î¤T¸U¦Ü¤@¸U¤K¤d¦~«e¦­´Á¤W¥Û¾¹®É¥Nªº¼Ú¦{¤H¡C¥L­Ì°ò©ó¤ú¾¦¿i·lªºµ{«×¨Ó§PÂ_¹Ø©R¡A¥H­pºâ¦Ñ¦~¦¨¤H¡]¤Ê·³¥H¤W¡^©M¦~»´¦¨¦~¤H¡]¤Q¦Ü¤Ê·³¡^ªº¤ñ¨Ò¡C¥L­Ì©w¸q¦~¦Ñªº¦~¬ö¬O©Ê¦¨¼ô¦~¬öªº¨â­¿¡A³o·N¨ýµÛ¤Q¤­·³©Ê¦¨¼ôªº¤H¦b¤Ê·³¦³¥i¯à·í¤W¯ª¤÷¥À¡Cµ²ªG¥L­Ìµo²{¤HÃþªº¹Ø©RÀHµÛºt¤Æªº®É¶¡ªº½T¦³©Ò¼Wªø¡A³Ì¤j´T¼Wªøªº®É­Ô¬O¤T¸U¦~«e¡C

¦b¤W¥Û¾¹®É¥N¡A¤HÃþªº±Ú¸s¤j´T¦¨ªø¡A¦ñÀHµÛ¡u³Ð³y¤O¤jÃzµo¡v¡A¥X²{¤F²Å¸¹ÃÀ³N¡B¹¢ª«©M©_¯Sªº³­¸®ª«¡CCaspari«ü¥X¡A¹Ø©R¤jÅD¶i«á¡A´N¯à°÷§âª¾ÃѶǻ¼¨ì¤£¦P¥@¥N¡A³o¹ï¤HÃþªº¤å¤Æ¬O«D±`­«­nªº¡C¦Ó¹Ø©R¼Wªø«á¡A±Ú¸s¼Æ¤]·|¤W¤É¡A¦p¦¹¤@¨Ó´N¦³§ó¦h·sÂAªºÂI¤l¥i¥Hµo¥Í¡C

¼C¾ô¤j¾Çªº¥Íª«¤HÃþ¾Ç®aPhyllis Leeªí¥Ü¡A¥Û¾¹®É¥N¤HÃþ©M¥§¦w¼w¶ð¤H¶¡ªº¹Ø©R¤jÅD¶i¥i¥H¸ÑÄÀ¬°¦ó¥§¦w¼w¶ð¤Hªº¤£ÀÙ¡CLee»{¬°¥L­Ì¹ï¹Ø©R¦b¤W¥Û¾¹®É¥Nªº­²·s§êºtµÛ­«­n¨¤¦âªº±À´ú¬O«D±`¦X²zªº¡C¤£¹LLee»{¬°Áٻݭn§ó¦hªº¸ê®Æ¤~¯à½T©w¤HÃþªº¹Ø©R¤jÅD¶i¬Oµo¥Í¦b¤T¸U¦~«e¡A©ÎªÌ¬O²{¥N¤HÃþÂX´²¨ì¥þ²yªº¤Q¤G¸U¦Ü¤»¸U¦~«e¡C

­ì©l¤åÄm¡GR. Caspari & S.-H. Lee. Older age becomes common late in human evolution. PNAS published July 13, 2004, 10.1073/pnas.0402857101

¨È¬w¬×¤Wªº¤Ï¤é±¡ºü»P¾H¤p¥­ªº¥ý´I²z½×

8/24/2004, ¤é¸gBPºô, ¡§¤p¤é¥»¶Ì¡Ñ¡I¡¨--¸s±¡¿E©ùªº¦~»´¤H¤@Ãä´§»RµÛ¤­¬P¬õºX¡B¤@Ã䤣°±¦a©I³Û¤f¸¹¡C¤j·§¦³2000¡ã3000¤H§a¡C 8¤ë7¤é©]¡Aµ§ªÌ´N¦b¥_¨Ê¤u¤HÅé¨|³õ¥~­±¡A´N¦b¨È¬w¬×¨¬²y¨MÁÉ¡A¤é¥»¶¤¥H3¤ñ1À»±Ñ¤¤°ê¶¤«á¡A¡§³¡¤À¡¨¤¤°ê²y°g¹L¿E¦æ¬°ªº²{³õ¡C

¥¿¦p¤é¥»ªº³ø¯È»P¹qµøªø½g²ÖÃ|³ø¹D¹Lªº¨º¼Ë¡A¤é¥»¤½¨Ï­¼§¤ªº¨T¨®¨®µ¡¬Á¼þ³Q¥´¸H¡A¤é¥»²y°g¦b¤ñÁɵ²§ô«á2­Ó¦h¤p®É«á¤´µMµLªkÂ÷¶}Åé¨|À]¡C¾¨ºÞ¥_¨Ê¥«¤½¦w§½°Ê­û¤F¼Æ¸U¦Wĵ¹î§Ù³Æ¡A¦ý¤´µM¥¼¯à§¹¥þªý¤î¥X²{Ä̰ʡC¡§´Nºâ§A¦b·P±¡¤W¬O¦h»ò¦a°Q¹½¤é¥»¡A³o»ò°µ¤]¤Ó¹L¤F¡¨¡A¬Û«H³\¦hŪªÌ¹ï¹L¿E¦æ¬°¤]·|½K¬ÜÀY¡C

¡¿µLµø¬F©²Äµ§i¡A¤]µL¥ô¦ó°Ê¾÷

¦b¥þ¥@¬Éªºª`·N¤O¦ü¥G³£Âಾ¨ì¤F¶®¨å¶ø¹B·|¤Wªº¤µ¤Ñ¡A¥»Äæ¥Ø­«´£¨È¬w¬×ªº¸ÜÃD¡A¬O¦]¬°¿Ë²´¥Ø¸@8¤ë7¤é©]ùتºµo¥Íªº¨º¤@¤Á¤§«á¡A©¿µMµo²{¦p¦P¬Ý¨ì¤F·í¥N¤¤°êªÀ·|©Ò¾Ö¦³¥Ù¬Þªº¤@­ÓÁY¼v¡C¤£ª¾¬°¤°»ò¡A¤ßùجðµM«_¥X¤F³o¼Ë¤@­Ó©ÀÀY¡A¡§¦pªG¾H¤p¥­¬Ý¨ì³o¤@¹õªº¸Ü¡A·|¦³¦ó·P·Q©O¡H¡¨¡C

1989¦~6¤ë4¤é¡A·í®É´xºÞµÛ¤¤°ê³Ì°ªÅv¤Oªº¾H¤p¥­°Ê¥Î­x¶¤¥ÎªZ¤O¤è¦¡¸Ñ¨M¤F¤Ñ¦wªù¨Æ¥ó¡C»P·í®É¬Û¤ñ¡Aªñ¦~¨Ó¾¨ºÞ¤¤°êªº¨¥½×¤w¸g¬Û·í¦Û¥Ñ¡A¦ý¦b¤¤°ê¤½µMµLµø¦@²£ÄÒ¬FÅvªº¦æ¬°¤´µM¬O³Q¸T¤îªº¡C¦b15¦~«áªº¤µ¦~³o­Ó®L©]¡A³o¨Ç¤@Ãä»Pĵ¹î±À±Àݺݺ¡A¤@Ãä°ª©I¤Ï¤é¤f¸¹ªº¦~»´¤H¡A¦ü¥G¨Ã¨S¦³¤@ºØÅý°õ¬FªÌ·P¨ì¾_¾Ùªº®ð·§¡C ·íµM¡A¤H©È¤ã°ï¡Aµ§ªÌ·í®É¤]·P¨ì¹L®£Äß¡A¨º¬O¤@ºØ¦pªG¦b²{³õ³Q¤Hµo²{¬O¤é¥»¤Hªº¸Ü¤£ª¾¹D·|¦³¤°»òµ²ªGªº®£Äß¡C¦ý¬O¡A¦pªG­ç°£¤F³o­Ó¦]¯À¡A´N·|ı±o¤£¹L¬O³o¨Ç¦~»´¤H±N¤Ï¤é§@¬°¤@­Ó¤f¸¹¡A­É¾÷µoªn¦Ó¤w¡C¦V½Ö¶D¨D¤°»ò¡A¦³¤°»òµo¦Û¤º¤ßªº­¢¤Á­n¨D¡A³o¨Ç¥þµM¤£¨£¡C¦ô­p¨­¸g¦Ê¾Ôªº¾Ô²¤®a¾H¤p¥­¡A®Ú¥»¤£·|§â¥L­Ì©ñ¦b²´ùØ¡C »P¦¹¬Û¤ñ¡A¤Þ°_µ§ªÌ¿³½ìªº­Ë¬O¨º¨Ç¦b²{³õ«o¨S¦³°Ñ¥[ªº¤H­Ì¡C

¡¿¤J³õ¨é«D±`©ù¶Q

³oÃþ¤H¤j­P¥i¥H¤À¬°¨âºØÃþ«¬¡C ²Ä¤@Ãþ¤H¬O¨º¨Ç¤ñÁɵ²§ô«á¨«¥XÅé¨|³õªº¤H­Ì¡C¦b6¸U¦h¦WÆ[²³¤¤¡A¤ñÁɵ²§ô«á°Ñ¥[¤Ï¤éÄ̶꺳̦h¥u¦³´X¤d¤H¡C¦b¤ñÁÉ´Á¶¡¾¨ºÞ¥L­Ì¤]³Ü­Ë±m¡A¦ý9¦¨¥H¤W¦b¤ñÁɵ²§ô«á´N¥ß°¨¦^®a¡C ­±¹ï¦bÅé¨|³õ¥X¤f³B¸s±¡¿E©ùªº¦~»´¤H¡A§ó¦hªº¤H¬Æ¦Ü³s¬Ý³£¤£¬Ý´N¨«¶}¤F¡C³o¤]¬O¤@¹õ«D±`©_¯Sªº³õ´º¡C¥L­Ì¨Ã«D¬O¦]¬°¤½¦w³¡ªùªºÄµ³Æ´ËÄY¦Ó¾á¤ß³Q±²¤J¨ì³Â·Ð¤¤¥h¡A¬Ý°_¨Ó§ó¹³¬O®Ú¥»¤£·P¿³½ì¡A©ÎªÌ»¡¤£Ä@»P°ªÁn§o³ÛªÌ¬°¥î¡C

¨ä¹ê¡A¨È¬w¬×¨MÁɪºªù²¼«ö·Ó¥_¨Ê¥«¥Áªºª«»ù«ü¼Æ¨Ó»¡ÁÙ¬O«D±`©ù¶Qªº¡C³Ì«K©yªº®u¦ì¤]­n200¤¸¡C³Ì¶Qªº®u¦ì°ª¹F2000¤¸¡A´X¥G¬Û·í©ó¤uÁ~¶¥¼h¤@­Ó¤ëªº¦¬¤J¡C¦ý¦b¨MÁÉÅܬ°¤¤¤é¹ï¨M«á¡A²y²¼°¨¤W¾P°â¤@ªÅ¡A¶Â¥«»ù®æ¬°¹ê»Ú²¼»ùªº2¡ã3­¿¡C´N³s¤ñÁɳ£¶i¦æ¨ì¤F¤U¥b³õªº®É­Ô¡A¦V²¼³c¤l¥´Å¥¤@¤U¡A­ì»ù400¤¸ªº²¼¤´­n½æ600¤¸¡C ¤]´N¬O»¡¡A¯à°÷¶i¤JÅé¨|³õÆ[¾Ôªº¤¤°ê²y°g¤j³£¨ã¦³¸û°ªªºÁʶR¤O¡AÄݩ󤤲£¶¥¯Å¥H¤Wªº´I¸Î¶¥¼h¡C ³o¨Ç´I¸Î°_¨Óªº¤H­Ì¨ü¯q©ó¡§§ï­²¶}©ñªºÁ`³]­p®v¡¨¾H¤p¥­¡C1978¦~12¤ë¡A¾H¤p¥­¦b¤¤°ê¦@²£ÄÒªº­«­n·|ij¤W´£¥X¡§­n¥ýÅý¤@³¡¤À¦a°Ï¡B¤@³¡¤À¥ø·~¡B¤@³¡¤À¤u¤H©M¹A¥Áªº¦¬¤J¦h°_¨Ó¡A­n¤¹³\¥L­Ì¥ý´I°_¨Ó¡¨¡C³o´N¬OµÛ¦Wªº¥ý´I²z½×¡C¤]´N¬O»¡³q¹L¤¹³\¦b±µ¨ü®ü¥~§ë¸ê³B©ó¦³§Q¦ì¸mªºªu®ü¦a°Ï¡A¥H¤Î©é©R¤u§@ªº¤H¥ý´I°_¨Ó¡A¨Ï±o³o¨Ç¦a°Ï©M³o¨Ç¤H¦¨¬°²o¤Þ¤¤°ê¸gÀÙµo®iªº¤õ¨®ÀY¡C

¥ý´I½×ªº²z·Q¬O¡A¥ý´I°_¨Óªº¤H¦b´I¸Î¤§«áÀ°§U³h§xªÌ¡A³Ì²×¹ê²{¡§¦@¦P´I¸Î¡¨¡C¦ý¬O¦b¨È¬w¬×¨MÁɪº¨º¤Ñ±ß¤W¡A¤Ï¤éªº¥DÅé¬O¨º¨Ç¨S¦³¶R¨ì²y²¼¦Ó¦b²y³õ¥~¥[ªo§U«Âªº¾Ç¥Í©ÎªÌ¬O¬Ý¤W¥h¹³¾Ç¥Íªº¦~»´¤H¡C¥i¬O¨«¥XÅé¨|³õªº´I¸Î¤H¸s¬J¤£¦P±¡¥L­Ì¡A¤]¤£Äþ³d¥L­Ì¡A¥u¬O®¨µMÂ÷¥h¡C

¡¿  ³h´I®t¶ZªºÂE·¾

¥t¥~¤@Ãþ¤H´N¬OÁöµM¦b¦P¤@¦a¤è¡A¦ý²@¤£Ãö¤ßªº¤H­Ì¡C³o´N¬O¦bÅé¨|³õ¥|©Pªº¤p³c­Ì¡C°£©ï°ª²¼»ùªº¶À¤ûÄÒ¥~¡AÁÙ¦³¾P°â°êºX¡B³â¥z¡B¦B¿EÕæ¡BÄq¬u¤ô¡B¨àµ£ª±¨ã¥H¤Î¨ä¥L¥ô¦ó¥i¥H¾P°âªºªF¦èªº¤H­Ì¡C ³o¨Ç¤p³cªº¦h¼Æ³£¬O°êÀç¥ø·~ªº¤U±^¾¤u¡A©ÎªÌ¬O¥~¦a¨Ó¨Êªº¥´¤u¤H­û¡C´N¦bÄ̶óv¨B¤É·Å¡A¬Æ¦Ü¶}©l»Pĵ¹î¶¤¥îµo¥Í½Ä¬ð®É¡A³o¨Ç¤p³c¤´µø­YµL¸@¦a°Â°âµÛ¥L­ÌªºªF¦è¡C©Î³\¦b¥L­Ìªº¸£®ü¤¤¡A¦p¦ó±Ã¥X¤µ¤Ñªº¥Í¬¡¶O¡A¤~¬O²Ä¤@»Ý¨D¡C

¾H¤p¥­ªº¥ý´I²z½×¬°¤¤°ê±a¨Ó¤FÅå¤Hªº¸gÀÙ¼Wªø©M¥Í¬¡¤ô¥­ªº´£°ª¡A¦ý¦P®É¤]²£¥Í¤F³h´I®t¶ZÂX¤j³o¤@ªÀ·|¥Ù¬Þ¡C¤u¤HÅé¨|³õ«e¡A¤¬¤£Ãö¤ßªº¤H¸sºc¿v¥XªºÂA©ú¹ï¤ñ¡AÅý¤H²`²`·P¨ì´I¤H»P½a¤Hªº¥¨¤jÂE·¾¡C 8¤ë22¤é¡A¥¿­È¾H¤p¥­½Ï¨°100¶g¦~¡C¦pªG¾H¤p¥­ÁÙ¬¡µÛªº¸Ü¡A±N·|«ç¼Ë¶ñ¸É³o¤@ÂE·¾©O¡H

¦L«×¸gÀÙ¶}©l°_­¸¡Aµo®i¼ç¤O¶W¹L¤¤°ê

8/18/2004, ¤é¸gBPºô, ¤È¶¡®ð·Å¶W¹L47«×ªº5¤ë¡A¦L«×­º³£·s¼w¨½­¥¥~ªº¥»¥ÐÁº¸¥d¯÷¦L«×¤u¼t¤´¦b¨S¦³ªÅ½Õªº¨®¶¡ùضi¦æº¡­t²ü¥Í²£¡C¥Ñ©ó¥h¦~10¤ë¤W¥«ªº¤p«¬Ã⨮¡§CITY¡¨¦b¦L«×¤@¬¶¨«¬õ¡A¦b³o®a¾Ö¦³1400¦W¹µ­ûªº¤u¼tùØ¡A¤H­Ì¦£±o³sÀ¿§â¦½ªº¤u¤Ò³£¨S¦³¡C

³o¬O¤@®a¥»¥Ð»P·í¦a¸ê¥»ªº¦X¸ê¤½¥q¡A¥Í²£¥H¤é¥»¡§­¸«×¡¨¬°­ì«¬ªº4ªùÃ⨮¡§CITY¡¨¡C¥h¦~³q¹LÂ૬¡A¦b´£°ª¿U®Ä©M°t¸mªº¦P®É¡A¤ñ³Ì¨üÅwªïªº­ì¨®«¬ÁÙ­°»ù10%¡A¥H65¸U¿c¤ñ¡]¬ù150¸U¤é¤¸¡^ªº»ù®æ¶i¦æ¾P°â¡C±À¥X«á²`¨ü¤uÁ~¶¥¼hªºÅwªï¡A¥Ø«e¥æ¨®®É¶¡­nµ¥¤W1­Ó¥b¤ë¡C9¤ë¥÷¥H«á±N³q¹L§ï¶i¥Í²£¤u§Ç¡A§â¥Í²£¯à¤O´£°ª20%¡A¹ê²{¦~²£3¸U6000½øªº¥Í²£Åé¨î¡C ¸Ó¤½¥qÁ`µô¤s¥Ð¤@¯º³vÃC¶}¦a»¡¡G¡§³q¹L¼Ò¨ãªº¥»¦a±ÄÁʵ¥¤â¬q«d´î¦¨¥»¡AºZ¾Pªº¥D­n­ì¦]¬O»ù®æ­°¨ì¤F¤uÁ~¶¥¼h¥i¥H©Ó¨üªº¤ô¥­¡C¦b³]­p¤¤ÁÙ¤j¶q±Ä¥Î¤F¦L«×¤H°¾·Rªº¦±½u¡C¸gÀç¾Ô²¤«D±`¹ï¸ô¡¨¡C

¥Ñ©ó°ò¦³]¬IÁ¡®z¡B»Ý¨D§C°g¡A³o®a¦¨¥ß©ó1995¦~ªº¤½¥q¦b2000¦~¥H«e¤@ª½³B©óÁ«·lª¬ºA¡C¬°µo´§³Ò°Ê¤O¦¨¥»Àu¶Õ¡B­°§C§ë¸ê¦¨¥»¡A¸Ó¤½¥q¥u¤Þ¶i¤F2¥x¤u·~¾÷¾¹¤H¡C·s´ÚCITYªº2800­Ó²k±µÂI¥þ³¡±Ä¥Î¤H¤u§@·~¡C¯à¦b¦p¦¹Á}Ãø±ø¥ó¤U¨ú±o¦¨¥\¡A»¡©ú¸Ó¤½¥q¹ïCITY©ê¦³ªº´Á±æ¤§¤j¡C

¡§¥þ²y¦¨ªø³Ì§Öªº¥«³õ¡¨

¦L«×ªº¨T¨®¾P°â¼Æ¶q±q1999¦~«×¨ì2002¦~«×¤@ª½¦b¨C¦~70¸U½øªº¤ô¥­¤W±r«Þ¡C¨ì¤F2003¦~«×¡A¥«³õ»Ý¨D¶}©l¤É·Å¡A­º¦¸¬ð¯}¤F90¸U½ø¤jÃö¡C¹w­p¥»¦~«×ÁÙ·|¦b¦¹°ò¦¤W¼Wªø10%¥H¤W¡C °£¨T¨®¥~¡A¤â¾÷»Ý¨D¤]§e²{¥X­¸³t¼Wªøªº¶ÕÀY¡C¥Î¤á¼Æ¶q¥H¨C¤ë150¸U¤Hªº³t«×¼Wªø¡A¤µ¦~6¤ë¹F¨ì¤F2921¸U¡C¾Ú»¡¦³ªº®a®x³s¹q¿OÁÙ¨S¦³´N¥Î¤W¤F¤â¾÷¡C

¥þ²y³Ì¤jªº¤â¾÷»s³y°Ó¿Õ°ò¨È¡]ªâÄõ¡^¤½¥q¸³¨Æªø­ÝCEO¡]­º®u°õ¦æ©x¡^¬ùº¿¡P¶ø§Q©Ôªí¥Ü¡G¡§²{¦b¦L«×Åܦ¨¤F¥þ²y¼Wªø³Ì§Öªº¥«³õ¡¨¡C¿Õ°ò¨È¦b³o­Ó°ê®a¤]¬O³Ì¤jªº¤½¥q¡A³q¹L­±¦Vµo®i¤¤°ê®a¶}µo100¬ü¤¸¡]¬ù1¸U1000¤é¤¸¡^¥ª¥kªº§C»ù¦ì¾÷«¬¡A§l¤Þ¨º¨Ç­º¦¸¨Ï¥Î¤â¾÷ªº®ø¶OªÌ¡C ¿Õ°ò¨Èªº¦L«×¾P°â¤½¥qÁ`µô®á¦N¤Ò¡P®Lº¸°¨±j½Õ»¡¡G¡§ÀHµÛ¦U¤j¤â¾÷¼t°Ó¶i¤J¦L«×¥«³õ¡AÄvª§±N·|¶V¨Ó¶V¿E¯P¡C¥»¤½¥q­p¹º±À¥X20­Ó´Ú«¬¡A¥H½T«OÀu¶Õ¦a¦ì¡C¦L«×¥Á²³ªº¤â¾÷´¶¤Î²v©|¤£¨¬¤@¦¨¡A¼Wªø¼ç¤OÁÙ«D±`¤j¡¨¡C

«°¥«¥H¥~¦a°Ïªº°ò¯¸ºôµ¸ªººc¿v¤]¦b±À¶i¤§¤¤¡A¦]¦¹¤â¾÷²£·~¦b°ò¦³]¬I¤è­±¤]¬O­¸³t¼Wªø¡C¦bµo®i°ª§Þ³N¤è­±¡A¿Õ°ò¨Èªº­·ÀI§ë¸ê³¡ªù¶i¤J¤F¦L«×¡C±q¥þ²y½d³ò¨Ó¬Ý¡A¿Õ°ò¨Èªº¤â¾÷¾P°âÃB¦s¦b¤£Â_¤U­°ªºÁͶաC¦b³oºØ±¡ªp¤U¡A§Ö³t¼Wªøªº¦L«×¦¨¤F¸Ó¤½¥q¥¼¨Óµo®iªº­«­n¥«³õ¡C

¨ü®ø¶O¬¡ÅDªº¤ä¼µ¡A¦L«×¸gÀ٥ثe«O«ùµÛ¨}¦nªºµo®i¶ÕÀY¡C2003¦~ªºGDP¡]°ê¤º¥Í²£Á`­È¡^¹ê»Ú¼Wªø²v¬°8.3%¡A¹w­p¤µ«á¤´±N«O«ù¦b5¡ã6%ªº°ª¤ô·Ç¤W¡C7¤ë¥÷¥@¬É»È¦æµoªí¤F¦©°£ª«»ù¦]¯À«á«ö·Ó¥­§¡ÁʶR¤O´«ºâªºGDP¡A¦L«×¦b2003¦~¬°3.962¸U»õ¬ü¤¸¡A¬Û·í©ó¤é¥»ªº86%¡C¦³¤H»{¬°¡A¦pªG§Öªº¸Ü¦L«×¥Î5¦~®É¶¡´N¯à¶W¹L¤é¥»¡C ¦Û¤W­Ó¥@¬ö80¦~¥N¥H«á¡A¦L«×¶}©l¹ê¬I¸gÀÙ¶}©ñ»P©ñ¼e­­¨î¡C¦ý»P¤¤°ê¬Û¤ñ¡A¶}©ñªº¨B¤lÁÚ±o¤Ó¤p¡A°_ÂI¤]¤£°ª¡C¦L«×¸¨«á©ó¤¤°êªº¥t¤@­Ó­ì¦]´N¬O¨ä¸gÀÙ±À°Ê¤O¬O³nÅé»PIT²£·~¡C­^°ê¬ã¨s¾÷ºcARANCA¤ÀªR»{¬°¡G¡§³nÅé¶}µo»P¥~¥]µ¥ªA°È·~³Ð³y¥X¤F55%ªºGDP¡A¦ý¶±¶Ä¤H¼Æ¥u¦û³Ò°Ê¤O¤H¤fªº23%¡A¿ç®g®ÄÀ³¤£°÷©úÅ㡨¡C

IT®ÄÀ³¿ç®g°ê¤º¨ä¥L¦æ·~

¥Ø«e¡A¦L«×IT²£·~ªº¯A¤Î½d³ò¶}©lÂX¤j¡A¸gÀÙ®ÄÀ³³vº¥¦V¤é¥»º¯³z¡C¨Ò¦p¡A¦ì©ó¦L«×°ª§Þ³N¤¤¤ß--¯Z¥[ùº¸Wipro´N¬O¤ä¼µ¤é¥»¼Æ¦r®a¹qÁcºaªº¹õ«á¥D¨¤¡C¸Ó¤½¥q¤@ª½¬O¤â¾÷»P¼Æ½X¬Û¾÷µ¥´O¤J³nÅ骺¶}µo©Ó¥]°Ó¡C¸Ó¤½¥qªº¤é¥»ªk¤H¦@¦³50¦W¦L«×©M¤é¥»¤H¾­û¡C¥L­Ì©¹¨Ó©ó¯Á¥§¡BNEC¡BªFªÛµ¥¤j«¬¤é¥»¥ø·~¡A¦³®ÉÁÙ±`¦í¿ì¤½«Ç­t³dÁpµ¸·~°È¡C©Ó¾á¹ê»Ú¶}µo§@·~ªº¬O³]¦b¦L«×ªº¶}µo³¡ªù¡A®Ú¾Ú¶}µo´Á­­©M¦¨¥»±¡ªp¡A¦³ªº¶}µo¶µ¥Ø¬Æ¦Ü­n°Ê¥Î300¤H°Ñ¥[¡C

Wipro¤é¥»ªk¤HÁ`µôªø§À¥¿¾ð»¡¡G¡§¦p¯à¥R¤Àµo´§¦L«×¤À¤½¥qªºÀu¶Õ¡A¶}µo¦¨¥»¥i¥H±±¨î¦b¥Ø«eªº70%¥ª¥k¡C¿n·¥¶i¦æ¶}µo·~°È­«²Õªº¥ø·~¤w±N¦L«×µø¬°¶}µo·~°Èªº¤@Àô¡¨¡C ¹w­pWipro¤é¥»ªk¤H2004¦~«×ªº¾P°âÃB±N¹F¨ì55»õ¤é¤¸¥ª¥k¡A¤ñ¤W¤@¦~«×¼Wªø30%¡C¹ï©ó¾Ö¦³3¸U2000¦W¹µ­ûªº¾ã­ÓWipro¤½¥q¨Ó»¡¡A«Ü¦n¦a§â´¤¦í¤F·~°ÈÃþ³nÅé¶}µo»P¨t²ÎºÞ²zµ¥¶µ¥Ø¶}µo¤§¶¡ªº¥­¿Å¡A¥»¦~«×ªº¾P°âÃB±N¦b¤W¤@¦~«×588»õ¿c¤ñ¡]¬ù1352»õ¤é¤¸¡^°ò¦¤W¼Wªø42%¡C¦b¤é¥»Áö»¡¹F¨ì¤F30%ªº¦~¼Wªø²v¡A¦ý¤´»°¤£¤W¾ã­Ó¤½¥qªº¼Wªø²v¡A¥Ñ¦¹¤]¥i¥H¬Ý¥X¸Ó¤½¥qªº±j«lµo®i¶ÕÀY¡C

¦L«×ªº¥~¥]·~°Èªº¥[³tµo®i¬O¦b2001¦~ªº9.11®£©Æ¨Æ¥ó¤§«á¡A¬ü°ê¶}©l¹ï¥~°ê¤HªºÃ±ÃÒ¥[±j¤F­­¨î¡C¦b¦¹¤§«e¾Ö¦³¼Æ²z±M·~Àu¶Õªº¦L«×ºë­^¦b¨«¥X¤j¾Ç®Õªù«á¨ì¬ü°ê¯d¾Ç¡AµM«á¦bª¿¨¦µ¥¦a¤u§@¡B³Ð·~¡C³Ì¿³²±®É´Á¦b¬ü°ê¦³100¸U¦L«×¸Ç©~¥Á¡C©~¦í¦b¥~°êªº¦L«×¤H³QºÙ¬°¡§NRI¡]«D±`¦í¦L«×¤H¡^¡¨¡A¾Ú»¡¤­¤j¬w¦X­p¶W¹L¤F2000¸U¤H¡C ³o¨Ç¤H¥Ñ©óñÃÒ°ÝÃD¦bªð¦^¦L«×«á­n»ò¶i¤J·í¦a¥ø·~¡A­n»ò³q¹L­·ÀI¸ê¥»¶i¦æ³Ð·~¡A©Ó±µ°ê¥~ªº¥~¥]·~°È¡C¦¹®É¥~¥]·~°Èªº½d³ò¤]¤w¸gÂX¤j¡C¨Ò¦p¡A¦b³W¹º»P¤g¤ì«Ø¿vµ¥¤è­±¡A¦³ªº¥ø·~±N³¡¤À³]­p©e°Uµ¹¦L«×¨Ó­°§C¦¨¥»¡C¨îÃIJ£·~¬É¶V¨Ó¶V¦hªº¥ø·~¦b¦L«×¶i¦æÁ{§É¶}µo¡C¦Ó¬ü°ê³q¥Î¹q¾¹¡]GE¡^¡B¼¯¦«Ã¹©Ô¡B³q¥Î¨T¨®¡]GE¡^µ¥¤]»{ÃѨì¤F¦L«×¤Hªº¯À½è¡A¶}©l¦b¦L«×³]¥ß¬ã¨s¾÷ºc¡C

ÁaÆ[1991¡ã2003¦~ªº¥~°êª½±µ§ë¸ê¡A¬ü°ê¦û20%¡A¬°5743»õ¿c¤ñ¡]¬ù1.3209¸U»õ¤é¤¸¡^¡C¤é¥»¶È¦û4%¡A¤£¤Î¬ü°êªº1/5¡C»P¦L«×ªº­ì©v¥D°ê­^°ê¥H¤Îªñ¨Ó¤£Â_ÂX¤j§ë¸êªºÁú°ê¬Û¤ñ¡A¤é¥»ªº¼vÅT¤O¤´Åã±o«D±`¤p¡C5¤ë¥÷½Ï¥Íªº°Ò²öº~¡P¨¯®æ¬F©²¬°ºû«ù¸gÀÙµo®i¶ÕÀY¡A¥¿¦bÄ~Äò©ñ¼e¹ï¥~¸ê¥ø·~ªº­­¨î¡A¤µ«á¤é¥»¥ø·~¦b³o­Ó°ª³t¦¨ªøªº¥«³õ±N·|¾Ö¦³«ç¼Ëªº¦ì¸m©O¡H

¶W¹L¤¤°êªºµo®i¼ç¤O

³Ì¯à»¡©ú¦L«×»P¤¤°ê¤§¶¡®t¶Zªº´N¬O©Ò§l¤Þ¨ìªºª½±µ§ë¸ê¡C¦b³o¤è­±¡A¦L«×¬°30»õ¬ü¤¸¡A¦Ó¤¤°ê«h°ª¹F530»õ¬ü¤¸¡B¬°¦L«×ªº17­¿¥H¤W¡C¤¤°ê¹ï¥~¸ê¤j¶}ªù¤á¡A¨Ã¥H¥~¸ê¬°°ò¦¹ê²{¤F¸gÀÙªº°ª³t¼Wªø¡C¥Ø«e¡AÁöµM¤¤°ê¤H¤f¬ù¬°¦L«×ªº1.2­¿¡A¦ÓGDP«o¤j¬ù¬°¦L«×ªº2.5­¿¡C¨â°ê¶¡¤H§¡GDP¦s¦b¤@­¿¥H¤Wªº®t¶Z¡A¤â¾÷´¶¤Î²v¤è­±¦L«×¤]¥u¦³5.2%¡A»P¤¤°êªº32.8%¬Û¥h¬Æ»·¡C

¦L«×¦b°ò¦³]¬I«Ø³]¤è­±¤]¬Û·í¸¨«á¡A³o¤è­±¦ô­p¦Ü¤Ö¤]±o§ë¤J33¸U»õ¤é¤¸¡]¬ù¦X©ó¤H¥Á¹ô25380»õ¤¸¡^ªº¸êª÷¡A¦Ó¦Ü¬°ÃöÁ䪺¬O¬F©²«o¦]°]¬F¦¬¤J¤£¨¬¦Ó§ô¤âµLµ¦¡C­^°ê´í¥´»È¦æ¡]Standard charted Bank¡^¸gÀپǮaHelen Henton«ü¥X¡G¡§¥¢·~²v°ª¹F8%¡A»Ý­n¥X»O¬Fµ¦¡B§ß«ù¥i´£¨Ñ¤j¶q´N·~¾÷·|ªº»s³y·~¡¨¡C ¦¹¥~¡A¥Ø«e¦b¦L«×ÁÙ¤£¤¹³\¥~°ê¤HÁʶR¤£°Ê²£¡C¤£¹L¡A¹´©~°ê¥~ªº¦L«×¤H°£¥~¡C³o¨Ç¤H±N¦Û¤v¦b°ê¥~¿n²Öªº¸êª÷§ë¤J¯ª°ê¡B¬O¦L«×ª½±µ§ë¸êªº¥D¤O¡C¹´©~­^°êªº¦L«×¤H¤T¦~«e¥æ¯Ç7¸U¤é¤¸©wª÷Áʸmªº¤g¦a¤µ¦~´N¥iÂà¤â140¸U¤é¤¸¡C¦b¥«³õ°ª³t¼Wªøªº±¡ªp¤U¡A¥Ñ©ó­±¦V¥~¸êªºªù¤á³Q­­©wªº«Ü¦º¡A©Ò¥H¤~·|¦b¦L«×°ê¤º²£¥Í³oºØ¤£¥¿±`ªº²{¶H¡C¨¯®æ¬F©²­n·Q¹ê²{¥­¿Åªº¸gÀÙ¼Wªø¡A´N¥²¶·¥X»O©ñ¼e¥~¸ê­­¨îªº¬Fµ¦¡C

¦ý¬O¦L«×°ÝÃD±M®a¡B­^°ê¤ÀªR®v§JµÜº¸¡P¦L¯÷¡]­µ¡^»{¬°¡G¡§¾¨ºÞ¥Ø«e¦L«×½T¹ê¸¨«á©ó¤¤°ê¡A¦ý¤µ«á¤¤°ê±N­±Á{»È¦æ¨t²Î¾ã¹yµ¥°ÝÃD¡C¦Ò¼{¨ì¤¤°ê¦b¦¹´Á¶¡ªº¼Wªø³t«×±N©ñ½w¡A¦]¦¹¥i¥H»{¬°¦L«×ªºµo®i¼ç¤O§ó¤j¡¨¡C¦L«×¦b­^°ê²Îªv®É´Á«Ø¥ß¤F§¹µ½ªºªk«ßÅé¨t©M»È¦æ¨t²Î¡A¤@¥¹¶i¤J°ª³t¼Wªø´Á¡A³o¨ÇÀu¶Õ±N¦¨¬°¦L«×¸gÀÙªº±j«l§U±À¾¹¡C

¦Û¦¨­·®æ¡Bµo®i¨³²rªº¤¤°ê³]­p¬É

8/16/2004, ¤é¸gBPºô, ¤é¥»°ê»Ú³]­p¥æ¬y¨ó·|©ó2003¦~7¤ë¦Ü2004¦~3¤ë¦b¤W®ü¤Î¼s¦{¨â¦a¥H¥]¬A100®a²£«~³]­pÃþ³]­p¨Æ°È©Ò¦b¤º¡BÁ`­p356®a³]­p¨Æ°È©Ò¬°¹ï¶H¡A³q¹L°Ý¨÷©M±Ä³Xªº¤è¦¡¶i¦æ¤F¤@¦¸½Õ¬d¡C½Õ¬d³ø§i¤w¸g¥H¡m¤¤°ê³]­p·~°È²{ª¬¡n¬°ÃDµo§G¦b¨ó·|ºô¯¸¤W¡C

 

³W¼Ò«æ¼@ÂX¤j

 

±q³o100®a²£«~³]­pÃþ³]­p¨Æ°È©Òªº¦¨¥ß®É¶¡¨Ó¬Ý¡A¦³65%¬O¦b2000¦~¥H«á¡A¦pªG¦A©¹«e±À¡A1995¦~¥H«áªº¤ñ¨Ò°ª¹F90%¡C¥t¾Ú¤W®ü¤Î¼s¦{¤u·~³]­p«P¶i·|ªº±Àºâ¡A¥]¬A¹Ï§Î¡B¸Ë¹¢¦b¤ºªº³]­p¨Æ°È©Ò¼Æ¶q¨â¦a§¡¹F¨ì¤F1¸U®a¡C¤¤°ê³]­p¬É¥i¥H»¡¥¿³B¦b¡§¤jÃz¬µ¡¨¶¥¬q¡A¹w­p¦b2008¦~¥_¨Ê¶ø¹B¥H«e¤´±N«æ¼@ÂX¤j¡C´X¦~«e¥Ñ¨â¤T­Ó¤Hµo°_¦¨¥ß¡B¥Ø«e¤wµo®i¦Ü³W¼Ò¹F50¤H¡ã100¤Hªº¨Æ°È©Ò¹ð¨£¤£ÂA¡C

¡¶¦ñÀHµÛ¤¤°ê°ê¤º¥«³õ»Ý¨DªºÂX¤j¡A³]­p¨Æ°È©Ò¦bªñ¦~¨Ó¦³¤FÅãµÛªº¼W¥[¡C´X¦~«eÁÙ¬O2¡B3¤H¦¨¥ßªº¤½¥q¡A²{¦b¤w¸gµo®i¦¨¬°50¡ã100¤H¡C³o¼Ëªº¨Æ¨Ò¹ð¨£¤£ÂA



¨ä­I´º¦b©ó³]­p»Ý¨DÀHµÛ¸gÀÙªº°ª³t¼Wªø¦Ó¤éÁÍ©ô²±¡A¦P®É¤¤°ê¥ø·~¹ï³]­pªº»{ÃѤ]¥¿¦bµo¥ÍÅܤơC¹L¥h¡A²£«~³]­p¶È¶È¥u¬O¹ï®ü¥~²£«~ªº¼Ò­À¡A¦ý²{¦b¶V¨Ó¶V¦hªº¥ø·~¤w¸g³vº¥»{ÃѨì­n·Q¦b¿E¯PªºÄvª§¤¤Àò³Ó¡A¥²¶·­n¦³¦Û¤v¿W¯Sªº³]­p¡C ½Ð¯d·N¤@¤U¤¤°ê³]­p¬Éªºªø³B¡C¤¤°ê³]­p¬É¤£¦P©ó¤é¥»¼Ò¦¡¡A»P¼Ú¬ü°ê®aªº³]­p¨Æ°È©Ò§ó¥[±µªñ¡C¤]´N¬O»¡¥~³¡³]­p¨Æ°È©Ò©Ó¾áµÛ¤ñ¥ø·~¤º³¡ªº³]­p¤H­û§ó¤jªº§@¥Î¡C¤ñ¦p¤j«¬®a¹q¼t°Ó®üº¸¡A»P¤é¥»³]­p¨Æ°È©Ò¦X¸ê¦¨¥ßªº³]­p¨Æ°È©Ò´N©Ó¾áµÛ¸Ó¤½¥q¥D¤O²£«~ªº³]­p¡C

 

¬°¤F¿Eµo¬¡¤O¡B«d´î¸g¶O¦Ó±qµÛ¦W®a¹q¼t°Ó¡§¬üªº¶°¹Î¡¨¿W¥ß¥X¨Óªº¬üªº¤u·~³]­p¤½¥q¡A§â¯S®íªº³]­p·~°È©M·F¤£§¹ªº³]­p·~°È¥æµ¹»P¤§¦s¦b¦X§@Ãö«Yªº¥~³¡³]­p¨Æ°È©Ò¨Ó°µ¡C¦Ó¬üªº¤u·~³]­p¤½¥q¦Û¨­±q¬üªº¶°¹Î¥H¥~©Ó±µªº³]­p·~°È¤w¸g¹F¨ì¾ã­Ó·~°È¶qªº4¦¨¡C

¶}µo³t«×Áö§Ö¡Aµ¦¹º¯à¤O¤£¨¬

 

»¡¨ì¤¤°ê³]­p¨Æ°Èªº¹ê¤O©M¯Sªø¡A¥D­n¬O¡G­pºâ¾÷¾Þ§@¯à¤O±j¡B¤H­û¡]6¡ã15¤H¥H¤Wªº¨Æ°È©Ò¦ûÁ`¶qªº¬ù9¦¨¡^¥R¨¬¡B¶}µo³t«×§Ö¡C¥t¤@¤è­±¦s¦bªº¯ÊÂI¬O¡A½Õ¬d¡Bµ¦¹º¡B³Ð·N¯à¤O¸û®z¡AÁٶȶȰ±¯d¦b³y«¬³]­pªº¼h¦¸¤W¡F¥Ñ©ó¸gÅç©M§Þ¥©¤£¨¬¡A³]­p½è¶q¤£°ª¡A³]­p¬yµ{¤¤¦U¶¥¬qªº¤u§@¤ñ¸û²ÊÁW¡C ¤¤°ê³]­p¨Æ°È©ÒÁö»¡¦s¦b¤W­z¯ÊÂI¡A¦ý¦³¨Ç¤è­±«hÅý¤H«D±`¸r¼}¡C¤@¬O±q¥~Æ[³]­p¨ìµ²ºc³]­p¡B¸Õ»s¼Ò«¬»s§@¡A¤j¦h´£¨Ñ¤@±øÀs³]­pªA°È¡CÁ|¨Ò¨Ó»¡¡A´X¥G©Ò¦³ªº³]­p¨Æ°È©Ò§¡¾Ö¦³¥i¶i¦æµ²ºc³]­pªº¤uµ{®v¡A¦Ó¥B«Ü¦h¼Ò«¬»s§@³£¥i¥H¦b¨Æ°È©Ò¤º³¡¶i¦æ¡C

¡¶³]­p¤½¥qªº¾ú¥v¤j³£¤ñ¸ûµu,­û¤u¤]³£¦b20·³¥ª¥k¡C¤½¥qªº¸gÀçªÌ¤]¦h¬°30¦h·³


¦A´N¬O¤H­û´¶¹M¤ñ¸û¦~»´¡A³]­p¤H­û³£¬O«C¤@¦â20¨Ó·³ªº¦~»´¤H¡A¸g²z¤]¤j³£30¨Ó·³¡C±q°ê¥~¯d¾Ç¦^°êªº³]­p®v¥H¤Î¦b¥~¸ê³]­p¨Æ°È©Ò¤u§@«á¿W¥ß¥X¨Óªº³]­p®v¶V¨Ó¶V¦h¡A¥L­Ì¤£¶Èºë³q­^»y¡A¦Ó¥BÁÙ«D±`¿n·¥¦a¤Þ¶i¼Ú¬ü­·®æªº³]­pºÞ²z²z©À¡C ¦³¤@®a³]­p¨Æ°È©Ò¡A¤£¶È´£¨Ñ¤ñ¸g²zÁÙ°ªªº«Ý¹J¡B¦bºô¤W¥þ²y©Û¸u¤H§÷¡A¦Ó¥B±Ä¥Î¥þ·sªº·~°ÈÅé¨î--²Õ«Ø¦h­Ó¥Ñ«È¤á¥DºÞ¡B³]­p®v©M¤uµ{®v¦@¦P²Õ¦¨ªº¹Î¶¤¡A¤À§O­t³d¨C­Ó«È¤á¶µ¥Ø¡C¾ÌÂdzoºØ¼ç¦bªº¹ê¤O¥H¤Î§l¦¬³Ì·s³]­pºÞ²z²z©Àªº¿n·¥©Ê¡A¥H¤Î³q¹L¤j¶qÆ[¼¯®ü¥~¡§Àu¨q³]­p¡¨§@«~¡A¤¤°ê³]­p¨Æ°Èªº³]­p¯à¤O¦bµu´Á¤ºÀ³¸Ó·|¨³³t´£°ª¡C ¦ý¬O±q¥Ø«e±¡ªp¨Ó¬Ý¡A¤j³¡¤À¤¤°ê³]­p¨Æ°È©Òªº¹ê¤OÁÙ¤£¯à§¹¥þº¡¨¬¤é¥»¥ø·~ªº³]­p­n¨D¡C¦b¤@®a³]­p¨Æ°È©Ò¤u§@¤W3¦~¥ª¥k¡A¹ï¤u§@¦³©Ò¤F¸Ñ«á¡A¤H­û´N·|¥X¨Ó³æ·F¡A³]­p¨Æ°È©Ò²r¼Wªº­ì¦]´N¦b¦¹¡C¦]¦¹¡A­n·Q§Q¥Î¤¤°êªº³]­p¨Æ°È©Ò¡A¥²¶·¹ï¨ä·~ÁZ¡B§Þ³N¡B§Þ¥©©M¦W®ð°µ¥R¤Àªº¤F¸Ñ¡C

¡§³]­p¡¨¥]¬Aª÷ÄݼҨã³]­p¹Ï

¡¶¤¤°êªº²£«~³]­p¨Æ°È©Ò¡A¤j³£¶i¦æºc³y³]­p©M¼Ò¨ã³]­p¡C¤½¥q¾Ö¦³µ²ºc³]­p³¡ªù¡A¨Ï¥Î¥ú³y«¬³]³Æ©MNC¾÷§É¨Ó»s§@©Ò³]­pªº¼Ò«¬


¥t¤@¤è­±¡A¶i¤J¤¤°êªº¤é¸ê³]­p¨Æ°È©Ò¶}®i·~°Èªº¤èªk«h¤À¬°¨â¤jÃþ¡C¨ãÅé¦Ó¨¥¡A¤@Ãþ¬O¦P¤¤°ê¥ø·~²£¥Í¹L³]­p¶O¥ÎªÈ¯É¡B¥Ø«e¥u»P¥~¸ê¥ø·~¥´¥æ¹Dªº¥ø·~¡F¥t¤@Ãþ¬O³q¹L¥R¹ê¤H­û¡B¥R¤À¦Ò¼{¤¤°ê¹ê»Ú±¡ªp¡A»P¤¤°ê¥ø·~ªº¦X§@·~°Èº¥¤J¨Î¹Òªº¥ø·~¡C ¦b¤¤°ê¶}®i·~°È®É³Ì­«­nªº¬O­n¥R¤À¦Ò¼{¨ì¤¤°ê¦b³]­p·NÃÑ¡B°Ó·~²ßºD¥H¤Î°ê¥Á©Êµ¥¤è­±»P¤é¥»ªº¤£¦P¤§³B¡C¤ñ¦p¡A²£«~Ãþ³]­p¨Æ°È©Ò¦b±µ¨ü·~°È®É¡A¦b¤é¥»°ò¥»¤W¤£·|¶i¦æª÷ÄݼҨ㪺³]­p¡CµM¦Ó»Ý­nª`·Nªº¬O¡A¦b¤¤°ê¤@´£¨ì³]­p¡A³q±`±¡ªp¤U¥]¬A±q³y«¬¨ìª÷ÄݼҨ㪺¥þ³¡³]­p¹Ï¡C ¾Ú±x¡A¾ÕªøCI¡]¥ø·~§Î¶H¡^¾Ô²¤©M«~µP¾Ô²¤¡B¥]¬A¤é¥»¦b¤ºªº²£«~Ãþ¤Î¼s§i»P¹Ï§ÎÃþ¥~¸ê³]­p¨Æ°È©Òªº·~ÁZ¨Ã¤£¤Ó¦n¡C­ì¦]¥i¯à¦b©ó¤¤°ê¥ø·~©|¨S¦³¥R¤À»{ÃѨì³]­p¤u§@¤¤ªºµ¦¹º¤è®×»P³Ð·Nªº­«­n©Ê¡A¦]¦¹¤£Ä@·N¤ä¥I¬ÛÀ³ªº¶O¥Î¡C

®ø¶OªÌ³ß¦n¦]¦a¦Ó²§

¦b¹ï¤¤°ê³]­p¨Æ°È©Ò¶i¦æ½Õ¬dªº¦P®É¡A§Ú­ÌÁÙ¹ï¤é¥»°ê¤ºªº15®a¼t°Ó¶i¦æ¤F±Ä³X¡A´N¨ä¹ïµØ³]­p¾Ô²¤°µ¤F¤@µf¤F¸Ñ¡Cµ²ªGµo²{¡A«Ü¦h¼t°Ó¤w¸g¦b¤¤°ê¦¨¥ß¤F³]­p©Î°Ó«~¶}µo¤¤¤ß¡A©ÎªÌ¤w¸g¨î©w¤F¶i¤J¤¤°êªº­p¹º¡C¦bµØ¦¨¥ß³]­p¤¤¤ß¥i¥H»¡¬O¥vµL«e¨Òªº¨Æ±¡¡A¯S§O­È±o¤@´£¡C¤]¥i¥H»¡³o¬O¤é¥»¥ø·~¤w¸g¶}©l¦æ°Ê¶}©Ý¤¤°ê¥«³õªº©úÃÒ¡C ¹L¥h¤é¥»¥ø·~¶i¤J¤¤°ê¥«³õ®É¡A©¹©¹¹L¦h¦a¦Ò¼{»ù®æ¡A¤£¤Óª`·N¤¤°ê®ø¶OªÌªº¨ãÅé»Ý¨D¡A±À¥X¤@¨Ç¦Ñ¾÷«¬©ÎªÌ¹ï¦Ñ²£«~ªº³¡¤À§Îª¬©MÃC¦âµ¥¶i¦æ¤p´T§ï¶iªº¾÷«¬¡C¦ý¬O¡A¤¤°ê¥Hªu®ü¦a°Ï¬°¥Dªº´I¸Î¶¥¼hªñ¦~¤w¸g¤j´T¼W¥[¡A¦A¥[¤W¤¤°ê¤Hª`­«Åé­±µ¥­ì¦]¡A¹ï±Ä¥Î¥@¬É³Ì·s¬ì§Þ©M³]­pªº°Ó«~»Ý¨D¥¿¨³³t°ªº¦¡C³o´N­n¨D«Ø¥ß¥iº¡¨¬¦¹Ãþ®ø¶OªÌ»Ý¨D©M»ù®æÆ[ªº³]­p¾Ô²¤¡C

¹ê»Ú¤W¡A±q¤w¸g¦b¤¤°ê¥«³õ¤W¨ú±o¦¨¥\ªº5®a¤é¸ê¼t°Ó¨Ó¬Ý¡A§¡±Ä¨ú¤F»P¦Û¨­ªº«~µPª¾¦W«×©M¥Ø¼Ð¥«³õ¬Û¾AÀ³ªº¿W¯S°µªk¡C¦³ªº§Q¥Î¨ä¥þ²y©Êªº«~µPª¾¦W«×¡A¦b¤¤°ê¹ý©³½T¥ß¨ä«~µP¦a¦ì¡F¦³ªº«h³q¹L´£¥X¥þ·sªº¥Í¬¡¼Ò¦¡¡A§Æ±æ¥H¦¹³Ð³y·sªº»Ý¨D¡F±q³]·Qªº®ø¶OªÌ¨Ó¬Ý¡A5®a¼t°Ó¤¤¦³4®a±N¥Ø¼ÐÂê©w¦b´I¸Î¶¥¼h¡A³Ñ¾l1®a«hºË·Ç¤F³B©ó´I¸Î¶¥¼h¤§¤Uªº¤¤¶¡¶¥¼h¡C¥u­n¤ÀªR¤@¤U³o¨Ç¦¨¥\¨Æ¨Ò¡A´N·|µo²{¦b¤¤°ê¥«³õ±Ä¨úªº³]­p¾Ô²¤ÃöÁä¦b©ó¼t°Ó¦Û¨­­n³q¹L¹ï¥«³õ¶i¦æºë¤ß¬ã¨s¡A§ä¥X¦X¾Aªº¥Ø¼Ð¥«³õ¥H¤Î»P¦¹¬Û¾AÀ³ªº°Ó«~¶}µo¤è¦V¡C¤×¨ä­«­nªº¬O³q¹L¹ï¦U¦a°Ï¤£¦Pªº®ø¶OªÌ³ß¦n¶i¦æ·V­«¬ã¨s¡A½T©w³]­p©M°Ó«~¶}µoªº¤è¦V¡C¦b³o¤@ÂI¤W¡A¥»¦a³]­p¨Æ°È©Ò¥i¥H»¡·¥¦³¨Ï¥Î»ù­È¡C

µ½©ó§Q¥Î¡§¤é¥»«~µP¡¨

¦b2008¦~¥_¨Ê¶ø¹B¥H«e¹w­p»P³]­p¬ÛÃöªº¤u§@±N·|¶V¨Ó¶V¦h¡C¤¤°ê¦³400¦h©Ò¤j¾Ç³]¦³³]­p«Y¡A¨C¦~¦VªÀ·|¿é°eªº³]­p±M·~²¦·~¥Í¶W¹L10¸U¤H¡C³o¨Ç¥¼¨Óªº³]­p®vªº°Ñ»P¶i¤@¨B¥[¼@¤F¸Ó»â°ìªºÄvª§¡Aµ²ªG¤w¸g¾É­P³]­p¶O¤£Â_¤U­°¡C¥t¥~¡A¤£¶È¯d¾Ç¦^°êªº¡§®üÂk¬£¡¨¥¿¦b¤£Â_¼W¥[¡A¦Ó¥B¶V¨Ó¶V¦hªº¼Ú¬ü¤Î¨È¬wªº³]­p¨Æ°È©Ò¤]¦b³°Äò¶i¤J¤¤°ê¥«³õ¡C ¦b³oºØ§Î¶Õ¤U¡A¶i¤J¤¤°êªº¤é¥»³]­p¨Æ°È©ÒÀ³·í±Ä¨úªº¾Ô²¤¥]¬A3­Ó­«ÂI¡C

²Ä1ÂI¬O¡§¤é¥»¡¨¦b¤¤°ê¥«³õ¤W¥i¥H·í§@¤@­Ó³q¥Î«~µP¨Ó¨Ï¥Î¡C¡§¤é¥»»s³y¡¨¥NªíµÛ¥þ²y³Ì°ªªº²£«~½è¶q¡A³Ð³y³o¦¹²£«~ªº¤é¥»³]­p®vÀò±oªºµû»ù«D±`°ª¡C³q¹L¦¹¦¸½Õ¬dÁÙ±oª¾¡A¦³«Ü¦h³]­p¨Æ°È©Ò¼ö°J©ó©Û¸u¤é¥»³]­p®v¡A¨Ã¥BÁÙ´£¨Ñ»·°ª©ó¤¤°ê¥­§¡¤ô¥­ªº°ªÃB¤u¸ê¡C¹ï©ó¦b¥»¦a¶}®i·~°Èªº¤é¥»³]­p¨Æ°È©Ò¡A³Ì¬°­«­nªº¬O§Q¥Î·í¦a¹ï¤é¥»«~µPªº°ª«×µû»ù©Ó±µ·~°È¡AµM«á³q¹L»·»·°ª©ó¤¤°ê³]­p¨Æ°Èªº°ª¤ô¥­¬ð¥X¦Û¨­ªº¯SÂI¡C

 

²Ä2ÂI¬O§Q¥Î¤¤°ê³]­p¨Æ°È©Òªº¯Sªø¡A¿Ñ¨D¤¤¤é¤§¶¡ªº¬Û¤¬¨ó§@¡C¥R¤À§Q¥Î¤¤°ê³]­p¨Æ°È©Ò¨ã³Æªº±j¤jªº­pºâ¾÷¾Þ§@¯à¤O¡AÂ×´Iªº¤H§÷¸ê·½¡A¥H¤Î§Ö³tªº¶}µoµ¥¯SÂI¡A½T¥ß³o¼Ëªº·~°È¾Ô²¤«D±`­«­n¡C

²Ä3ÂI¬O¤H»ÚÃö«Y¡C¤¤°ê³]­p¬Éªº°_ÂI¬O¦b¤j¾Çùس]¥ßªº³]­p¨Æ°È©Ò¡A¤¤°êµ´¤j¦h¼Æ³]­p¨Æ°È©Ò³£¬O¥Ñ³o¸Ì¬£¥Í¥X¨Óªº¡A³oºØ±¡ªp¨ã¦³±Ò¥Ü·N¸q¡C¦b¤¤°ê³Ì¦­³Ð¥ß¤u·~³]­p±M·~ªº¦PÀÙ¤j¾Ç¡B¦¿«n¤j¾Ç¡]­ìµL¿ü»´¤u·~¤j¾Ç¡^©M´ò«n¤j¾Ç¬O¤¤°ê³]­p¬Éªº¤T¤j»ó¯ª¡C¦b¤¤°ê¥Ñ©ó®v®{Ãö«Y»·»·¶W¥X¤é¥»¡A¦]¦¹¹M§G¥þ°êªº³]­p®vÃö«Yºô±N·|«D±`¦³¥Î¡C
¡@¡@

¡¶¹qµø±µ¦¬¾÷¡C¼t®a:ªø­i¡A³]­p¤½¥q:«ü«n³]­p

¡¶Åç¶r¾÷¡C¼t®a:ªFªÛ¡A³]­p¤½¥q:³y«¬§{

¡¶¯È´C¼s§i¡C¼t®a:¤W®ü¥@³Õ·|²Õ©e·|¡A³]­p¤½¥q:¤W®ü¬ü³N³]­p

¡¶¬ü®e¾¹¡C¼t®a:ªø­i¡A³]­p¤½¥q:¤W®ü¬P¨q³]­p¿Ô¸ß

¡¶«~µP³]­p¡C¼t®a:¤W®üª÷®p°s·~¡A³]­p¤½¥q:¤E¤ì¶Ç²±¼s§i

¡¶µ¹¤ô¾÷¡C³]­p¤½¥q:­¸³½²£«~³]­p



TAINANO NEWSLETTER, Issued once per month, Editor & Publisher: Dr. Sinclair T. Wang,
Subscription Rate: NT$100 per issue, Minimum subscription 1 year, Yearly Rate: NT$1,200
Subscription contact: tnn@tainano.com, Website: tainano.com
© 2002--2004 TAINANO, Inc., USA, All Rights Reserved.